<SEC-DOCUMENT>0001193125-24-026790.txt : 20240207
<SEC-HEADER>0001193125-24-026790.hdr.sgml : 20240207
<ACCEPTANCE-DATETIME>20240207170501
ACCESSION NUMBER:		0001193125-24-026790
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240207
DATE AS OF CHANGE:		20240207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sana Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001770121
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-266547
		FILM NUMBER:		24605120

	BUSINESS ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUITE 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		(206) 701-7914

	MAIL ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUITE 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d55600d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Filed Pursuant to Rule 424(b)(5) <BR>Registration No. 333-266547 </I></B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus supplement is not
complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer
to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED FEBRUARY&nbsp;7, 2024 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated May&nbsp;1,
2023) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$125,000,000 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g55600g23i89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. is
offering $125,000,000 of shares of its common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#147;SANA.&#148; The
last reported sale price of our common stock on the Nasdaq Global Select Market on February&nbsp;6, 2024 was $6.29 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging
growth company&#148; as defined under the federal securities laws, and as such, have elected to comply with certain reduced public company reporting requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><I>See the section titled &#147;<A HREF="#supptoc55600_5">Risk Factors</A>&#148; beginning on page&nbsp;S-11&nbsp;of this prospectus supplement and in the
documents incorporated or deemed to be incorporated by reference into this prospectus supplement and the accompanying prospectus, to read about factors you should consider before deciding to invest in shares of our common stock. </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and
commissions<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriters&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-22</FONT> for additional
information regarding underwriter compensation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have granted the underwriters an option for a period of 30 days to purchase up to an
additional $18,750,000&nbsp;of shares of our common stock at the public offering price set forth above, less underwriting discounts and commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
underwriters expect to deliver the shares against payment in New York, New York on or about February &#8195;, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"><B>Morgan&nbsp;Stanley</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>BofA&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>February &#8195;, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Prospectus Supplement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_1">About This Prospectus Supplement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_2">Market, Industry, and Other Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_3">Prospectus Supplement Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_4">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_5">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_6">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_7">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_9">Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_10">Underwriters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_11">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-33</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_12">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-33</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_13">Where You Can Find Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-33</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptoc55600_14">Incorporation By Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-34</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Prospectus</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_2">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_3">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_6">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_7">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_8">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_9">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_10">GLOBAL SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering of common
stock and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part is the accompanying prospectus,
which gives more general information, some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to both the prospectus supplement and the accompanying prospectus. In this prospectus supplement, as
permitted by law, we &#147;incorporate by reference&#148; information from other documents that we file with the Securities and Exchange Commission, or the SEC. This means that we can disclose important information to you from those documents which
we may file with the SEC from time to time. The information incorporated by reference is considered to be a part of this prospectus supplement and the accompanying prospectus and should be read with the same care. This prospectus supplement
describes the specific details regarding this offering and also adds to and updates information contained in the documents incorporated by reference into the accompanying prospectus. To the extent there is a conflict between the information
contained in this prospectus supplement, on the one hand, and the information contained in any document incorporated by reference filed prior to the date of this prospectus supplement, on the other hand, you should rely on the information in this
prospectus supplement. However, if any statement in one of these documents is inconsistent with a statement in another document having a later date&#151;for example, a document incorporated by reference in this prospectus supplement&#151;the
statement in the document having the later date modifies or supersedes the earlier statement as our business, financial condition, results of operations, and prospects may have changed since the earlier dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not consider any information in this prospectus supplement or the accompanying prospectus to be investment, legal, or tax advice.
You should consult your own counsel, accountants, and other advisers for legal, tax, business, financial, and related advice regarding the purchase of the common stock offered by this prospectus supplement. If the description of the offering varies
between this prospectus supplement and the accompanying prospectus, you should rely on the information contained in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of a &#147;shelf&#148; registration statement that we filed with the SEC.
Under the shelf registration process, we may offer from time to time various securities, of which this offering of shares of our common stock is a part. Such registration statement also includes exhibits that provide more detail on the matters
discussed in this prospectus supplement and the accompanying prospectus. You should read this prospectus supplement, the accompanying prospectus, including the information incorporated by reference and the exhibits filed with the SEC that we have
authorized for use in connection with this offering, in their entirety before making an investment decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the
underwriters have authorized anyone to provide any information other than that contained or incorporated by reference in this prospectus supplement, the accompanying prospectus or in any free writing prospectus prepared by or on behalf of us or to
which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus supplement and the accompanying prospectus do not
constitute an offer to sell, or a solicitation of an offer to purchase, the securities offered by this prospectus supplement and the accompanying prospectus in any jurisdiction to or from any person to whom or from whom it is unlawful to make such
offer or solicitation of an offer in such jurisdiction. The information contained in this prospectus supplement or the accompanying prospectus, or incorporated by reference herein or therein is accurate only as of the respective dates thereof,
regardless of the time of delivery of this prospectus supplement and the accompanying prospectus or of any sale of our common stock. It is important for you to read and consider all information contained in this prospectus supplement and the
accompanying prospectus, including the documents incorporated by reference herein and therein, in making your investment decision. You should also read and consider the information in the documents to which we have referred you in the sections
titled &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by Reference&#148; in this prospectus supplement and in the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are offering to sell, and seeking offers to buy, shares of our common stock only in
jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the common stock in certain jurisdictions may be restricted by law. Persons outside the United
States who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of the common stock and the distribution of this prospectus supplement
and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities
offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We further note that the representations, warranties, and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference in this prospectus supplement or the accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such
agreements, and should not be deemed to be a representation, warranty, or covenant to you. Moreover, such representations, warranties, and covenants were accurate only as of the date when made; therefore, such representations, warranties, and
covenants should not be relied on as accurate representations of the current state of our affairs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When we refer to &#147;Sana
Biotechnology,&#148; &#147;Sana,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; in this prospectus, we mean Sana Biotechnology, Inc. and its subsidiaries, unless otherwise specified. When we refer to
&#147;you,&#148; we mean the potential holders of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SANA BIOTECHNOLOGY,&#148; the Sana Biotechnology logos, and
other trade names, trademarks, or service marks of Sana Biotechnology appearing in this prospectus supplement are the property of Sana Biotechnology. Other trade names, trademarks, or service marks appearing in this prospectus supplement are the
property of their respective holders. Solely for convenience, trade names, trademarks, and service marks referred to in this prospectus supplement appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, and SM symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will
not assert its rights, to these trade names, trademarks, and service marks. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_2"></A>MARKET, INDUSTRY, AND OTHER DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus, including the information incorporated by reference herein, contains estimates,
projections, and other information concerning our industry, our business, and the markets for certain drugs, including data regarding the estimated size of those markets. Information that is based on estimates, forecasts, projections, or similar
methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business,
market, and other data from reports, research surveys, studies, and similar data prepared by third parties, industry, medical and general publications, government data, and similar sources. In some cases, we do not expressly refer to the sources
from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless
otherwise expressly stated or the context otherwise requires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary provides a general overview of selected information and does not contain all of the information you should consider before
buying our common stock. Therefore, you should read the entire prospectus supplement, the accompanying prospectus, and the information incorporated by reference herein and therein, before deciding to invest in our common stock. Investors should
carefully consider the information set forth under &#147;Risk Factors&#148; beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-11</FONT> of this prospectus supplement and in the documents incorporated by reference into this prospectus
supplement as well as our financial statements and related notes incorporated by reference in this prospectus supplement before making an investment decision. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were founded on the belief
that engineered cells will be one of the most important transformations in medicine over the next several decades. The burden of diseases that can be addressed at their root cause through engineered cells is significant. We view engineered cells as
having the potential to be as therapeutically disruptive as biologics to clinical practice. Our long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve
access to cellular and gene-based medicines. We have brought together an experienced group of scientists, engineers, and company builders and combined them with the necessary technologies to move this vision forward. We are developing <I>ex vivo</I>
and <I>in vivo</I> cell engineered cell therapies to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including in oncology, diabetes, autoimmune diseases, and central nervous system disorders, among
others. Our platform progress, broad capabilities, and strong balance sheet enable us to execute on a broad vision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Frequently in
disease, cells are damaged or missing entirely, and an effective therapy needs to replace the entire cell, an approach referred to as cell therapy or <I>ex vivo</I> cell engineering. A successful therapeutic requires an ability to manufacture cells
at scale that engraft, function, and have the necessary persistence in the body. Of these requirements, long-term persistence related to overcoming immunologic rejection of another person&#146;s cells has been the most challenging, which has led
many to focus on autologous, or a patient&#146;s own, cells as the therapeutic source. However, autologous therapies require a complex process of harvesting cells from the patients, manipulating them outside the body, and returning them to the
patient. Products using this approach have had to manage significant challenges such as scalability, product variability, product quality, cost, patient accessibility, and limits on number of cell types that are amenable to this approach. Given
these limitations, rather than using autologous cells to overcome immune rejection, we have invested in creating hypoimmune-modified cells that can &#147;hide&#148; from the patient&#146;s immune system. We are striving to make therapies that use
pluripotent stem cells with our hypoimmune genetic modifications as the starting material, which we then differentiate into a specific cell type, such as a pancreatic islet cell, before treating the patient. Additionally, there are cell types for
which effective differentiation protocols from a stem cell have not yet been developed, such as T cells. For these cell types, instead of starting from a pluripotent stem cell, we can use allogeneic, fully-differentiated cells sourced from a donor
as the starting material to which we then apply our hypoimmune genetic modifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process of repairing and controlling genes in
the body, referred to as gene therapy or <I>in vivo</I> cell engineering, requires <I>in vivo</I> delivery of a therapeutic payload and modification of the genome. There are multiple methods available to modify the genome, but limited ability to
deliver therapeutic payloads <I>in vivo</I>. Thus, delivery of a therapeutic payload is at the core of our strategic focus for our <I>in vivo</I> gene therapy program, with our ultimate goal being the delivery of any payload to any cell in a
specific and repeatable way. Our initial effort is on cell-specific delivery and increasing the diversity and size of payloads. Using our fusogen technology, we have shown in preclinical studies that we can specifically target numerous cell surface
receptors that, when combined with delivery vehicles to form fusosomes, allow cell-specific delivery across multiple different cell types. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the time is right to develop engineered cell therapies across a broad range of
therapeutic areas. Substantial progress in the understanding of genetics, gene editing, protein engineering, stem cell biology, immunology, process analytics, and computational biology have converged to create an opportunity to markedly increase the
breadth and depth of the potential impact of cellular medicines. We are focused on creating transformative engineered cell therapies across a range of therapeutic areas. We are developing a broad pipeline of product candidates, which are summarized
below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g55600g07g07.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Investigator sponsored trial. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Abbreviations: ANCA-associated vasculitis (AAV); chronic lymphocytic leukemia (CLL); extrarenal systemic lupus erythematosus (ERL); Huntington&#146;s disease
(HD); lupus nephritis (LN); multiple myeloma (MM); <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> lymphoma (NHL); <FONT STYLE="white-space:nowrap">Pelizaeus-Merzbacher</FONT> Disease (PMD); secondary progressive multiple sclerosis (SPMS); type
1 diabetes (T1D); worldwide (WW). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical Updates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>SC291 &#150;
ARDENT </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2024, we disclosed initial interim clinical data from our ongoing Phase 1 clinical trial evaluating our
CD19-targeted directed allogeneic chimeric antigen receptor (CAR) T program, SC291, in patients with B-cell mediated autoimmune diseases, including non-Hodgkin&#146;s lymphoma (NHL) and chronic lymphoblastic leukemia (CLL), which we refer to as the
ARDENT trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of January 5, 2024, the cut-off date for our early interim analysis, six patients had been dosed with SC291 and four
patients were evaluable (defined as patients dosed with SC291 who had at least one disease assessment), of whom three were dosed with 60M CAR T cells (Dose Level 1) and the other was dosed with 120M CAR T cells (Dose Level 2). With respect to the
four evaluable patients at these two dose levels, we observed no dose limiting toxicities, no SC291-related serious adverse events, and no incidences of graft versus host disease. We also observed no cytokine release syndrome (CRS) or immune
effector cell-associated neurotoxicity syndrome (ICANS) of any grade or any infections of Grade 3 or higher. Additionally, we observed at least a partial response in three of the patients, including ongoing complete responses in one patient from
Dose Level 1 after three months and the patient from Dose Level 2 after two months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SC291 drug product contains CAR T cells that are
fully edited hypoimmune cells, which we describe as HIP-edited CAR-T cells, along with partially edited cells, which we describe as non-HIP CAR T cells. <I>In vitro</I> testing showed evidence that blood and immune cells from each of the four
evaluable patients had mounted an </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immune response to the non-HIP CAR T cells but not to the HIP-edited CAR T cells. Specifically, HIP-edited CAR T cells from the drug product were not rejected by the innate immune response
mediated by the patient&#146;s natural killer (NK) cells, nor did the patients have T cell or antibody responses that recognized these cells. In contrast, we observed immune responses against the non-HIP CAR T cells in the drug product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Importantly, this evidence suggests that the patients had an intact immune system capable of recognizing allogeneic cells and that the HIP CAR
T cells were able to evade these responses. These results were consistent across all four evaluable patients and provide early support for the idea that the immune evasion profile of our HIP gene edits in multiple pre-clinical models may translate
into human subjects. We believe this observation supports further dose escalation and dose expansion in the ARDENT trial and broader application of our HIP technology in allogeneic cell therapies in other indications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are continuing to enroll and dose patients in the ARDENT trial and expect to share additional data in 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>SC291 &#150; GLEAM </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
November 2023, the FDA cleared our Investigational New Drug application (IND) to evaluate SC291 in patients with lupus nephritis, extrarenal lupus, and antineutrophil cytoplasmic antibody-associated vasculitis, which we refer to as our GLEAM trial.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ongoing ARDENT trial, we have observed the pharmacodynamic effect of peripheral blood B cell depletion, which refers to
diminishing B cell counts in the peripheral blood, associated with SC291 treatment in patients. We believe this may increase the possibility that SC291 treatment may confer similar benefit to patients with B cell-mediated autoimmune disorders as
autologous CD19 CAR T cell therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to share data from the GLEAM trial in 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>SC262 &#150; VIVID </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
January 2024, the FDA cleared our IND to evaluate SC262, our hypoimmune-modified CD22 CAR T program, in patients with relapsed or refractory B-cell malignancies who have received prior CD19 CAR T therapy, which we refer to as our VIVID trial. We
expect to share data from the VIVID trial in 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Pancreatic Islet Cell Program </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2024, we presented data from a study transplanting allogeneic HIP-modified pancreatic islet cells into a fully immunocompetent,
diabetic non-human primate (NHP). Subsequent to diabetes being induced in the NHP with streptozotocin, daily insulin injections were performed to re-establish glucose control. After 78 days, the NHP underwent transplantation of HIP primary islets by
intramuscular injection, resulting in insulin independence without the use of any immunosuppression. As early as one week after the transplantation, the NHP&#146;s serum c-peptide level had normalized, and it remained stable throughout the follow-up
period of six months. The NHP showed tightly controlled blood glucose levels for six months, was completely insulin-independent, and was continuously healthy throughout this period with no use of any immunosuppression. Up to six months following HIP
primary islet transplantation, peripheral blood mononuclear cells and serum were obtained from the NHP for immune analyses. HIP primary islets showed no T cell recognition, no graft-specific antibodies, and were protected from NK cell and macrophage
killing. To demonstrate that the NHP&#146;s insulin-independence was fully dependent on the HIP primary islets and that there was no regeneration of the animal&#146;s endogenous islet cell population, we triggered the destruction of the HIP primary
islets using a CD47-targeting antibody. This resulted in a loss of glycemic control and return to exogenous insulin dependence. We believe these data demonstrate potential evidence for immune evasion of HIP primary islets, graft-mediated
insulin-independence of the diabetic NHP, and a potential safety strategy. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2023, the Swedish Medical Products Agency authorized a clinical trial
application for an investigator-sponsored, first-in-human study (IST) evaluating UP421, an allogeneic, primary islet cell therapy engineered with our HIP technology, in patients with type 1 diabetes mellitus. Subjects in this study will receive no
immunosuppression. We expect data from the IST to be shared in 2024. We believe that immunology insights gained from the IST, particularly with respect to whether HIP modifications lead to long-term survival and evasion of either allogeneic or
autoimmune killing of the transplanted cells, may provide direct insights applicable to our preclinical-stage pluripotent stem cell-derived hypoimmune pancreatic islet product candidate, SC451. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Preliminary Financial Information (Unaudited) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our financial statements for the quarter and year ended December&nbsp;31, 2023 will not be available until after this offering is completed and
consequently will not be available to you prior to investing in our securities. Based upon preliminary estimates and information available to us as of the date of this prospectus supplement, we had approximately $205.4&nbsp;million of cash, cash
equivalents and marketable securities as of January&nbsp;2, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This estimate of our cash, cash equivalents and marketable securities
as of January&nbsp;2, 2024 is preliminary, has not been audited, is based on information available to us only as of the date of this prospectus supplement, and is subject to change. Additional information and disclosure would be required for a more
complete understanding of our financial position as of January&nbsp;2, 2024. Our independent registered public accounting firm has not audited, reviewed, or performed any procedures with respect to this preliminary information and, accordingly, does
not express an opinion or any other form of assurance about it. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate and Other Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were founded in July 2018 as a Delaware corporation. Our principal executive offices are located at 188&nbsp;East Blaine Street, Suite 400,
Seattle, Washington 98102, and our telephone number is (206) <FONT STYLE="white-space:nowrap">701-7914.</FONT> Our website address is www.sana.com. The information on, or that can be accessed through, our website is not part of this prospectus
supplement and is not incorporated by reference herein. We have included our website address as an inactive textual reference only. We also use our website as a means of disclosing material <FONT STYLE="white-space:nowrap">non-public</FONT>
information and for complying with our disclosure obligations under Regulation FD. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). We will remain an emerging
growth company until the earlier of (i)&nbsp;December&nbsp;31, 2026, (ii)&nbsp;the last day of the year in which we have total annual gross revenue of at least $1.235&nbsp;billion, (iii)&nbsp;the last day of the year in which we are deemed to be a
&#147;large accelerated filer&#148; as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2&nbsp;under</FONT> the Securities Exchange Act of 1934, as amended (the Exchange Act), which would occur if the market value of our common stock held <FONT
STYLE="white-space:nowrap">by&nbsp;non-affiliates&nbsp;exceeded</FONT> $700.0&nbsp;million as of the last business day of the second fiscal quarter of such year or (iv)&nbsp;the date on which we have issued more than $1.0&nbsp;billion <FONT
STYLE="white-space:nowrap">in&nbsp;non-convertible&nbsp;debt</FONT> securities during the prior three-year period. An emerging growth company may take advantage of specified reduced reporting requirements and is relieved of certain other significant
requirements that are otherwise generally applicable to public companies. As an emerging growth company, we may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">present only two years of audited financial statements, plus unaudited financial statements for any interim
period, and related management&#146;s discussion and analysis of financial condition and results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">avail ourselves of the exemption from the requirement to obtain an attestation and report from our auditors on
the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act); </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide less extensive disclosure about our executive compensation arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not require <FONT STYLE="white-space:nowrap">stockholder&nbsp;non-binding&nbsp;advisory</FONT> votes on executive
compensation or golden parachute arrangements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">take advantage of extended transition periods to comply with new or revised accounting standards, delaying the
adoption of these accounting standards until they would apply to private companies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, the information in
this prospectus and that we provide to our investors in the future may be different than what you might receive from other public reporting companies. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_4"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>$125,000,000 of shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to purchase additional shares from us </P></TD>
<TD>We have granted the underwriters an option for a period of 30 days from the date of this prospectus supplement to purchase up to an additional $18,750,000 of shares of our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering </P></TD>
<TD>&#8195;&#8195;&#8195;&#8195; shares, or &#8195;&#8195;&#8195;&#8195; shares if the underwriters exercise in full their option to purchase additional shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We estimate that the net proceeds to us from this offering will be approximately $&#8195;&#8195;&#8195;&#8195;million, or approximately $&#8195;&#8195;&#8195;&#8195;million if the underwriters exercise their option to purchase additional shares
in full, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We currently intend to use the net proceeds from this offering, if any, together with our existing cash, cash equivalents, and marketable securities, to fund our ongoing and planned preclinical and clinical development
of our most advanced product candidates, including SC291 and SC262, and support the investigator-sponsored trial of UP421, the continued development of our preclinical product candidates, including SC451 and SC379, and our earlier-stage research
programs, and for working capital and other general corporate purposes. See the section titled &#147;Use of Proceeds&#148; on <FONT STYLE="white-space:nowrap">page&nbsp;S-15</FONT> for more information. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD>You should read the &#147;Risk Factors&#148; section of this prospectus supplement beginning on <FONT STYLE="white-space:nowrap">page&nbsp;S-11</FONT> and the &#147;Risk Factors&#148; sections contained in the accompanying prospectus and in the
documents incorporated by reference herein and therein, including our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2022 and our subsequent Quarterly Reports on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-Q,</FONT> for a discussion of factors to consider carefully before deciding to invest in shares of our common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq trading symbol </P></TD>
<TD>&#147;SANA&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock shown above to be outstanding after this offering is based on
197,062,884 shares of common stock outstanding as of September&nbsp;30, 2023, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">29,385,343 shares of common stock issuable upon exercise of outstanding stock options as of September&nbsp;30,
2023, with a weighted-average exercise price of $6.79 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">359,480 shares of common stock issuable upon exercise of stock options granted subsequent to September&nbsp;30,
2023, with a weighted-average exercise price of $3.97 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,677,955 shares of common stock issuable upon the vesting and settlement of restricted stock units granted as of
September&nbsp;30, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">975,568 shares of common stock issuable upon the vesting and settlement of restricted stock units granted
subsequent to September&nbsp;30, 2023; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">16,456,229 shares of common stock reserved for future issuance under our 2021 Incentive Award Plan as of
September&nbsp;30, 2023, as well as an automatic increase of 9,890,934 shares of common stock available for issuance under the 2021 Incentive Award Plan that became effective on January&nbsp;1, 2024 in accordance with its terms and any additional
automatic increases in the number of shares of common stock reserved for issuance thereunder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,814,262 shares of common stock reserved for future issuance under our 2021 Employee Stock Purchase Plan as of
September&nbsp;30, 2023, as well as an automatic increase of 1,978,186 shares of common stock available for issuance under the 2021 Employee Stock Purchase Plan that became effective on January&nbsp;1, 2024 in accordance with its terms and any
additional automatic increases in the number of shares of common stock reserved for issuance thereunder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
the number of shares outstanding immediately after this offering does not include shares of common stock that we have sold since September&nbsp;30, 2023 and may offer and sell in the future pursuant to our sales agreement dated August&nbsp;4, 2022
(the Sales Agreement), with Cowen and Company, LLC (Cowen), as sales agent, in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;at-the-market&#148;</FONT></FONT> offerings pursuant to the Sales Agreement. Between
October&nbsp;1, 2023 and the date of this prospectus supplement, we sold an aggregate of 150,000 shares of our common stock for net proceeds of approximately $1.1&nbsp;million, after deducting $0.03&nbsp;million of commissions and other offering
expenses payable to Cowen, and up to $119.4&nbsp;million of shares of our common stock remains available for future sale, provided no sales shall be made under the Sales Agreement until the earlier of the underwriters exercising their option to
purchase additional shares in full or the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the date of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the number of shares of our common stock described above assumes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise or settlement of outstanding options and restricted stock units referred to above; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their option to purchase additional shares of our common stock from us.
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. Before making a decision to invest in our common stock, you should consider
carefully the risks and uncertainties described below and discussed under the section captioned &#147;Risk Factors&#148; contained in our most recent annual report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as updated by our subsequent
filings under the Exchange Act, each of which is incorporated by reference in this prospectus supplement and the accompanying prospectus in their entirety, together with other information in this prospectus supplement, and the information and
documents incorporated by reference in this prospectus supplement before you make a decision to invest in our common stock. If any of the following events actually occur, our business, operating results, prospects, or financial condition could be
materially and adversely affected. This could cause the trading price of our common stock to decline and you may lose all or part of your investment. The risks described below are not the only ones that we face. Additional risks not presently known
to us or that we currently deem immaterial may also affect our business operations. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future
periods. If any of these risks actually occurs, our business, financial condition, results of operations or prospects could be harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your
investment. Please also carefully read the section below titled &#147;Special Note Regarding Forward-Looking Statements.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to
This Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Our management team has broad discretion to use the net proceeds from this offering and its investment of these
proceeds may not yield a favorable return. They may invest the net proceeds from this offering in ways with which investors disagree. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will have broad discretion over the use of net proceeds from this offering and could spend the net proceeds in ways our
stockholders may not agree with or that do not yield a favorable return, if at all. If we do not invest or apply the net proceeds from this offering in ways that improve our operating results, we may fail to achieve expected financial results, which
could cause our stock price to decline and could harm our business, financial condition, results of operations, and prospects. Pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that
loses value. For additional details, see the section titled &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>You will experience immediate and
substantial dilution in the net tangible book value per share of the common stock you purchase in this offering. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The public
offering price of our common stock in this offering is substantially higher than the net tangible book value per share of our common stock. Therefore, if you purchase shares of our common stock in this offering, you will pay a price per share that
substantially exceeds our net tangible book value per share after this offering. Based on the public offering price of $&#8195;&#8195;&#8195;&#8195;per share, you will experience immediate dilution of $&#8195;&#8195;&#8195;&#8195;per share,
representing the difference between our as adjusted net tangible book value per share after giving effect to this offering and the public offering price. To the extent outstanding options are exercised, restricted stock units vest and settle or we
raise additional capital, you will incur further dilution. For additional information on the dilution that you will experience immediately after this offering, see the section titled &#147;Dilution.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>We may issue additional equity or convertible debt securities in the future, which may result in additional dilution to you.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent outstanding stock options are exercised, there will be dilution. In addition, in order to raise additional capital,
we expect to in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock. We cannot assure you that we will be able to sell shares
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or other securities in any other offering at a price per share that is equal to or greater than the price per share paid by investors in this offering, and investors purchasing shares or other
securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future transactions
may be higher or lower than the price per share in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Future sales or issuances of our common stock in the public
markets, or the perception of such sales, could depress the trading price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The sale of a substantial number of
shares of our common stock or other equity-related securities in the public markets, or the perception that such sales could occur, could depress the market price of our common stock and impair our ability to raise capital through the sale of
additional equity securities. We may sell large quantities of our common stock at any time pursuant to one or more separate offerings in the future. We cannot predict the effect that future sales of common stock or other equity-related securities
would have on the market price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>We do not currently intend to pay dividends on our common stock, and,
consequently, investors&#146; ability to achieve a return on their investment will depend on appreciation in the price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any future earnings to
support operations and to finance the growth and development of our business. We do not intend to declare or pay any cash dividends on our capital stock in the foreseeable future. As a result, any investment return on our common stock will depend
upon increases in the value of our common stock, which is not certain. There is no guarantee that our common stock will appreciate or even maintain the price at which investors have purchased it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_6"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus, including the documents incorporated by reference or deemed to be incorporated by
reference into this prospectus supplement and the accompanying prospectus, contain forward-looking statements concerning our business, operations, and financial performance and condition, as well as our plans, objectives, and expectations for our
business, operations, and financial performance and condition. Any statements contained, or incorporated by reference, herein that are not statements of historical facts may be deemed to be forward-looking statements. These statements involve known
and unknown risks, uncertainties related to global events and macroeconomic conditions, and other important factors that are in some cases beyond our control and may cause our actual results, performance, or achievements to be materially different
from any future results, performance, or achievements expressed or implied by the forward-looking statements. In some cases, you can identify these statements by forward-looking words such as &#147;aim,&#148; &#147;anticipate,&#148;
&#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;should,&#148;
&#147;would,&#148; or &#147;will,&#148; the negative of these terms, and other comparable terminology. These forward-looking statements, which are subject to risks include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the potential market size and size of the potential patient populations for our
product candidates and any future product candidates, if approved for commercial use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our clinical and regulatory development plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations with regard to our preclinical studies, clinical trials, and research and development programs,
including our beliefs regarding the impact, timing, and availability of data from such studies and trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of commencement and advancement of future preclinical studies, clinical trials, and research and
development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to acquire, discover, and develop product candidates and timely advance them into and through
clinical data readouts and successful completion of clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the potential safety, efficacy, or clinical utility of our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our intentions with respect to and our ability to establish collaborations or partnerships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing or likelihood of regulatory filings and approvals for our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our commercialization, marketing, and manufacturing expectations, including with respect to the buildout of our
manufacturing facility and capabilities and the timing thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impact of future regulatory, judicial, and legislative changes or developments in the United States and foreign
countries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our intentions with respect to the commercialization of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pricing and reimbursement of our product candidates, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential effects of public health crises on our preclinical and clinical programs and business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the impact of global events and macroeconomic conditions on our business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation of our business model and strategic plans for our business and product candidates, including
additional indications that we may pursue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage our growth, including our ability to retain and recruit personnel and maintain
our culture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our
product candidates, including the projected terms of patent protection; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of our expenses, future revenue, capital requirements, needs for additional financing, and ability to
obtain additional capital; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected use of proceeds from our initial public offering and our existing cash, cash equivalents, and
marketable securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance of our third-party suppliers and manufacturers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our anticipated use of proceeds from this offering and our existing cash, cash equivalents and marketable
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future financial performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the duration for which we will be an emerging growth company under the JOBS Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments and projections relating to our competitors and our industry, including competing products; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties, including those listed under the caption &#147;Risk Factors.&#148;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement, the accompanying prospectus and the documents incorporated by reference
herein completely and with the understanding that our actual results may differ materially from what we expect as expressed or implied by our forward-looking statements. In light of the significant risks and uncertainties to which our
forward-looking statements are subject, you should not place undue reliance on or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all.
Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section titled &#147;Risk Factors&#148; and elsewhere in this prospectus supplement, the accompanying prospectus
and the discussion in our most recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> in each of the sections titled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations.&#148; These forward-looking statements represent our estimates and assumptions only as of the dates of this prospectus supplement and are subject to such risks and uncertainties, regardless of the time of delivery of this
prospectus supplement or any sale of our common stock and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after
the date of this prospectus supplement. You should, however, review the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus supplement. See &#147;Where You Can Find More
Information.&#148; For all forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs and opinions on the relevant subject. These
statements are based upon information available to us as of the date of this prospectus supplement, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements
should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds to us from the sale of shares of common stock offered by us in this offering will be approximately
$&#8195;&#8195;&#8195;&#8195;million (or $&#8195;&#8195;&#8195;&#8195;million if the underwriters exercise their option to purchase additional shares in full), after deducting underwriting discounts and commissions and estimated offering expenses
payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently intend to use the net proceeds from this offering, together with our existing cash, cash equivalents, and
marketable securities, to fund our ongoing and planned preclinical and clinical development of our most advanced product candidates, including SC291 and SC262, and support the investigator-sponsored trial of UP421, the continued development of our
preclinical product candidates, including SC451 and SC379, and our earlier-stage research programs, and for working capital and other general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also use a portion of the remaining net proceeds and our existing cash and cash equivalents
<FONT STYLE="white-space:nowrap">to&nbsp;in-license,&nbsp;acquire</FONT> or invest in complementary businesses, technologies, products, or assets. However, we currently have no agreements or commitments to complete any such transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amounts and timing of our actual expenditures of the net proceeds from this offering will depend on numerous factors, including our
development and commercialization efforts with respect to our product candidates, as well as the amount of cash used in our operations. We therefore cannot estimate with certainty the amount of net proceeds to be used for the purposes described
above. We may find it necessary or advisable to use the net proceeds for other purposes, and we will have broad discretion in the application of the net proceeds. Pending the uses described above, we plan to invest the net proceeds, if any, from
this offering in short-term, investment-grade, interest-bearing securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be diluted to the extent of the difference between the public
offering price per share and the as adjusted net tangible book value per share of our common stock after this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our historical
net tangible book value as of September&nbsp;30, 2023 was approximately $365.9&nbsp;million, or $1.86 per share of common stock. Historical net tangible book value per share is determined by dividing our total tangible assets, less total
liabilities, by the number of shares of our common stock outstanding as of September&nbsp;30, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without taking into account any other
changes in our historical net tangible book value after September&nbsp;30, 2023, other than to give effect to the issuance and sale of &#8195;&#8195;&#8195;&#8195; shares of our common stock in this offering at the public offering price of
$&#8195;&#8195;&#8195;&#8195; per share, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of September&nbsp;30, 2023 would have been
$&#8195;&#8195;&#8195;&#8195; million, or $&#8195;&#8195;&#8195;&#8195; per share. This represents an immediate increase of $&#8195;&#8195;&#8195;&#8195; in as adjusted net tangible book value per share to existing stockholders and immediate
dilution of $&#8195;&#8195;&#8195;&#8195; in as adjusted net tangible book value per share to investors purchasing shares of our common stock in this offering. Dilution per share to investors purchasing shares of our common stock in this offering is
determined by subtracting as adjusted net tangible book value per share after this offering from the public offering price per share paid by investors purchasing shares of our common stock in this offering. The following table illustrates this
calculation on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value per share as of September&nbsp;30, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to investors purchasing shares of
common stock in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As adjusted net tangible book value per share after giving effect to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to investors purchasing shares of common stock in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their option to purchase additional shares in full, the dilution in as adjusted
net tangible book value per share to investors purchasing shares of common stock in this offering would be $&#8195;&#8195;&#8195;&#8195; per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing tables and calculations (other than historical net tangible book value) are based on 197,062,884 shares of common stock
outstanding as of September&nbsp;30, 2023, and exclude: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">29,385,343 shares of common stock issuable upon exercise of outstanding stock options as of September&nbsp;30,
2023, with a weighted-average exercise price of $6.79 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">359,480 shares of common stock issuable upon exercise of stock options granted subsequent to September&nbsp;30,
2023, with a weighted-average exercise price of $3.97 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,677,955 shares of common stock issuable upon the vesting and settlement of restricted stock units granted as of
September&nbsp;30, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">975,568 shares of common stock issuable upon the vesting and settlement of restricted stock units granted
subsequent to September&nbsp;30, 2023; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">16,456,229 shares of common stock reserved for future issuance under our 2021 Incentive Award Plan as of
September&nbsp;30, 2023, as well as an automatic increase of 9,890,934 shares of common stock available for issuance under the 2021 Incentive Award Plan that became effective on January&nbsp;1, 2024 in accordance with its terms and any additional
automatic increases in the number of shares of common stock reserved for issuance thereunder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,814,262 shares of common stock reserved for future issuance under our 2021 Employee Stock Purchase Plan as of
September&nbsp;30, 2023, as well as an automatic increase of 1,978,186 shares of common stock available for issuance under the 2021 Employee Stock Purchase Plan that became effective on January&nbsp;1, 2024 in accordance with its terms and any
additional automatic increases in the number of shares of common stock reserved for issuance thereunder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
the number of shares outstanding immediately after this offering does not include shares of common stock that we have sold since September&nbsp;30, 2023 and may offer and sell in the future in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;at-the-market&#148;</FONT></FONT> offerings pursuant to the Sales Agreement. Between October&nbsp;1, 2023 and the date of this prospectus supplement, we sold an aggregate of 150,000 shares of our common stock for net
proceeds of approximately $1.1&nbsp;million, after deducting $0.03&nbsp;million of commissions and other offering expenses payable to Cowen, and up to $119.4&nbsp;million of shares of our common stock remains available for future sale, provided no
sales shall be made under the Sales Agreement until the earlier of the underwriters exercising their option to purchase additional shares in full or the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the date of this
prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any additional shares are issued, including in connection with the exercise of options, the vesting and
settlement of restricted stock units or if the underwriters exercise their option to purchase additional shares of our common stock, you may experience further dilution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The as adjusted information discussed above will be based on the number of shares, the offering price and other terms determined at pricing of
this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_9"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of the material U.S. federal income tax
consequences to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders (as defined below) of the ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax
effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws are not discussed. This discussion is based on the U.S. Internal
Revenue Code of 1986, as amended, or the Code, Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service, or the IRS, in each case in effect as of
the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance that the IRS or a court will not take a contrary position to that
discussed below regarding the tax consequences of the purchase, ownership, and disposition of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is
limited to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that hold our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not
address all U.S. federal income tax consequences relevant to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s particular circumstances, including the impact of the Medicare contribution tax on net investment income and the
alternative minimum tax. In addition, it does not address consequences relevant to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders subject to special rules, including, without limitation: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as part of a
conversion transaction or other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies, and other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers, dealers, or traders in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise
as compensation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership or an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a
partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships
should consult their tax advisors regarding the U.S. federal income tax consequences to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS FOR INFORMATIONAL
PURPOSES ONLY AND IS NOT TAX ADVICE. THE INVESTOR SHOULD CONSULT ITS TAX ADVISOR WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO ITS PARTICULAR SITUATION AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND
DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
UNDER THE LAWS OF ANY STATE, LOCAL, OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Definition of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; is any beneficial owner of our common
stock that is neither a &#147;U.S. person&#148; (as defined below) nor an entity treated as a partnership for U.S. federal income tax purposes. A &#147;U.S. person&#148; is any person that, for U.S. federal income tax purposes, is or is treated as
any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation created or organized under the laws of the United States, any state thereof, or the District of
Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust that (1)&nbsp;is subject to the primary supervision of a U.S. court and the control of one or more
&#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code), or (2)&nbsp;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not anticipate
declaring or paying cash dividends to holders of our common stock in the foreseeable future. However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax
purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and
will first be applied against and reduce a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below
under the heading &#147;Sale or Other Taxable Disposition.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below on effectively connected income,
dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty,
provided the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder furnishes a valid IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or other
applicable documentation) certifying qualification for the lower treaty rate). A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may
obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding their entitlement to benefits under
any applicable income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder are effectively
connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Holder maintains a permanent establishment in the United States to which such dividends are attributable), the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will be exempt from the U.S. federal withholding tax described above. To claim the
exemption from withholding, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder must furnish to the applicable withholding agent a valid IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> certifying that the dividends are
effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular income tax rates. A <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as
adjusted for certain items. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale or Other Taxable Disposition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or
other taxable disposition of our common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct
of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder maintains a permanent establishment in the United States to which such gain is
attributable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is a nonresident alien individual present in the
United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our common stock constitutes a U.S. real property interest, or USRPI, by reason of our status as a U.S. real
property holding corporation, or USRPHC, for U.S. federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point
above generally will be subject to U.S. federal income tax on a net income basis at the regular rates. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or
such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale
or other taxable disposition of our common stock, which may be offset by U.S. source capital losses of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder (even though the individual is not considered a resident of the United States),
provided the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder has timely filed U.S. federal income tax returns with respect to such losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the third bullet point above, we believe we are not, and do not anticipate becoming, a USRPHC. Because the determination of
whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> real property interests and our other business assets, there can be no
assurance we are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder
will not be subject to U.S. federal income tax if our common stock is &#147;regularly traded&#148; (as defined by applicable Treasury Regulations) on an established securities market and such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder
owned, actually and constructively, 5% or less of our common stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition or the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s
holding period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding potentially
applicable income tax treaties that may provide for different rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments of dividends on our common stock will not be subject to backup withholding, provided the applicable withholding agent does not have
actual knowledge or reason to know the holder is a United States person and the holder either certifies its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status, such as by furnishing a valid IRS
<FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> or <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> or otherwise establishes an exemption. However,
information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder, regardless of whether such distributions constitute dividends or
whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding
or information reporting if the applicable withholding agent receives the certification described above and does not have actual knowledge or reason to know that such holder is a United States person or the holder otherwise establishes an exemption.
Proceeds of a disposition of our common stock conducted through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker generally will not be subject to backup withholding or information
reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Copies of information returns that are filed with the IRS may also be made available under
the provisions of an applicable treaty or agreement to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder resides or is established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit
against a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Withholding Tax on Payments Made to Foreign Accounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax
Compliance Act, or FATCA) on certain types of payments made to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> financial institutions and certain other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities. Specifically, a 30% withholding tax
may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#147;foreign financial institution&#148; or a <FONT
STYLE="white-space:nowrap">&#147;non-financial</FONT> foreign entity&#148; (each as defined in the Code), unless (1)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations, (2)&nbsp;the <FONT
STYLE="white-space:nowrap">non-financial</FONT> foreign entity either certifies it does not have any &#147;substantial United States owners&#148; (as defined in the Code) or furnishes identifying information regarding each substantial United States
owner, or (3)&nbsp;the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the
diligence and reporting requirements in (1)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#147;specified United States
persons&#148; or &#147;United States owned foreign entities&#148; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to <FONT STYLE="white-space:nowrap">non-compliant</FONT>
foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. Under the
applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or
other disposition of stock on or after January&nbsp;1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury
Regulations are issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospective investor should consult its tax advisor regarding the potential application of withholding under
FATCA to their investment in our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS NOT INTENDED TO BE TAX ADVICE. THE PROSPECTIVE INVESTOR SHOULD
CONSULT ITS TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES TO THE PROSPECTIVE INVESTOR OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR COMMON STOCK, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, OR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> TAX LAWS AND ANY U.S. FEDERAL <FONT STYLE="white-space:nowrap">NON-INCOME</FONT> TAX LAWS. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_10"></A>UNDERWRITERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms and subject to the conditions in an underwriting agreement dated the date of this prospectus supplement, the underwriters
named below, for whom Morgan Stanley&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, Goldman Sachs&nbsp;&amp; Co. LLC and BofA Securities, Inc. are acting as representatives, have severally agreed to purchase, and we have agreed to sell to them,
severally, the number of shares indicated below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and the representatives are collectively referred to as the &#147;underwriters&#148; and the
&#147;representatives,&#148; respectively. The underwriters are offering the shares of common stock subject to their acceptance of the shares from us and subject to prior sale. The underwriting agreement provides that the obligations of the several
underwriters to pay for and accept delivery of the shares of common stock offered by this prospectus supplement are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are obligated to
take and pay for all of the shares of common stock offered by this prospectus supplement if any such shares are taken. However, the underwriters are not required to take or pay for the shares covered by the underwriters&#146; option to purchase
additional shares described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters initially propose to offer part of the shares of common stock directly to the public
at the offering price listed on the cover page of this prospectus supplement and part to certain dealers. After the initial offering of the shares of common stock, the offering price and other selling terms may from time to time be varied by the
representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus supplement, to
purchase up to&#8195;&#8195;&#8195;&#8195;additional shares of common stock at the public offering price listed on the cover page of this prospectus supplement, less underwriting discounts and commissions. To the extent the option is exercised, each
underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional shares of common stock as the number listed next to the underwriter&#146;s name in the preceding table bears to the total
number of shares of common stock listed next to the names of all underwriters in the preceding table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the per
share and total public offering price, underwriting discounts and commissions, and proceeds before expenses to us. These amounts are shown assuming both no exercise and full exercise of the underwriters&#146; option to purchase up to an
additional&#8195;&#8195;&#8195;&#8195;shares of our common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No<BR>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full<BR>Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions to be paid by us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The estimated offering expenses payable by us, exclusive of the underwriting discounts and commissions, are
approximately $0.9&nbsp;million. We have also agreed to reimburse the underwriters for expenses relating to clearance of this offering with the Financial Industry Regulatory Authority up to $40,000. In addition, the underwriters have agreed to
reimburse us for approximately $0.9 million of our expenses that we have incurred in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Global Select Market under the trading
symbol&nbsp;&#147;SANA.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and all of our directors and officers and certain of our stockholders have agreed that, without the
prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, Goldman Sachs&nbsp;&amp; Co. LLC and BofA Securities, Inc. on behalf of the underwriters, we and they will not, and will not publicly disclose an intention to,
during the period ending 60 days after the date of this prospectus supplement (the Restricted Period): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend or otherwise transfer, or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">submit or file any registration statement with the SEC relating to the offering of any shares of common stock
or any securities convertible into or exercisable or exchangeable for common stock; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of the common stock, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">whether any such transaction described in clause (1)&nbsp;or (3) above is to be settled
by delivery of common stock or such other securities, in cash or otherwise. In addition, each such person has agreed that, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, Goldman Sachs&nbsp;&amp;
Co. LLC and BofA Securities, Inc. on behalf of the underwriters, each such other person will not, and will not publicly disclose an intention to, during the Restricted Period, make any demand for, or exercise any right with respect to, the
registration of any shares of common stock or any security convertible into or exercisable or exchangeable for common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
restrictions described in the immediately preceding paragraph do not apply to us with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares sold pursuant to the underwriting agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issuance of securities upon the exercise of options or warrants or conversion of any securities outstanding on
the date of this prospectus supplement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">grants of options, restricted stock or other equity awards and issuance of securities to employees, officers,
directors, advisors, or consultants of our company pursuant to a plan in effect on the date of this prospectus supplement, provided that the recipient of such grants shall sign and deliver a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">filing of a Form <FONT STYLE="white-space:nowrap">S-8;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">securities issued in connection with any merger, joint venture, strategic alliances, commercial or other
collaborative transaction or the acquisition or licenses of the business, property, technology or other assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition, provided the
aggregate number of securities that we may issue or agree to issue shall not exceed 5% of our total share capital following this offering, and the recipient of such securities shall sign and deliver a <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">facilitating the establishment of a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan on behalf
of a securityholder, officer or director of our company, provided such plan does not provide for the transfer of securities during the Restricted Period and to the extent a public announcement or filing under the Exchange Act, if any, is required of
or voluntarily made, such announcement or filing shall include a statement to the effect that no transfer of securities may be made under such plan during the Restricted Period; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuance of shares of our common stock in connection with sales under our <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;at-the-market&#148;</FONT></FONT> equity offering program pursuant to the Sales Agreement, provided no sales shall be made under the Sales Agreement until the earlier of the underwriters exercising their option to
purchase additional shares in full or the 30<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> day following the date of this prospectus supplement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described above do not apply to our directors, officers and securityholders
with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transactions relating to our securities acquired in open market transactions or those purchased after the
completion of this offering, provided that no filing under Section&nbsp;16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made in connection with subsequent sales of securities acquired in such open
market transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of our securities as a bona fide gift or to a charitable organization or educational institution in a
transfer not involving a disposition for value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">distributions or transfers of our securities to partners, members, stockholders or affiliates of the
securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">facilitating the establishment of a trading plan on behalf of a shareholder, officer, or director of the
company pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of our securities, provided that (i)&nbsp;such plan does not provide for the transfer of our securities during the Restricted
Period, (ii)&nbsp;no filing or notification by any party under the Exchange Act or other public announcement shall be made voluntarily in connection with such transfer or distribution and (iii)&nbsp;any required public announcement or filing under
the Exchange Act regarding the establishment of such plan during the Restricted Period shall include a statement that the undersigned is not permitted to transfer, sell or otherwise dispose of securities under such plan during the Restricted Period
in contravention of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of shares of securities pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT>
plan; provided that such plan was established prior to the execution of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, and the existence and details of such plan were communicated to the representatives and their counsel; provided,
further, that if any filing under Section&nbsp;16(a) of the Exchange Act is required to be made in connection with such transfer or disposition, it shall indicate that such transfer or disposition was pursuant to a
<FONT STYLE="white-space:nowrap">10b5-1</FONT> plan and no other public announcement shall be required or shall be made voluntarily in connection with such transfer or disposition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of our securities to any member of the immediate family of the securityholder or any
trust for the direct or indirect benefit of the securityholder or the immediate family of the securityholder in a transaction not involving a disposition for value; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of our securities (i)&nbsp;by will, other testamentary document or intestate
succession to the legal representative, heir, beneficiary or a member of the immediate family of the securityholder upon the death of the securityholder, provided no filing or notification by any party under the Exchange Act or other public
announcement shall be required or shall be made voluntarily in connection with such transfer or distribution, and (ii)&nbsp;by operation of law pursuant to orders of a court or other regulatory agency, in connection with a negotiated divorce
settlement or pursuant to a qualified domestic relations order, provided no public filing, report or announcement shall be voluntarily made and if any filing under Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership
of our securities is required, it shall indicate in the footnotes thereto the nature and conditions of such transfer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of our securities to any corporation, partnership, limited liability company or other
entity all of the beneficial ownership interests of which are held by the securityholder or the immediate family of the securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers to the securityholder&#146;s affiliates or to any investment fund or other entity controlled or
managed by, controlling or managing, or under common control with, the securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of our securities to the Company pursuant to any contractual arrangement in effect on
the date of this prospectus supplement and disclosed to the representatives in writing that provides for the repurchase of the securityholder&#146;s common stock or other securities by us or in connection with the termination of the
securityholder&#146;s employment with or service to us; provided that </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
(i)&nbsp;the repurchase price for any such shares or securities shall not exceed the original purchase price (subject to appropriate adjustment in the event of any stock dividend, stock split,
combination or other similar recapitalization) paid, and (ii)&nbsp;if the securityholder is required to file a report reporting a reduction in beneficial ownership of shares of common stock during the Restricted Period, the securityholder shall
clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and no public filing, report or announcement shall be voluntarily made; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers or dispositions of our securities to us in connection with the exercise of any option or warrant for,
shares of our common stock (by way of &#147;net&#148; or &#147;cashless&#148; exercise solely to cover withholding tax obligations in connection with such exercise or transfer to the Company for the payment of taxes as a result of such exercise) or
transfers or dispositions of our securities to cover tax withholding obligations of the securityholder in connection with a vesting or settlement of our securities; provided that (i)&nbsp;such option or warrant is described in this prospectus
supplement (including the documents incorporated by reference herein), or was granted under a stock incentive plan or other equity award plan, which plan is described in this prospectus supplement (including the documents incorporated by reference
herein), (ii) any such shares of common stock received by the securityholder shall be subject to the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement and (iii)&nbsp;if the securityholder is required to file a report reporting a
reduction in beneficial ownership of shares of our common stock during the Restricted Period, the securityholder shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and that the
shares of common stock received upon exercise of the stock option or warrant or vesting event are subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, and no public filing, report or announcement shall be voluntarily made;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exercise on a cash basis of options to purchase shares of our common stock granted under any stock
incentive plan or other equity award plan of the company disclosed in this prospectus supplement (including the documents incorporated by reference herein), provided that the underlying shares shall continue to be subject to the restrictions on
transfer set forth in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, and provided further that any filing under Section&nbsp;16(a) of the Exchange Act with regard to this clause (k)&nbsp;shall clearly indicate in the footnotes
thereto that the filing relates to the circumstances described in this clause (k)&nbsp;and no public filings, report or announcement shall be voluntarily made; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of our securities pursuant to a bona fide third-party tender offer, merger, consolidation or other
similar transaction made to all holders of our common stock and involving a change of control of our company approved by our board of directors, provided that in the event that the tender offer, merger, consolidation or other such transaction is not
completed, the common stock owned by the securityholder shall remain subject to the restrictions contained in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that in the case of any transfer or distribution pursuant to clauses (b), (c), (f), (g), (h) or (i), (x) each transferee, donee or distributee shall
sign and deliver a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, (y)&nbsp;no filing or notification by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act or other public
announcement shall be required or shall be made voluntarily in connection with such transfer or distribution and (z)&nbsp;such transfer shall not involve a disposition for value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, Goldman Sachs&nbsp;&amp; Co. LLC and BofA Securities, Inc., in their sole
discretion, may release the common stock and other securities subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above in whole or in part at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to facilitate the offering of the common stock, the underwriters may engage in transactions that stabilize, maintain or otherwise
affect the price of the common stock. Specifically, the underwriters may sell more shares than they are obligated to purchase under the underwriting agreement, creating a short position. A short sale is covered if the short position is no greater
than the number of shares available for purchase by the underwriters under the option to purchase additional shares. The underwriters can close out a covered short sale by exercising the option to purchase additional shares or purchasing shares in
the open market. In determining the source of shares to close out a covered short sale, the underwriters will consider, among other things, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
open market price of shares compared to the price available under the option to purchase additional shares. The underwriters may also sell shares in excess of the option, creating a naked short
position. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the
common stock in the open market after pricing that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering, the underwriters may bid for, and purchase, shares of common stock in the open
market to stabilize the price of the common stock. These activities may raise or maintain the market price of the common stock above independent market levels or prevent or retard a decline in the market price of the common stock. The underwriters
are not required to engage in these activities and may end any of these activities at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the underwriters have agreed to
indemnify each other against certain liabilities, including liabilities under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A prospectus supplement in electronic
format may be made available on websites maintained by one or more underwriters, or selling group members, if any, participating in this offering. The representatives may agree to allocate a number of shares of common stock to underwriters for sale
to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters that may make Internet distributions on the same basis as other allocations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates
have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. For example, certain of the underwriters also
served as underwriters in our initial public offering in February 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their various business
activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their
own account and for the accounts of their customers and may at any time hold long and short positions in such securities and instruments. Such investment and securities activities may involve our securities and instruments. The underwriters and
their respective affiliates may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long or short
positions in such securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the European Economic Area </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area, or, each a Member State, no shares of common stock have been offered or will be
offered pursuant to the offering to the public in that Member State prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the competent authority in that Member State or, where appropriate,
approved in another Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation, except that offers of common stock shares may be made to the public in that Member State at any time
under the following exemptions under the Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the underwriters; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares of common stock shall require us or any underwriter to publish a
prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation and each person who initially acquires any shares or to whom any offer is made will be deemed to have
represented, acknowledged and agreed to and with each of the underwriters and us that it is a &#147;qualified investor&#148; within the meaning of Article 2(e) of the Prospectus Regulation. In the case of any shares of common stock being offered to
a financial intermediary as that term is used in the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of common stock acquired by it in the offer have not been
acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any shares of common stock
to the public other than their offer or resale in a Member State to qualified investors as so defined or in circumstances in which the prior consent of the underwriters have been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to shares in any Member State means the
communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the
expression &#147;Prospectus Regulation&#148; means Regulation (EU)&nbsp;2017/1129. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No shares of common stock have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior
to the publication of a prospectus in relation to the common stock which has been approved by the Financial Conduct Authority, except that the common stock may be offered to the public in the United Kingdom at any time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under Article 2 of the U.K. Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the
U.K. Prospectus Regulation), subject to obtaining the prior consent of the representatives of the underwriters for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Section&nbsp;86 of the FSMA, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of the common stock shall require our company or any underwriter to publish a prospectus pursuant to Section&nbsp;85 of the FSMA
or supplement a prospectus pursuant to Article 23 of the U.K. Prospectus Regulation. For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the common stock in the United Kingdom means the communication
in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock and the expression &#147;U.K.
Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the United Kingdom, this prospectus or the accompanying prospectus supplement is being distributed only to, and is directed
only at, and any offer subsequently made may only be directed at persons who are &#147;qualified investors&#148; (as defined in the Prospectus Regulation)&nbsp;(i) who have professional experience in matters relating to investments falling within
Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended, or the Order, and/or (ii)&nbsp;who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within
Article 49(2)(a) to (d)&nbsp;of the Order, or, all such persons together being referred to as relevant persons, or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom
within the meaning of the Financial Services and Markets Act 2000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person in the United Kingdom that is not a relevant person should not act or rely on the
information included in this prospectus or the accompanying prospectus supplement or use it as basis for taking any action. In the United Kingdom, any investment or investment activity that this prospectus or the accompanying prospectus supplement
relates to may be made or taken exclusively by relevant persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined
in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National
<FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the common stock must be made in accordance with an exemption from, or in a transaction not
subject to, the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of
Canada may provide a purchaser with remedies for rescission or damages if this prospectus or the accompanying prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages
are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the
purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of
National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are not required to comply with the disclosure requirements of NI <FONT
STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective
Investors in Russia </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Russian law, shares of common stock may be considered securities of a foreign issuer. Neither we, nor
this prospectus, nor the accompanying prospectus supplement, nor shares of our common stock have been, or are intended to be, registered with the Central Bank of the Russian Federation under the Federal Law No.
<FONT STYLE="white-space:nowrap">39-FZ</FONT> &#147;On Securities Market&#148; dated April&nbsp;22, 1996 (as amended, the &#147;Russian Securities Law&#148;), and none of the shares of our common stock are intended to be, or may be offered, sold or
delivered, directly or indirectly, or offered or sold to any person for reoffering or <FONT STYLE="white-space:nowrap">re-sale,</FONT> directly or indirectly, in the territory of the Russian Federation or to any resident of the Russian Federation,
except pursuant to the applicable laws and regulations of the Russian Federation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information provided in this prospectus or the
accompanying prospectus supplement does not constitute any representation with respect to the eligibility of any recipients of this prospectus or the accompanying prospectus supplement to acquire shares of our common stock under the laws of the
Russian Federation, including, without limitation, the Russian Securities Law and other applicable legislation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus or the
accompanying prospectus supplement is not to be distributed or reproduced (in whole or in part) in the Russian Federation by the recipients of this prospectus or the accompanying prospectus supplement. Recipients of this prospectus or the
accompanying prospectus supplement undertake not to offer, sell or deliver, directly or indirectly, or offer or sell to any person for reoffering or <FONT STYLE="white-space:nowrap">re-sale,</FONT> directly or indirectly, shares of our common stock
in the territory of the Russian Federation or to any resident of the Russian Federation, except pursuant to the applicable laws and regulations of the Russian Federation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recipients of this prospectus or the accompanying prospectus supplement understand that respective receipt/acquisition of shares of our common
stock is subject to restrictions and regulations applicable from the Russian law perspective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock
exchange or regulated trading facility in Switzerland. This prospectus or the accompanying prospectus supplement does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance
prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility
in Switzerland. Neither this prospectus, nor the accompanying prospectus supplement nor any other offering or marketing material relating to the common stock or the offering may be publicly distributed or otherwise made publicly available in
Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this prospectus supplement nor the accompanying prospectus supplement, nor any other offering or marketing material
relating to the offering, us or the common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this prospectus or the accompanying prospectus supplement will not be filed with, and the offer of common
stock will not be supervised by, the Swiss Financial Market Supervisory Authority, or FINMA, and the offer of common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or CISA. The investor
protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice
to Prospective Investors in the Dubai International Financial Centre (DIFC) </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus or the accompanying prospectus
supplement relates to an Exempt Offer in accordance with the Markets Rules 2012 of the Dubai Financial Services Authority (DFSA). This prospectus or the accompanying prospectus supplement is intended for distribution only to persons of a type
specified in the Markets Rules 2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this
prospectus, nor the accompanying prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this prospectus or the accompanying prospectus supplement. The securities to which this prospectus or the
accompanying prospectus supplement relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the
contents of this prospectus or the accompanying prospectus supplement you should consult an authorized financial advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to
its use in the DIFC, this prospectus or the accompanying prospectus supplement is strictly private and confidential and is being distributed to a limited number of investors and must not be provided to any person other than the original recipient,
and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the public in the DIFC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
prospectus or the accompanying prospectus supplement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth)
(Corporations Act); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">has not been, and will not be, lodged with the Australian Securities and Investments Commission (ASIC), as a
disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document for the purposes of the Corporations Act; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may only be provided in Australia to select investors who are able to demonstrate that they fall within one or
more of the categories of investors, available under section 708 of the Corporations Act, Exempt Investors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may not be directly or indirectly offered for subscription or purchased or
sold, and no invitations to subscribe for or buy the common stock may be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any shares may be distributed in Australia, except where disclosure
to investors is not required under Chapter 6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for the common stock, you represent and warrant to us that you are
an Exempt Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As any offer of common stock under this prospectus or the accompanying prospectus supplement will be made without
disclosure in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter 6D.2 if none of
the exemptions in section 708 applies to that resale. By applying for the common stock you undertake to us that you will not, for a period of 12 months from the date of issue of the common stock, offer, transfer, assign or otherwise alienate those
common stock to investors in Australia except in circumstances where disclosure to investors is not required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in New Zealand </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock offered hereby have not been offered or sold, and will not be offered or sold, directly or indirectly in New Zealand
and no offering materials or advertisements have been or will be distributed in relation to any offer of shares in New Zealand, in each case other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to persons whose principal business is the investment of money or who, in the course of and for the purposes of
their business, habitually invest money; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to persons who in all the circumstances can properly be regarded as having been selected otherwise than as
members of the public; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to persons who are each required to pay a minimum subscription price of at least NZ$500,000 for the shares
before the allotment of those shares (disregarding any amounts payable, or paid, out of money lent by the issuer or any associated person of the issuer); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in other circumstances where there is no contravention of the Securities Act 1978 of New Zealand (or any
statutory modification or <FONT STYLE="white-space:nowrap">re-enactment</FONT> of, or statutory substitution for, the Securities Act 1978 of New Zealand). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than
(i)&nbsp;to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or the SFO, of Hong Kong and any rules made thereunder; or (ii)&nbsp;in other circumstances which do not result in
the document being a &#147;prospectus&#148; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong), or the CO, or which do not constitute an offer to the public within the meaning of the CO. No
advertisement, invitation or document relating to the common stock has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of
which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares of common stock which are or are intended to be disposed of only to persons
outside Hong Kong or only to &#147;professional investors&#148; as defined in the SFO and any rules made thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective
Investors in Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock have not been and will not be registered pursuant to Article 4, Paragraph 1 of the
Financial Instruments and Exchange Act. Accordingly, none of the common stock nor any interest therein </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#147;resident&#148; of Japan (which term as used herein means any person resident in Japan, including
any corporation or other entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to
an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Singapore SFA Product Classification &#151; In connection with Section&nbsp;309B of the SFA and the CMP Regulations 2018, unless otherwise
specified before an offer of shares of common stock, we have determined, and hereby notify all relevant persons (as defined in Section&nbsp;309A(1) of the SFA), that the shares of common stock are &#147;prescribed capital markets products&#148; (as
defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice
<FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has acknowledged
that this prospectus or the accompanying prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, each underwriter has represented and agreed that it has not offered or sold any shares of common stock
or caused the common stock to be made the subject of an invitation for subscription or purchase and will not offer or sell any shares of common stock or cause the common stock to be made the subject of an invitation for subscription or purchase, and
has not circulated or distributed, nor will it circulate or distribute, this prospectus or the accompanying prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the common
stock, whether directly or indirectly, to any person in Singapore other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of
Singapore, as modified or amended from time to time, or the SFA) pursuant to Section&nbsp;274 of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA
and in accordance with the conditions specified in Section&nbsp;275 of the SFA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Where the shares of common stock are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, securities or securities-based derivatives contracts (each term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest
(howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;276(4)(i)(B) of the SFA, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and
Securities-based Derivatives Contracts) Regulations 2018. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the State of Israel this prospectus or the accompanying prospectus supplement shall not be regarded as an offer to the public to purchase
shares of common stock under the Israeli Securities Law, 5728 &#151; 1968, which requires a prospectus to be published and authorized by the Israel Securities Authority, if it complies with certain provisions of Section&nbsp;15 of the Israeli
Securities Law, 5728 &#151; 1968, including, inter alia, if: (i)&nbsp;the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions, or the Addressed Investors; or (ii)&nbsp;the offer is made, distributed or
directed to certain qualified investors defined in the First Addendum of the Israeli Securities Law, 5728 &#151; 1968, subject to certain conditions, or the Qualified Investors. The Qualified Investors shall not be taken into account in the count of
the Addressed Investors and may be offered to purchase securities in addition to the 35 Addressed Investors. The company has not and will not take any action that would require it to publish a prospectus in accordance with and subject to the Israeli
Securities Law, 5728 &#151; 1968. We have not and will not distribute this prospectus or the accompanying prospectus supplement or make, distribute or direct an offer to subscribe for our common stock to any person within the State of Israel, other
than to Qualified Investors and up to 35 Addressed Investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Qualified Investors may have to submit written evidence that they meet the
definitions set out in of the First Addendum to the Israeli Securities Law, 5728 &#151; 1968. In particular, we may request, as a condition to be offered common stock, that Qualified Investors will each represent, warrant and certify to us and/or to
anyone acting on our behalf: (i)&nbsp;that it is an investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728 &#151; 1968; (ii) which of the categories listed in the First Addendum to the Israeli
Securities Law, 5728 &#151; 1968 regarding Qualified Investors is applicable to it; (iii)&nbsp;that it will abide by all provisions set forth in the Israeli Securities Law, 5728 &#151; 1968 and the regulations promulgated thereunder in connection
with the offer to be issued common stock; (iv)&nbsp;that the shares of common stock that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728 &#151; 1968: (a) for its own account; (b)&nbsp;for investment
purposes only; and (c)&nbsp;not issued with a view to resale within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728 &#151; 1968; and (v)&nbsp;that it is willing to provide further evidence of its
Qualified Investor status. Addressed Investors may have to submit written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed Investor&#146;s name, address and passport number or
Israeli identification number. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered by this prospectus supplement will be passed upon for us by Wilson Sonsini
Goodrich&nbsp;&amp; Rosati, P.C., Palo Alto, California. The underwriters are being represented in connection with this offering by Cooley LLP, San Francisco, California. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in our
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, as set forth in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement. Our
financial statements are incorporated by reference in reliance on Ernst&nbsp;&amp; Young LLP&#146;s report, given on their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_13"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, of which
this prospectus supplement and the accompanying prospectus form a part. For further information about us and the securities we are offering under this prospectus supplement, you should refer to the registration statement and the exhibits and
schedules filed with the registration statement. With respect to the statements contained in this prospectus supplement regarding the contents of any agreement or any other document, in each instance, the statement is qualified in all respects by
the complete text of the agreement or document, a copy of which has been filed as an exhibit to the registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file
reports, proxy statements, and other information with the SEC under the Exchange Act. The SEC maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC.
The address of that website is<I></I>&nbsp;www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our website address is sana.com. The information on our website, or that can be
accessed through our website, however, is not, and should not be deemed to be, a part of this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptoc55600_14"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we file with them which means that we can disclose important
information to you by referring you to those documents instead of having to repeat the information in this prospectus supplement or the accompanying prospectus. The information incorporated by reference is considered to be part of this prospectus
supplement and the accompanying prospectus, and later information that we file with the SEC will automatically update and supersede this information. Any statement contained in a previously filed document incorporated by reference will be deemed to
be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained in this prospectus supplement modifies or replaces that statement. We incorporate by reference the documents listed below and any future
information filed (rather than furnished) with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act between the date of this prospectus supplement and the termination of this offering, including all such reports and other documents
filed with the SEC after the date of the initial filing of the registration statement of which this prospectus forms a part and prior to the effectiveness of such registration statement, provided, however, that we are not incorporating any
information furnished under Item&nbsp;2.02 or Item&nbsp;7.01 of any current report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K:</FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000156459023003798/sana-10k_20221231.htm">December
<U></U>&nbsp;31, 2022</A>, filed with the SEC on March&nbsp;16, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sections of our Definitive Proxy Statement on Schedule 14A for the 2023 Annual Meeting of Stockholders filed
with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1770121/000119312523123965/d405750ddef14a.htm">April<U></U>&nbsp;28, 2023</A> incorporated by reference in our 2022 Annual Report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;
10-Q</FONT> for the quarter ended on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000156459023007074/sana-10q_20230331.htm">March<U></U>&nbsp;31, 2023</A>, filed with the SEC on May&nbsp;8, 2023;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;
10-Q</FONT> for the quarter ended on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000095017023038050/sana-20230630.htm">June<U></U>&nbsp;30, 2023</A>, filed with the SEC on August&nbsp;3, 2023;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on <FONT STYLE="white-space:nowrap">Form&nbsp;
10-Q</FONT> for the quarter ended on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000095017023061171/sana-20230930.htm">September<U></U>&nbsp;30, 2023</A>, filed with the SEC on November&nbsp;8, 2023;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;
8-K,</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001770121/000119312523016245/d642303d8k.htm">January<U></U>&nbsp;
26, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001770121/000156459023000832/sana-8k_20230126.htm">January<U></U>&nbsp;
26, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000156459023005548/sana-8k_20230410.htm">April<U></U>&nbsp;
10, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000156459023006600/sana-8k_20230428.htm">April<U></U>&nbsp;
28, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000095017023027254/sana-20230608.htm">June<U></U>&nbsp;
9, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000095017023043683/sana-20230817.htm">August<U></U>&nbsp;
21, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1770121/000119312523253493/d526014d8k.htm">October<U></U>&nbsp;
10, 2023</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001770121/000119312524026692/d180813d8k.htm">February&nbsp;7, 2024</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1770121/000119312521092650/d124805dex43.htm">Exhibit&nbsp;4.3
</A> to the Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2020, filed with the SEC on March&nbsp;24, 2021, including any amendments or reports filed with the SEC for the purposes of
updating this description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC maintains a web site that contains reports, proxy and information statements and
other information about issuers, such as us, who file electronically with the SEC. The address of that website is http://www.sec.gov. These documents may also be accessed on our website at www.sana.com. These website addresses, and the website
addresses included in any documents incorporated by reference herein, are not intended to function as hyperlinks, and the information contained on such websites and on the SEC&#146;s website is not incorporated by reference in this prospectus
supplement and the accompanying prospectus and you should not consider it a part of this prospectus supplement and the accompanying prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will furnish without charge to each person, including any beneficial owner, to whom this prospectus supplement and accompanying prospectus
is delivered, upon written or oral request, a copy of any or all of the documents incorporated by reference in this prospectus supplement and accompanying prospectus but not delivered herewith, including exhibits that are incorporated by reference
to these documents by writing or telephoning us at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sana Biotechnology, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 East Blaine Street, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Seattle, Washington 98102 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(206) <FONT
STYLE="white-space:nowrap">701-7914</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g55600g23i89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>$350,000,000 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell up to
$350,000,000 in the aggregate of the securities identified above from time to time in one or more offerings. This prospectus provides you with a general description of the securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time we offer and sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts,
prices, and terms of the securities. The supplement may also add, update, or change information contained in this prospectus with respect to that offering. You should carefully read this prospectus and the applicable prospectus supplement before you
invest in any of our securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or
more underwriters, dealers, and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers, or agents are involved in the sale of any of the securities, their names and any applicable purchase price,
fee, commission, or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus titled &#147;About this
Prospectus&#148; and &#147;Plan of Distribution&#148; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE &#147;<A HREF="#toc55600_4">RISK FACTORS</A>&#148; ON PAGE&nbsp;6 OF THIS PROSPECTUS AND ANY SIMILAR
SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock
is listed on the Nasdaq Global Select Market under the symbol &#147;SANA.&#148; On March&nbsp;14, 2023, the last reported sale price of our common stock on the Nasdaq Global Select Market was $3.44 per share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is
May&nbsp;1,&nbsp;2023. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_2">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_3">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_6">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_7">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_8">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_9">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_10">GLOBAL SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_11">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_12">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc55600_13">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or the SEC, using a &#147;shelf&#148;
registration process. By using a shelf registration statement, we may sell securities from time to time and in one or more offerings up to a total dollar amount of $350,000,000, as described in this prospectus. Each time that we offer and sell
securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. We may also authorize one or more free writing
prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement or free writing prospectus may also add, update, or change information contained in this prospectus with respect to that
offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable. Before
purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement (and any applicable free writing prospectuses), together with the additional information described under the heading &#147;Where You
Can Find More Information; Incorporation by Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any information or to make any
representations other than those contained in, or incorporated by reference into, this prospectus, any applicable prospectus supplement, or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no
responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should
assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is
accurate only as of the date of that free writing prospectus, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial
condition, results of operations and prospects may have changed since those dates. This prospectus incorporates by reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference, market data and industry
statistics and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have
not independently verified this information. In addition, the market and industry data and forecasts that may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free writing prospectus may
involve estimates, assumptions, and other risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#147;Risk Factors&#148; contained in this prospectus, the applicable prospectus
supplement and any applicable free writing prospectus, and under similar headings in other documents that are incorporated by reference into this prospectus. Accordingly, investors should not place undue reliance on this information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we refer to &#147;Sana Biotechnology,&#148; &#147;Sana,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; in this
prospectus, we mean Sana Biotechnology, Inc. and its subsidiaries, unless otherwise specified. When we refer to &#147;you,&#148; we mean the potential holders of the applicable series of securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;SANA BIOTECHNOLOGY,&#148; the Sana Biotechnology logos, and other trade names, trademarks, or service marks of Sana Biotechnology appearing in this
prospectus are the property of Sana Biotechnology. Other trade names, trademarks, or service marks appearing in this prospectus are the property of their respective holders. Solely for convenience, trade names, trademarks, and service marks referred
to in this prospectus appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, and SM symbols, but those references are not intended to indicate, in any way, that we
will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade names, trademarks, and service marks. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_2"></A>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file reports, proxy
statements, and other information with the SEC. The SEC maintains a website that contains reports, proxy, and information statements and other information about issuers, including us, who file electronically with the SEC. The address of that website
is <I>www.sec.gov</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our website address is <I>www.sana.com</I>. The information on, or accessible through, our website, however, is not, and should
not be deemed to be, a part of this prospectus or any prospectus supplement. We have included our website address as an inactive textual reference only. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the
registration statement. The full registration statement may be obtained from the SEC or us, as provided above. Forms of the indenture and other documents establishing the terms of the offered securities are or may be filed as exhibits to the
registration statement or documents incorporated by reference in the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference
to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Incorporation by
Reference </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC&#146;s rules allow us to &#147;incorporate by reference&#148; information into this prospectus, which means that we can disclose
important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will
automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a
statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We incorporate by
reference our documents listed below and any future filings made by us with the SEC under Sections&nbsp;13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, between the date of this prospectus and the
termination of the offering of the securities described in this prospectus. We are not, however, incorporating by reference any documents or portions thereof, whether specifically listed below or filed in the future, that are not deemed
&#147;filed&#148; with the SEC, including any Compensation Committee report and performance graph or any information furnished pursuant to Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or related exhibits furnished pursuant
to Item 9.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any accompanying prospectus supplement incorporate by reference the
documents set forth below that have previously been filed with the SEC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1770121/000156459023003798/sana-10k_20221231.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A> for the year ended December&nbsp;31, 2022, filed with the SEC on March&nbsp;16, 2023; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;
8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001770121/000119312523016245/d642303d8k.htm">January&nbsp;
26, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0001770121/000156459023000832/sana-8k_20230126.htm">January&nbsp;26, 2023</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in <A HREF="http://www.sec.gov/Archives/edgar/data/1770121/000119312521092650/d124805dex43.htm">Exhibit
 4.3</A> to the Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December 31, 2020, filed with the SEC on March 24, 2021, including any amendments or reports filed with the SEC for the purposes of updating
this description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14, or 15(d) of the
Exchange Act prior to the termination of this offering, including all such reports and other documents filed with the SEC after the date of the initial filing of the registration statement of which this prospectus forms a part and prior to the
effectiveness of such registration statement, but excluding any information furnished to, rather than </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a free copy of any of the documents incorporated by reference in this prospectus by writing or telephoning us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sana Biotechnology, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 East
Blaine Street, Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Seattle, Washington 98102 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(206) <FONT STYLE="white-space:nowrap">701-7914</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to the
filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_3"></A>THE COMPANY </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were founded on the belief that engineered cells will be one of the most important transformations in medicine over the next several decades. Damage to
cells is the underlying pathology of almost every human disease, and we believe the ability to replace or repair damaged cells through cellular engineering can address the underlying root cause of a host of diseases. We view engineered cells as
having the potential to be as&nbsp;therapeutically disruptive as biologics to clinical practice. Our long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly
improve access to cellular and gene-based medicines. We have brought together an experienced group of scientists, engineers, and company builders and equipped them with technologies to move this vision forward. We are developing <I>ex vivo</I> and
<I>in vivo</I> cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, and genetic disorders, among others. We expect
clinical data from our CD19-targeted allogenic chimeric antigen receptor (CAR) T program, SC291, in 2023. We also continue to make progress on developing our cell engineering platforms and advancing our product candidates through preclinical
development, with the goal of submitting multiple Investigational New Drug applications, or INDs, in 2023 and beyond. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Frequently in disease, cells are
damaged or missing entirely, and an effective therapy needs to replace the entire cell, an approach referred to as cell therapy or <I>ex vivo</I> cell engineering. A successful therapeutic requires <FONT STYLE="white-space:nowrap">large-scale</FONT>
manufacturing of cells that engraft, function, and persist in the body. Of these, we view cell persistence as the greatest current limitation to dramatically expanding the impact of this class of therapeutics, and in particular, overcoming the
barrier of immune rejection of transplanted allogeneic cells. This challenge has led many to focus on autologous, or a patient&#146;s own, cells as the therapeutic source. However, autologous therapies require a complex process of harvesting cells
from patients, manipulating them outside the body, and returning them to the patient. Products using this approach have had to manage significant challenges such as scalability, product variability, product quality, cost, patient accessibility, and
limits with respect to the types of cells that are amenable to this approach. Given these limitations, rather than using autologous cells to address the challenge of immune rejection, we have invested in developing our hypoimmune technology to
create cells that can &#147;hide&#148; from the patient&#146;s immune system to enable persistence of allogeneic cells. We are striving to make therapies using pluripotent stem cells with our hypoimmune genetic modifications as the starting
material, which we then differentiate into a specific cell type, such as a pancreatic islet cell, before treating the patient. Additionally, there are cell types for which effective differentiation protocols from a stem cell have not yet been
developed, such as T cells. For such cell types, instead of starting from a pluripotent stem cell, we can use a fully differentiated allogeneic cell, sourced from a donor, as the starting material to which we then apply our hypoimmune genetic
modifications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process of repairing and controlling genes in the body, referred to as gene therapy or <I>in vivo</I> cell engineering, requires both
<I>in vivo</I> delivery of a therapeutic payload and genome modification. Of these, we view effective <I>in vivo </I>delivery as the greatest current limitation to dramatically expanding the impact of this class of therapeutics. To this end, our
initial focus is on cell-specific delivery as well as increasing the diversity and size of payloads, with our ultimate goal being the delivery of any payload, to any cell, in a specific and repeatable way. We have shown in preclinical studies that
our fusogen technology can specifically target numerous cell surface receptors that, when combined with delivery vehicles to form fusosomes, allow cell-specific delivery across multiple different cell types. We have initially chosen to focus our
fusogen technology on two cell types: T cells and hematopoietic stem cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe the time is right to develop engineered cell therapies across a
broad range of therapeutic areas. Substantial progress in the understanding of genetics, gene editing, gene control, protein engineering, stem cell biology, immunology, process analytics, and computational biology have converged to create an
opportunity to markedly increase the breadth and depth of the potential impact of genetic and cellular medicines. We are focused on creating transformative <I>ex vivo</I> and <I>in vivo</I> engineered cell therapies across a range of therapeutic
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
areas. We are in the early stages of development across a broad pipeline of product candidates, which are summarized below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g55600g01q01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were founded in July 2018 as a Delaware corporation. Our principal executive offices are located at 188 East Blaine
Street, Suite 400, Seattle, Washington 98102, and our telephone number is (206) <FONT STYLE="white-space:nowrap">701-7914.</FONT> Our website address is <I>www.sana.com</I>. The information on, or that can be accessed through, our website is not
part of this prospectus and is not incorporated by reference herein. We have included our website address as an inactive textual reference only. We also use our website as a means of disclosing material
<FONT STYLE="white-space:nowrap">non-public</FONT> information and for complying with our disclosure obligations under Regulation FD. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the
risk factors included in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and any subsequent Annual Reports on Form 10-K, Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> or Current Reports on
Form <FONT STYLE="white-space:nowrap">8-K,</FONT> and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information
contained in the applicable prospectus supplement and any applicable free writing prospectus before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered
securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_6"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following summary describes our capital stock and the material provisions of our amended and restated certificate of incorporation, our amended and
restated bylaws, the amended and restated investors&#146; rights agreement to which we and certain of our stockholders are parties, and of the General Corporation Law of the State of Delaware, or the DGCL. Because the following is only a summary, it
does not contain all of the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of incorporation, amended and restated bylaws, and amended and restated investors&#146; rights
agreement, copies of which are incorporated by reference as exhibits to the registration statement of which this prospectus is a part. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 750,000,000 shares of common stock, par value $0.0001 per share, and 50,000,000 shares of preferred stock,
par value $0.0001 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outstanding Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, we had
191,033,332 shares of our common stock outstanding, including 11,675 shares of unvested restricted common stock outstanding as of December 31, 2022, held of record by 53 stockholders. The actual number of stockholders is greater than the number of
record holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other
entities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of our
common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders
of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of <FONT STYLE="white-space:nowrap">66-2/3%</FONT> of the voting power of all of the then outstanding voting stock is required to
take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, such as the provisions relating to amending our amended and restated bylaws, the classified board and director liability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to preferences that may be
applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of our liquidation,
dissolution or winding up, holders of our common stock are entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any
liquidation preference granted to the holders of any then outstanding shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights, Preferences, and Privileges </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of our common stock have no preemptive, conversion, or subscription rights, and there are no redemption or sinking fund provisions applicable to our
common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in
the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has the authority, without further action by our stockholders, to issue up to 50,000,000 shares of preferred stock in one or more series
and to fix the rights, preferences, privileges, and restrictions thereof. These rights, preferences, and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and
the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of our common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and
the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other
corporate action. As of December 31, 2022, no shares of preferred stock were outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, we had outstanding options to purchase an aggregate of 23,686,340 shares of our common stock, with a weighted-average exercise price
of $7.79 per share, under our 2018 Equity Incentive Plan and 2021 Incentive Award Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Units </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, we had 884,878 outstanding restricted stock units subject to vesting conditions under our Restricted Stock Unit Plan and 2021
Incentive Award Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain
holders of shares of our common stock are entitled to certain rights with respect to registration of their shares under the Securities Act. These shares are referred to as registrable securities. The holders of these registrable securities possess
registration rights pursuant to the terms of our amended and restated investors&#146; rights agreement and are described in additional detail below. The registration of shares of our common stock pursuant to the exercise of the registration rights
described below would enable the holders to trade these shares without restriction under the Securities Act when the applicable registration statement is declared effective. We will pay the registration expenses, other than underwriting discounts,
selling commissions and stock transfer taxes, of the shares registered pursuant to the demand, piggyback, and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registrations described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions and limitations, to limit the number
of shares the holders may include. The demand, piggyback, and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights described below will terminate upon the earliest of (i)&nbsp;with respect to each stockholder, such date on which all
registrable shares held by such stockholder may immediately be sold during any <FONT STYLE="white-space:nowrap">90-day</FONT> period pursuant to Rule 144 of the Securities Act, or Rule 144; and (ii)&nbsp;the occurrence of a deemed liquidation event,
as defined in our amended and restated certificate of incorporation, as currently in effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, holders of approximately 82.3 million shares of our common stock were entitled to certain demand registration rights. Certain major
investors holding, collectively, at least 40% of registrable securities may, on not more than two occasions, request that we register all or a portion of their shares, subject to certain specified exceptions. If any of these holders exercises its
demand registration rights, then holders of approximately 82.3 million shares of our common stock are entitled to register their shares, subject to specified conditions and limitations in the corresponding offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that
we propose to register any of our securities under the Securities Act in an underwritten registered offering, either for our own account or for the account of other security holders, the holders of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registrable securities will be entitled to certain &#147;piggyback&#148; registration rights allowing them to include their shares in such registration, subject to specified conditions and
limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">S-3</FONT> Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, holders of approximately 82.3&nbsp;million shares of our common stock were entitled to certain Form
<FONT STYLE="white-space:nowrap">S-3</FONT> registration rights. Certain major investors holding at least 25% of registrable securities may, on not more than two registrations on Form <FONT STYLE="white-space:nowrap">S-3</FONT> within any <FONT
STYLE="white-space:nowrap">12-month</FONT> period, request that we register all or a portion of their shares on Form <FONT STYLE="white-space:nowrap">S-3</FONT> if we are qualified to file a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3,</FONT> subject to specified exceptions. Such request for registration on Form <FONT STYLE="white-space:nowrap">S-3</FONT> must cover securities with an aggregate offering price which equals or exceeds
$15.0&nbsp;million, net of selling expenses. The right to have such shares registered on Form <FONT STYLE="white-space:nowrap">S-3</FONT> is further subject to other specified conditions and limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Provisions of our Amended and Restated Certificate of Incorporation, our Amended and Restated Bylaws, Delaware Law, and Washington
Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some provisions of Delaware law, Washington law, our amended and restated certificate of incorporation, and our amended and restated bylaws could
make the following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could
make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our
shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are
also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or
unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Delaware Business Combination Statute </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have
elected to be subject to Section&nbsp;203 of the DGCL. Section&nbsp;203 prevents an &#147;interested stockholder,&#148; which is defined generally as a person owning 15% or more of a corporation&#146;s voting stock, or any affiliate or associate of
that person, from engaging in a broad range of &#147;business combinations&#148; with the corporation for three years after becoming an interested stockholder unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors of the corporation had previously approved either the business combination or the
transaction that resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, that
person owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, other than statutorily excluded shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following the transaction in which that person became an interested stockholder, the business combination is
approved by the board of directors of the corporation and holders of at least two-thirds of the outstanding voting stock not owned by the interested stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;203, the restrictions described above also do not apply to specific business combinations proposed by an interested stockholder following
the announcement or notification of designated extraordinary transactions involving the corporation and a person who had not been an interested stockholder during the previous three years or who became an interested stockholder with the approval of
a majority of the corporation&#146;s directors, if such extraordinary transaction is approved or not opposed by a majority of the directors who were directors prior to any person becoming an interested stockholder during the previous three years or
were recommended for election or elected to succeed such directors by a majority of such directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 may make it more difficult for a person who would be an interested stockholder to effect
various business combinations with a corporation for a three-year period. Section&nbsp;203 also may have the effect of preventing changes in our management and could make it more difficult to accomplish transactions that our stockholders may
otherwise deem to be in their best interests. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Washington Business Corporation Act </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws of Washington, where our principal executive offices are located, impose restrictions on certain transactions between certain foreign corporations and
significant stockholders. In particular, the Washington Business Corporation Act, or WBCA, prohibits a &#147;target corporation,&#148; with certain exceptions, from engaging in certain &#147;significant business transactions&#148; with a person or
group of persons that beneficially owns 10% or more of the voting securities of the target corporation, an &#147;acquiring person,&#148; for a period of five years after such acquisition, unless the transaction or acquisition of shares is approved
by a majority of the members of the target corporation&#146;s board of directors prior to the time of acquisition. Such prohibited transactions may include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation with, disposition of assets to, or issuance or redemption of stock to or from, the
acquiring person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any termination of 5% or more of the employees of the target corporation as a result of the acquiring
person&#146;s acquisition of 10% or more of the shares; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">allowing the acquiring person to receive any disproportionate benefit as a stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the five-year period, a significant business transaction may take place as long as it complies with certain fair price provisions of the statute or is
approved at an annual or special meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will be considered a &#147;target corporation&#148; so long as our principal executive
office is located in Washington, and: (i)&nbsp;a majority of our employees are residents of the state of Washington or we employ more than one thousand residents of the state of Washington; (ii)&nbsp;a majority of our tangible assets, measured by
market value, are located in the state of Washington or we have more than $50.0&nbsp;million worth of tangible assets located in the state of Washington; and (iii)&nbsp;any one of the following: (a)&nbsp;more than 10% of our stockholders of record
are resident in the state of Washington; (b)&nbsp;more than 10% of our shares are owned of record by state residents; or (c) 1,000 or more of our stockholders of record are resident in the state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we meet the definition of a target corporation, the WBCA may have the effect of delaying, deferring, or preventing a change of control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Election and Removal of Directors; Vacancies </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
directors are elected by a plurality of the votes of the shares of our capital stock present in person or represented by proxy at a meeting and entitled to vote on the election of directors. Because our stockholders do not have cumulative voting
rights, stockholders holding a majority of the shares of our common stock outstanding will be able to elect all of our directors. Our amended and restated certificate of incorporation provides for the removal of any of our directors only for cause
only by an affirmative vote of shares representing not less than a majority of the shares then entitled to vote at an election of directors. Furthermore, any vacancy occurring on our board of directors and any newly created directorship may be
filled only by a majority of the remaining directors in office. This system of electing and removing directors and filling vacancies may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us,
because it generally makes it more difficult for stockholders to replace a majority of the directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Staggered Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors is divided into three classes. The directors in each class serve for a three-year term, one class being elected each year by our
stockholders, with staggered three-year terms. Only one class of directors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Limitation on Action by Written Consent </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
amended and restated certificate of incorporation and our amended and restated bylaws provide that holders of our common stock are not able to act by written consent without a meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Meetings </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated
certificate of incorporation and our amended and restated bylaws provide that special meetings of our stockholders may be called only by the chairman of the board, our chief executive officer (or president, in the absence of a chief executive
officer), or a majority of the directors. Our amended and restated certificate of incorporation and our amended and restated bylaws specifically deny any power of any other person to call a special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forum Selection </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated
certificate of incorporation provides that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (i)&nbsp;any derivative action
or proceeding brought on behalf of us; (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any director, officer, or other employee of our company to us or our stockholders; (iii)&nbsp;any action asserting a claim arising
pursuant to any provision of the DGCL or our amended and restated certificate of incorporation and bylaws; or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine. This provision would not apply to claims brought to
enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, our
amended and restated certificate of incorporation also provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any
complaint asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in our shares of capital stock shall be deemed to have notice of and consented to the foregoing forum
selection provisions. Nothing in our amended and restated certificate of incorporation and amended and restated bylaws preclude stockholders that assert claims under the Exchange Act from bringing such claims in state or federal court, subject to
applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our exclusive forum provision will not relieve us of our duties to comply with the federal securities laws and the rules and regulations
thereunder, and our stockholders will not be deemed to have waived our compliance with these laws, rules, and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The enforceability of similar
federal court choice of forum provisions in other companies&#146; certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find this type of provision to be inapplicable or unenforceable. If a
court were to find either of the choice of forum provisions contained in our amended and restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated
with resolving such action in other jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The choice of forum provisions may limit a stockholder&#146;s ability to bring a claim in a judicial
forum that it finds favorable for disputes with the company or its directors, officers, or other employees, which may discourage such lawsuits against the company and its directors, officers and other employees and result in increased costs for
investors to bring a claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Certificate of Incorporation and Bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The provisions of our amended and restated certificate of incorporation described under &#147;&#151;Election and Removal of Directors; Vacancies,&#148;
&#147;&#151;Stockholder Meetings,&#148; &#147;&#151;Limitation on Action by Written Consent,&#148; &#147;&#151;Limitations of Liability of Directors and Officers and Indemnification Matters,&#148; &#147;&#151;Common Stock&#151;Voting Rights,&#148;
and &#147;&#151; Forum Selection&#148; and provisions relating to amendments to our amended and restated certificate of incorporation may be amended only by the affirmative vote of holders of at least <FONT STYLE="white-space:nowrap">66-2/3%</FONT>
of the voting power of our outstanding shares of voting stock. The affirmative vote of holders of at least a majority of the voting power of our outstanding shares of stock will generally be required to amend other provisions of our amended and
restated certificate of incorporation. The provisions of the DGCL, our amended and restated certificate of incorporation, and our amended and restated bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a
consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management.
It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain provisions of our amended and restated bylaws may generally be altered, amended, or repealed, and new bylaws may be adopted, with the affirmative vote
of a majority of directors present at any regular or special meeting of the board of directors called for that purpose, provided that any alteration, amendment, or repeal of, or adoption of any bylaw inconsistent with specified provisions of the
bylaws, including those related to special and annual meetings of stockholders, action of stockholders by written consent, nomination of directors, transfers of capital stock and dividends requires the affirmative vote of at least <FONT
STYLE="white-space:nowrap">66-2/3%</FONT> of all directors in office at a meeting called for that purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All other provisions of our amended and
restated bylaws may generally be altered, amended, or repealed, and new bylaws may be adopted, with the affirmative vote of holders of <FONT STYLE="white-space:nowrap">66-2/3%</FONT> of the voting power of our outstanding shares of voting stock.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Limitations on Stockholder Actions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
amended and restated bylaws impose some procedural requirements on stockholders who wish to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make nominations in the election of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose that a director be removed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose any repeal or change in our amended and restated bylaws; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose any other business to be brought before an annual or special meeting of stockholders.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under these procedural requirements, in order to bring a proposal before a meeting of stockholders, a stockholder must deliver timely
notice of a proposal pertaining to a proper subject for presentation at the meeting to our corporate secretary along with the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the business or nomination to be brought before the meeting and the reasons for conducting such
business at the meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder&#146;s name and address; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material interest of the stockholder in the proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares beneficially owned by the stockholder and evidence of such ownership; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the names and addresses of all persons with whom the stockholder is acting in concert and a description of all
arrangements and understandings with those persons, and the number of shares such persons beneficially own. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be timely, a stockholder must generally deliver notice not less than 90 nor more than 120 days prior to
the date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event that the date of the annual meeting is more than 30 days before or more than 60 days after the anniversary date of the preceding annual
meeting of stockholders, a stockholder notice will be timely if received by us not later than the close of business on the later of (i)&nbsp;the 90th day prior to the date of the annual meeting and (ii)&nbsp;the 10th day following the day on which
we first publicly announce the date of the annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to submit a nomination for our board of directors, a stockholder must also submit all
information with respect to the nominee that would be required to be included in a proxy statement, as well as other information. If a stockholder fails to follow the required procedures, the stockholder&#146;s proposal or nominee will be ineligible
and will not be voted on by our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations of Liability of Directors and Officers and Indemnification Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent
permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to our company or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of
the DGCL; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result, neither we nor our stockholders have the right, through stockholders&#146; derivative suits on our behalf, to recover monetary damages against a
director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior, except in the situations described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation also provides that, to the fullest extent permitted by law, we will indemnify any officer or director of
our company against all damages, claims, and liabilities arising out of the fact that the person is or was our director or officer or served any other enterprise at our request as a director or officer. Amending this provision will not reduce our
indemnification obligations relating to actions taken before an amendment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the Nasdaq Global Select Market under the symbol &#147;SANA.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and
registrar for our common stock is American Stock Transfer&nbsp;&amp; Trust Company, LLC. The transfer agent and registrar&#146;s address is 6201 15th Avenue, Brooklyn, New York 11219. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_7"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description, together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes
certain general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus.
We will also indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this
prospectus. Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one
or more series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debt securities will be issued under an indenture between us and a third party to be identified therein, as trustee. We have
summarized select portions of the indenture below. The summary is not complete. The form of the indenture has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you. In
the summary below, we have included references to the section numbers of the indenture so that you can easily locate these provisions. Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this section only, &#147;Sana Biotechnology,&#148; &#147;Sana,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148;
refer to Sana Biotechnology, Inc., unless expressly stated or the context otherwise requires. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the
manner provided in a resolution of our board of directors, in an officer&#146;s certificate or by a supplemental indenture. (Section 2.2) The particular terms of each series of debt securities will be described in a prospectus supplement relating to
such series (including any pricing supplement or term sheet). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We can issue an unlimited amount of debt securities under the indenture that may be in one
or more series with the same or various maturities, at par, at a premium, or at a discount. (Section 2.1) We will set forth in a prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities being
offered, the aggregate principal amount and the following terms of the debt securities, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and ranking of the debt securities (including the terms of any subordination provisions);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal of the securities of the series is payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates
(including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable
and any regular record date for the interest payable on any interest payment date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where principal of, and interest, if any, on the debt securities will be payable (and the
method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period or periods within which, the price or prices at which and the terms and conditions upon which we may
redeem the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous
provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part,
pursuant to such obligation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which and the price or prices at which we will repurchase debt securities at the option of the
holders of debt securities and other detailed terms and provisions of these repurchase obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any
integral multiple thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be issued in the form of certificated debt securities or global debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity
date, if other than the principal amount; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency of denomination of the debt securities, which may be U.S. dollars or any foreign currency, and if
such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of the currency, currencies or currency units in which payment of principal of, premium and
interest on the debt securities will be made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or
currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities
will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions relating to any security provided for the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture
with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with
respect to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect
to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if
applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as
it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including
the terms of subordination, if any, of such guarantees. (Section 2.2) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities that provide for an amount less than their stated principal amount to be due
and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt
securities in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies
or a foreign currency unit or units, or if the principal of and any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the
restrictions, elections, general tax considerations, specific terms and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus
supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer and Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each debt
security will be represented by either one or more global securities registered in the name of The Depository Trust Company, or the Depositary, or a nominee of the Depositary (we will refer to any debt security represented by a global debt security
as a &#147;book-entry debt security&#148;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a &#147;certificated debt security&#148;) as set forth in the applicable
prospectus supplement. Except as set forth under the heading &#147;Global Debt Securities and Book-Entry System&#148; below, book-entry debt securities will not be issuable in certificated form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certificated Debt Securities. You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the
terms of the indenture. (Section 2.4) No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection
with a transfer or exchange. (Section 2.7) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium
and interest on certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of
a new certificate to the new holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Global Debt Securities and Book-Entry System. Each global debt security representing book-entry debt securities will
be deposited with, or on behalf of, the Depositary, and registered in the name of the Depositary or a nominee of the Depositary. Please see &#147;Global Securities.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus
supplement any restrictive covenants applicable to any issue of debt securities. (Article IV) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Protection in the Event of a Change of Control
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the
debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) that could adversely affect holders of debt securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets to any person (we will
refer to such person as a &#147;successor person&#148;) unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are the surviving entity or the successor person (if other than Sana) is a corporation, partnership, trust or
other entity organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be
continuing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its
properties to us. (Section 5.1) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Event of Default&#148; means with respect to any series of debt securities, any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and
continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of principal of any security of that series at its maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the performance or breach of any other covenant or warranty by us in the indenture (other than a
covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or
Sana and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of Sana; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other Event of Default provided with respect to debt securities of that series that is described in the
applicable prospectus supplement. (Section 6.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Event of Default with respect to a particular series of debt securities (except as
to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an Event of Default with respect to any other series of debt securities. (Section 6.1) The occurrence of certain Events of Default or an acceleration under the
indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will provide the
trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what
action we are taking or propose to take in respect thereof. (Section&nbsp;6.1) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an Event of Default with respect to debt securities of any series at
the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders),
declare to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if
any, on all debt securities of that series. In the case of an Event of Default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest, if any, on all outstanding debt securities will become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder of outstanding
debt securities. At any time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in
principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all Events of Default, other than the <FONT STYLE="white-space:nowrap">non-payment</FONT> of accelerated principal and interest, if any,
with respect to debt securities of that series, have been cured or waived as provided in the indenture. (Section 6.2) We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular
provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under the indenture unless the trustee receives indemnity satisfactory to it against any cost, liability, or expense that might be incurred by
it in performing such duty or exercising such right or power. (Section 7.1(e)) Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the
time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series. (Section 6.12) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No holder of any debt security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the
appointment of a receiver or trustee, or for any remedy under the indenture, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that holder has previously given to the trustee written notice of a continuing Event of Default with respect to
debt securities of that series; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made
written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the
outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section 6.7) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the
principal of, premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment. (Section&nbsp;6.8) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture.
(Section 4.3) If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail to each holder of the securities of that series
notice of a Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default. The indenture provides that the trustee may withhold notice to the
holders of debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice is
in the interest of the holders of those debt securities. (Section&nbsp;7.5) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and the trustee may modify, amend, or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to cure any ambiguity, defect or inconsistency; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with covenants in the indenture described above under the heading &#147;Consolidation, Merger and Sale
of Assets&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for uncertificated securities in addition to or in place of certificated securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add guarantees with respect to debt securities of any series or secure debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to surrender any of our rights or powers under the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add covenants or events of default for the benefit of the holders of debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with the applicable procedures of the applicable depositary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to make any change that does not adversely affect the rights of any holder of debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series
as permitted by the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to
or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under
the Trust Indenture Act. (Section 9.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also modify and amend the indenture with the consent of the holders of at least a
majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected debt security then
outstanding if that amendment will: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of,
or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal amount of discount securities payable upon acceleration of maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission
of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such
acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make the principal of or premium or interest on any debt security payable in currency other than that stated in
the debt security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change to certain provisions of the indenture relating to, among other things, the right of holders of
debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a redemption payment with respect to any debt security. (Section 9.3) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf
of the holders of all debt securities of that series waive our compliance with provisions of the indenture. (Section 9.2) The holders of a majority in principal amount of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding debt securities of any series may on behalf of the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its
consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series
may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration. (Section 6.13) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance
of Debt Securities and Certain Covenants in Certain Circumstances </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Legal Defeasance</I>. The indenture provides that, unless otherwise provided by
the terms of the applicable series of debt securities, we may be discharged from any and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the irrevocable deposit with the
trustee, in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. dollars, government obligations of the government that issued or caused to be issued such currency,
that, through the payment of interest and principal in accordance with their terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or
investment bank to pay and discharge each installment of principal, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the
terms of the indenture and those debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of
counsel stating that we have received from, or there has been published by, the U.S. Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable U.S. federal income tax law, in either
case to the effect that, and based thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the deposit, defeasance and
discharge and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the deposit, defeasance, and discharge had not occurred. (Section 8.3) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Defeasance of Certain Covenants</I>. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon
compliance with certain conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may omit to comply with the covenant described under the heading &#147;Consolidation, Merger and Sale of
Assets&#148; and certain other covenants set forth in the indenture, as well as any additional covenants that may be set forth in the applicable prospectus supplement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to
the debt securities of that series, or covenant defeasance. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conditions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities
denominated in a single currency other than U.S. dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide
money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments
in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that
series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner, and at the same
times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section 8.4) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Personal Liability of Directors, Officers, Employees or Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of our past, present, or future directors, officers, employees, or stockholders, as such, will have any liability for any of our obligations under the
debt securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security, each holder waives and releases all such liability. This waiver and release is part of the
consideration for the issue of the debt securities. However, this waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities,
including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably waive, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated thereby may
be instituted in the federal courts of the United States of America or the courts of the State of New York, in each case located in the City of New York, and we, the trustee and the holder of the debt securities (by their acceptance of the debt
securities) irrevocably submit to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any such suit, action or proceeding. The indenture will further provide that service of any process, summons, notice or
document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#146;s address set forth in the indenture will be effective service of process for any suit, action or other proceeding brought in any such court.
The indenture will further provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other
proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. (Section 10.10) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_8"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue warrants for the purchase of shares of our common stock or preferred stock or of debt securities. We may issue warrants independently or together
with other securities, and the warrants may be attached to or separate from any offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and the investors or a warrant agent. The
following summary of material provisions of the warrants and warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of
warrants. The terms of any warrants offered under a prospectus supplement may differ from the terms described below. We urge you to read the applicable prospectus supplement and any related free writing prospectus, as well as the complete warrant
agreements and warrant certificates that contain the terms of the warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The particular terms of any issue of warrants will be described in the
prospectus supplement relating to the issue. Those terms may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase
such shares and the price at which such number of shares may be purchased upon such exercise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation, stated value and terms (including, without limitation, liquidation, dividend, conversion and
voting rights) of the series of preferred stock purchasable upon exercise of warrants to purchase preferred stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise
price for the warrants, which may be payable in cash, securities or other property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date, if any, on and after which the warrants and the related debt securities, preferred stock or common
stock will be separately transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of any rights to redeem or call the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the warrants will commence and the date on which the right will expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. federal income tax consequences applicable to the warrants; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any additional terms of the warrants, including terms, procedures, and limitations relating to the exchange,
exercise and settlement of the warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of equity warrants will not be entitled: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to vote, consent or receive dividends; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or
any other matter; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exercise any rights as stockholders of Sana. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each warrant will entitle its holder to purchase the principal amount of debt securities or the number of shares of preferred stock or common stock at the
exercise price set forth in, or calculable as set forth in, the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified
time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A holder of warrant certificates may exchange them for new warrant certificates of different denominations, present them for registration of transfer and
exercise them at the corporate trust office of the warrant agent or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other office indicated in the applicable prospectus supplement. Until any warrants to purchase debt securities are exercised, the holder of the warrants will not have any rights of holders of the
debt securities that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying debt securities or to enforce covenants in the applicable indenture. Until any warrants to purchase
common stock or preferred stock are exercised, the holders of the warrants will not have any rights of holders of the underlying common stock or preferred stock, including any rights to receive dividends or payments upon any liquidation, dissolution
or winding up on the common stock or preferred stock, if any. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_9"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each
series of units by unit certificates that we will issue under a separate agreement. We may enter into unit agreements with a unit agent. Each unit agent will be a bank or trust company that we select. We will indicate the name and address of the
unit agent in the applicable prospectus supplement relating to a particular series of units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description, together with the additional
information included in any applicable prospectus supplement, summarizes the general features of the units that we may offer under this prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be
provided to you related to the series of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit
to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we offer any units, certain terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the
following, as applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the series of units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identification and description of the separate constituent securities comprising the units;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices at which the units will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date, if any, on and after which the constituent securities comprising the units will be separately
transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a discussion of certain U.S. federal income tax considerations applicable to the units; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the units and their constituent securities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_10"></A>GLOBAL SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Entry, Delivery, and Form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we indicate
differently in any applicable prospectus supplement or free writing prospectus, the securities initially will be issued in book-entry form and represented by one or more global notes or global securities, or, collectively, global securities. The
global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as depositary, or DTC, and registered in the name of Cede&nbsp;&amp; Co., the nominee of DTC. Unless and until it is exchanged for
individual certificates evidencing securities under the limited circumstances described below, a global security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary, or by the depositary or
its nominee to a successor depositary or to a nominee of the successor depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that it is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited-purpose trust company organized under the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;banking organization&#148; within the meaning of the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a member of the Federal Reserve System; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing corporation&#148; within the meaning of the New York Uniform Commercial Code; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing agency&#148; registered pursuant to the provisions of Section 17A of the Exchange Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC holds securities that its participants deposit with DTC. DTC also facilitates the settlement among its participants of securities
transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants&#146; accounts, thereby eliminating the need for physical movement of securities certificates. &#147;Direct
participants&#148; in DTC include securities brokers and dealers, including underwriters, banks, trust companies, clearing corporations and other organizations. DTC is a wholly-owned subsidiary of The Depository Trust&nbsp;&amp; Clearing
Corporation, or DTCC. DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries.
Access to the DTC system is also available to others, which we sometimes refer to as indirect participants, that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly. The rules applicable to DTC
and its participants are on file with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchases of securities under the DTC system must be made by or through direct participants, which will
receive a credit for the securities on DTC&#146;s records. The ownership interest of the actual purchaser of a security, which we sometimes refer to as a beneficial owner, is in turn recorded on the direct and indirect participants&#146; records.
Beneficial owners of securities will not receive written confirmation from DTC of their purchases. However, beneficial owners are expected to receive written confirmations providing details of their transactions, as well as periodic statements of
their holdings, from the direct or indirect participants through which they purchased securities. Transfers of ownership interests in global securities are to be accomplished by entries made on the books of participants acting on behalf of
beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the global securities, except under the limited circumstances described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To facilitate subsequent transfers, all global securities deposited by direct participants with DTC will be registered in the name of DTC&#146;s partnership
nominee, Cede&nbsp;&amp; Co., or such other name as may be requested by an authorized representative of DTC. The deposit of securities with DTC and their registration in the name of Cede&nbsp;&amp; Co. or such other nominee will not change the
beneficial ownership of the securities. DTC has no knowledge of the actual beneficial owners of the securities. DTC&#146;s records reflect only the identity of the direct participants to whose accounts the securities are credited, which may or may
not be the beneficial owners. The participants are responsible for keeping account of their holdings on behalf of their customers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as the securities are in book-entry form, you will receive payments and may transfer securities only
through the facilities of the depositary and its direct and indirect participants. We will maintain an office or agency in the location specified in the prospectus supplement for the applicable securities, where notices and demands in respect of the
securities and the indenture may be delivered to us and where certificated securities may be surrendered for payment, registration of transfer or exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants and by direct participants and
indirect participants to beneficial owners will be governed by arrangements among them, subject to any legal requirements in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption notices will be sent to DTC. If less than all of the securities of a particular series are being redeemed, DTC&#146;s practice is to determine by
lot the amount of the interest of each direct participant in the securities of such series to be redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither DTC nor Cede&nbsp;&amp; Co. (or such
other DTC nominee) will consent or vote with respect to the securities. Under its usual procedures, DTC will mail an omnibus proxy to us as soon as possible after the record date. The omnibus proxy assigns the consenting or voting rights of
Cede&nbsp;&amp; Co. to those direct participants to whose accounts the securities of such series are credited on the record date, identified in a listing attached to the omnibus proxy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as securities are in book-entry form, we will make payments on those securities to the depositary or its nominee, as the registered owner of such
securities, by wire transfer of immediately available funds. If securities are issued in definitive certificated form under the limited circumstances described below and unless if otherwise provided in the description of the applicable securities
herein or in the applicable prospectus supplement, we will have the option of making payments by check mailed to the addresses of the persons entitled to payment or by wire transfer to bank accounts in the United States designated in writing to the
applicable trustee or other designated party at least 15 days before the applicable payment date by the persons entitled to payment, unless a shorter period is satisfactory to the applicable trustee or other designated party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption proceeds, distributions and dividend payments on the securities will be made to Cede&nbsp;&amp; Co., or such other nominee as may be requested by
an authorized representative of DTC. DTC&#146;s practice is to credit direct participants&#146; accounts upon DTC&#146;s receipt of funds and corresponding detail information from us on the payment date in accordance with their respective holdings
shown on DTC records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the account of customers in bearer form or registered in &#147;street
name.&#148; Those payments will be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time. Payment of redemption proceeds, distributions and dividend payments to
Cede&nbsp;&amp; Co., or such other nominee as may be requested by an authorized representative of DTC, is our responsibility, disbursement of payments to direct participants is the responsibility of DTC, and disbursement of payments to the
beneficial owners is the responsibility of direct and indirect participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except under the limited circumstances described below, purchasers of
securities will not be entitled to have securities registered in their names and will not receive physical delivery of securities. Accordingly, each beneficial owner must rely on the procedures of DTC and its participants to exercise any rights
under the securities and the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws of some jurisdictions may require that some purchasers of securities take physical delivery of
securities in definitive form. Those laws may impair the ability to transfer or pledge beneficial interests in securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC may discontinue providing
its services as securities depositary with respect to the securities at any time by giving reasonable notice to us. Under such circumstances, in the event that a successor depositary is not obtained, securities certificates are required to be
printed and delivered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, beneficial owners of a particular series of securities generally will not receive
certificates representing their ownership interests in those securities. However, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC notifies us that it is unwilling or unable to continue as a depositary for the global security or securities
representing such series of securities or if DTC ceases to be a clearing agency registered under the Exchange Act at a time when it is required to be registered and a successor depositary is not appointed within 90 days of the notification to us or
of our becoming aware of DTC&#146;s ceasing to be so registered, as the case may be; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we determine, in our sole discretion, not to have such securities represented by one or more global securities;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Event of Default has occurred and is continuing with respect to such series of securities,
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">we will prepare and deliver certificates for such securities in exchange for beneficial interests in the global securities. Any
beneficial interest in a global security that is exchangeable under the circumstances described in the preceding sentence will be exchangeable for securities in definitive certificated form registered in the names that the depositary directs. It is
expected that these directions will be based upon directions received by the depositary from its participants with respect to ownership of beneficial interests in the global securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Euroclear and Clearstream </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If so provided in the
applicable prospectus supplement, you may hold interests in a global security through Clearstream Banking S.A., which we refer to as &#147;Clearstream,&#148; or Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we refer to as
&#147;Euroclear,&#148; either directly if you are a participant in Clearstream or Euroclear or indirectly through organizations which are participants in Clearstream or Euroclear. Clearstream and Euroclear will hold interests on behalf of their
respective participants through customers&#146; securities accounts in the names of Clearstream and Euroclear, respectively, on the books of their respective U.S. depositaries, which in turn will hold such interests in customers&#146; securities
accounts in such depositaries&#146; names on DTC&#146;s books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearstream and Euroclear are securities clearance systems in Europe. Clearstream and
Euroclear hold securities for their respective participating organizations and facilitate the clearance and settlement of securities transactions between those participants through electronic book-entry changes in their accounts, thereby eliminating
the need for physical movement of certificates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments, deliveries, transfers, exchanges, notices and other matters relating to beneficial interests in
global securities owned through Euroclear or Clearstream must comply with the rules and procedures of those systems. Transactions between participants in Euroclear or Clearstream, on one hand, and other participants in DTC, on the other hand, are
also subject to DTC&#146;s rules and procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors will be able to make and receive through Euroclear and Clearstream payments, deliveries,
transfers and other transactions involving any beneficial interests in global securities held through those systems only on days when those systems are open for business. Those systems may not be open for business on days when banks, brokers and
other institutions are open for business in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cross-market transfers between participants in DTC, on the one hand, and participants in
Euroclear or Clearstream, on the other hand, will be effected through DTC in accordance with the DTC&#146;s rules on behalf of Euroclear or Clearstream, as the case may be, by their respective U.S. depositaries; however, such cross-market
transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system.
Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the
global securities through DTC, and making or receiving payment in accordance with normal procedures for <FONT STYLE="white-space:nowrap">same-day</FONT> fund settlement. Participants in Euroclear or Clearstream may not deliver instructions directly
to their respective U.S. depositaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to time zone differences, the securities accounts of a participant in Euroclear or Clearstream
purchasing an interest in a global security from a direct participant in DTC will be credited, and any such crediting will be reported to the relevant participant in Euroclear or Clearstream, during the securities settlement processing day (which
must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a participant in Euroclear or
Clearstream to a direct participant in DTC will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following
DTC&#146;s settlement date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
information in this section of this prospectus concerning DTC, Clearstream, Euroclear and their respective book-entry systems has been obtained from sources that we believe to be reliable, but we do not take responsibility for this information. This
information has been provided solely as a matter of convenience. The rules and procedures of DTC, Clearstream and Euroclear are solely within the control of those organizations and could change at any time. Neither we nor the trustee nor any agent
of ours or of the trustee has any control over those entities and none of us takes any responsibility for their activities. You are urged to contact DTC, Clearstream and Euroclear or their respective participants directly to discuss those matters.
In addition, although we expect that DTC, Clearstream and Euroclear will perform the foregoing procedures, none of them is under any obligation to perform or continue to perform such procedures and such procedures may be discontinued at any time.
Neither we nor any agent of ours will have any responsibility for the performance or nonperformance by DTC, Clearstream and Euroclear or their respective participants of these or any other rules or procedures governing their respective operations.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_11"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may sell the securities from time to time pursuant to underwritten public offerings, &#147;at the market&#148; offerings, negotiated transactions, block
trades or a combination of these methods or through underwriters or dealers, through agents and/or directly to one or more purchasers. The securities may be distributed from time to time in one or more transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price or prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to such prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time that we sell securities covered by this prospectus, we will provide a prospectus supplement or supplements that will describe the method of
distribution and set forth the terms and conditions of the offering of such securities, including the offering price of the securities and the proceeds to us, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the
securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a dealer is
utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of
resale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the
underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, we or the
purchasers of securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities to or through dealers, and those dealers may receive
compensation in the form of discounts, concessions, or commissions from the underwriters and/or commissions from the purchasers for which they may act as agent. Unless otherwise indicated in a prospectus supplement, an agent will be acting on a best
efforts basis and a dealer will purchase securities as a principal, and may then resell the securities at varying prices to be determined by the dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions, or commissions
allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters, dealers, and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of
the Securities Act, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements to indemnify underwriters,
dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any common stock that we issue and sell will be listed on the Nasdaq Global Select Market, but any other securities may or may not be listed on a national
securities exchange. To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments or
short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases
in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if
securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the
open market. These transactions may be discontinued at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may engage in at the market offerings into an existing trading market in accordance
with Rule&nbsp;415(a)(4) under the Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable
prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use
securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of
stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge
securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short
position to investors in our securities or in connection with a concurrent offering of other securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The specific terms of any <FONT
STYLE="white-space:nowrap">lock-up</FONT> provisions in respect of any given offering will be described in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
underwriters, dealers, and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the issuance of our common stock offered hereby will be passed upon for us by Wilson Sonsini Goodrich &amp; Rosati, Professional Corporation,
Palo Alto, California. Additional legal matters may be passed upon for us or any underwriters, dealers, or agents, by counsel that we will name in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc55600_13"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in our Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022, as set forth in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement. Our financial statements
are incorporated by reference in reliance on Ernst&nbsp;&amp; Young LLP&#146;s report, given on their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>$125,000,000 </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g55600g23i89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:150pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:150pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" ALIGN="center"><B>Morgan&nbsp;Stanley</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>BofA&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>February &#8195;, 2024 </B></P> <P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g55600g01q01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g55600g01q01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2EH4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *4R^$%<CA"24T$!       2QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1Q
MP"   "   < @4 )U-A;F%?1FEG=7)E,#%?3W5R(%!I<&5L:6YE7S$P+4M?,C
M R,E]V,@ X0DE-!"4      !"FM'L +3A<F$^Q'CJH'VV9.$))300Z
M#E    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M  3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T
M]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M!'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D5%
M5N=$8C4FQT                0FQD(%5N=$8C4FQT                4G
M-L=%5N=$8C4'AL0'8DI_         *=F5C=&]R1&%T86)O;VP!     %!G4'
M-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M    !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M       !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;V
MUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%
M)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M   ! !8DI_  $  0%B2G\  0 !.$))300F       .             #^
M X0DE-! T       0    >.$))3009       $    'CA"24T#\P      "0
M           0 X0DE-)Q        H  0         !.$))30/U      !( "
M]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M &       ! #4    ! "T    &       !.$))30/X      !P  #_______
M______________________ ^@     _____________________________P
M/H     /____________________________\#Z     #_______________
M______________ ^@  #A"24T$"       $     $   )    "0      X0D
ME-!!X       0     .$))300:      ,U    !@             '\@  "+
MH          0                         !              BZ   '\@
M                     !                         !     !
M  ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M!4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   '\@
M    !29VAT;&]N9P  "+H    &<VQI8V5S5FQ,<P    %/8FIC     0
M  !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F
M<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96
MYE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F
M)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M   $QE9G1L;VYG          !"=&]M;&]N9P  !_(     4F=H=&QO;F<
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M]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M     ,     C_P        .$))3001       ! 0 X0DE-!!0       0
M !.$))300,     !ZI     0   *    "2   !X  !$<   !Z- !@  ?_8_^
MT #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0
ML*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,#
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M[F445";+;"&M:./<YQ1&XTO793*I[;:F6M#@VQH< X%K@"-WN8[W,=_)4@!
MY^\IF/;8QME;@]CP'-<W4$'5KFN"<3 U04PKN99;94 X.JC<3(!W"?:40"%%
MMC'/<QKP7LC>T<B>-REJFQNM2):G4>?R_X*3Y4NDDDG(?_TNWZA5TR[.OKR,
MJ^NR&N>RLN:QC S:Y[_:ZKT6[]]MW^!WJWTG*Z>X&C#M=8UTV5M<'@-8!5HQ
MUOYOZ6M_TOTGJ*OU#%RK,RVRK)Q:(?7L]1@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  #_X48A:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^"B @
M(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I#<F5A
M=&5$871E/C(P,C,M,#(M,C-4,38Z-#(Z,CDM,#@Z,# \+WAM<#I#<F5A=&5$
M871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,RTP,RTQ-%0Q.3HQ
M,3HU,BLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T
M861A=&%$871E/C(P,C,M,#,M,314,3DZ,3$Z-3(K,#4Z,S \+WAM<#I-971A
M9&%T841A=&4^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SII
M;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q
M+C O(CX*(" @(" @(" @/&EL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/D%)
M4F]B:6X\+VEL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E
M<'-F/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<]
M(G@M9&5F875L="(^4V%N85]&:6=U<F4P,5]/=7(@4&EP96QI;F5?,3 M2U\R
M,#(R7W8R/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @
M(" @/"]D8SIT:71L93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@
M(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(^"B @(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYP
M<F]O9CIP9&8\+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP
M34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C1E9C8P8V8Q+3$U-V0M-&$V,2TY-S9B
M+3DQ,C$S-C$W,6-F,#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.DEN<W1A;F-E240^>&UP+FEI9#I$-#$R044Q,39#0S)%1#$Q.3 S-D5"
M,S,Q0S)",T$V03PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F0R-#8W8S!E+3@T83$M.#(T92TY
M9C4U+3)C.68P96-C93$V,3PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED
M.D0S,3)!13$Q-D-#,D5$,3$Y,#,V14(S,S%#,D(S039!/"]S=%)E9CII;G-T
M86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED
M.C1E9C8P8V8Q+3$U-V0M-&$V,2TY-S9B+3DQ,C$S-C$W,6-F,#PO<W12968Z
M9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE
M;G1)1#YU=6ED.F0R-#8W8S!E+3@T83$M.#(T92TY9C4U+3)C.68P96-C93$V
M,3PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12
M968Z<F5N9&ET:6]N0VQA<W,^<')O;V8Z<&1F/"]S=%)E9CIR96YD:71I;VY#
M;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @
M/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.C=A9C-D.#<T+6%E,3DM-&,R92TX8V,T+3=D8C4T.38X,S<S,3PO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TP.2TQ-%0R,3HQ,#HR,"TP-SHP,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T
M<F%T;W(@,C0N,B H36%C:6YT;W-H*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z1# Q
M,D%%,3$V0T,R140Q,3DP,S9%0C,S,4,R0C-!-D$\+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,#,M,314
M,3@Z-3@Z,3(K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@:6UA9V4O:G!E9R!T;R!A<'!L
M:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O
M;2!I;6%G92]J<&5G('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H
M;W \+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.D0Q,3)!13$Q-D-#,D5$,3$Y,#,V14(S,S%#,D(S039!
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(S+3 S+3$T5#$X.C4X.C$R*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z1#,Q
M,D%%,3$V0T,R140Q,3DP,S9%0C,S,4,R0C-!-D$\+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C,M,#,M,314
M,3DZ,3$Z-3(K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D
M;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O
M;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P
M<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.D0T,3)!13$Q-D-#,D5$,3$Y,#,V14(S,S%#,D(S039!
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(S+3 S+3$T5#$Y.C$Q.C4R*S U.C,P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N
M8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!0
M1$8@;&EB<F%R>2 Q-RXP,#PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O
M8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#
M;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B
M/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0'_P  1" (G ET# 1$  A$! Q$!_\0 'P !  (" P$! 0$
M  <(!08!! D# @H+_\0 91   00" @ !!@@'#0,'!P8/!0,$!@<! @ (% D1
M$A,55!87(564E=35"ADQ6)+2TQ@T-4%14W1UDY:TM=@BF-8C)&%Q@9&A)C)(
M5Y>Q\"4H-D-69&6&QO$G1$:$16:CIL'1X?_$ !X! 0 # 0$! 0$! 0
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MW4=*CCZAJX2VHTWV9HYP"-J3[D9$K4+&L:[+;\ 7UMU&;J77X-?^D'0^F_\
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M:#TAU7K,O0M+U*<=8Z5JAH4U/39M;#''#&X7>AFABU$ZH98A,ACD1C\WU?\
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ML8SC&Z>^-=]-L8SYMM-]==M<^?7;&,XSCGYH11(XX-<$$<?0BP1^()!^,_0
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MQ8DQ=5XBX6:+V-'B4P&@1TMKI!RCLBO/8JZ-1!#?=OA4SIXIKE9U'0>I.DK
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M61=HAMZO9QBJ>Y+;:8(K[XSC/@=JZ-3+=\GG;":S=/9-7SIYSS^G/T83PMZ
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MZ[Z9HNDZV'0PZ/4WU/K^LZ?JSU'J$(75ZI-4$,VH>:5BKN[Q[%C@6*>B'4=
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MG66Z3J]2/U_5I/3^J4KU*2<A4GU$.EU>JA%L5596D1-U'JVHZ*W_ /7S _\
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M 6!EW2'3RA5)B<9Q3UQTYVFGA#LU/I'4NE4UAU^MR*T7U,C9^$65;IBH)4,
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ML^D).HLZ9V)9H#^J8DDH2<L/4?2P !Z3]2@#4#5@#TEK !JE 5=2!V:&H50
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MN_ZO_P!&NH_R\?C 8U^:OWX_W/;9^[>/Z"ZG^\WH?_2SI7\W'],8/[O^K_\
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M,;)[[:Y[M1Z<Z_JXF@U7KKTQJ8'VEX=1ZZT<T3%6#*6CDU+(VU@&6P:8 BB
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M&\CSP:C7=I(I?ZDZE^E_HFJ]/:F&'1:P]5UFAETS:62-/LL,T\!A>1I^X>Y
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M8DV1?==[\U)U1"LDSP<?(KD$)5NJ4J=B??QDW\'/AXT!+G1K%8^-1<1[&2V
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MO]HBVLQ+ *5!5D</;?= C*[SN/"TIW&ZNLPG6+MDGV1MCL[$1(1Z'BM'G*J
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M[^,8\&O\Z/\ ] =]W\8QX-?YT?\ Z [[OXQCP:_SH_\ T!WW?QC'@U_G1_\
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M:3RV1<IA<1Z33*KI3V9K[JYM9\6<7]V>>4[,$BL:ZY;:UZ2A)&/CM' $;*Q
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ML@2-T4'=(0';=QL4V%"@#DM1))/ H 6<EHB\T<C%=D6XHH4[M[#:2S75 70
M')LDT,MES+-\<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,
M<8QQC'&,<8R@_E(VK93K6/54;H;J_NF>D.GK=T4]E/0SW.H?7.GI[:YV]'.N
MVVN=?/YLXVVQYO-G/GWTW_>C_P DW^N%[_/.76?]T#\][3\_/_?QYH/?#LC,
M.EDEK^\4W!$Q4,DKVY*F>URU88<#G/8/>,;61UW?--&2.KQL_G!6%R^I%<[K
M89O2LRB"&^S99/1;>T$0G#)X<,C[B?\ P[VR<?.T,K_@%.1J)3IRLG)0JZ%
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MSMJB3-9-DQP$GZDP1DG.?1@"$@"@)M0 !X $\@ ^/C]V1#UZF77D".\I&Q[
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MH&'N&BQ,!WVG$YKJJSMBNA439B@3BSO@8Q'69D7K/1CTPSD215WI&%$@"J4
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M=K^O-V2-E$ZMM ++SI2%:6*%;,69QJVD,)RX%,W4BC)0F*8B9,Q$/S@@9(L
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MC<LL6LV8;K32T/<X$R%-NIZKX)6M$Y/MJ%=Y5C\J:M=U"0Y\".K-G$?:FC$
MB=B(U964V%:Y'-U?]9".?(^MC'V-)3J6FC6YG5D;VEU AC7SS]UU8@$D'Y%'
MGT1ZN,K?#417D9O>-1",VA#0^(7(DJ_4&ZP4ZG$UU0(>81(:*1:-XX$F 5B/
MD3>);,6*D35(+1W#?* U%=;GDV%V,98JQW#=]X7R58\V1XW7SY^<ZH0XC59
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M#KYFTA+24:.4EMG8<%MQ157;[V;VMO!9-I .[<!=@4!RQ R!J8R%VK([-O\
M8J^Y=A"ON!( VL0//)(VWG2 >4(J&=1.JI)54&NNVC%P1N<3>+UY"(,P3GH^
M!UW,%H')YG+QTNDL4#1(2G*$TQ(EB;/-9)('J^6(,$0(,BK0?)T[J7#LB!"%
M+,QVEF&X*"H8DUR2!0\DU1P-2C*A19'+AF"JON"JVUF8,5H \43N/P"00.J3
M\HI3&[F'CJ^A%WW,8FM-N[Y%@ZOKU-\58UV'D[^&R=S(4)4=B2<>/Q.3C7 (
MY$RJS:1X->8*+&DS&B[!$-._.XH@5PA+M0W$;@!0-@CFQ8KDD6,'4I[=JR.6
M0R (ED*#M)-E:(/!4G=? !YS:6/9UF8L;J?)(T9:'^OW<JOB.M;$51:@XL+L
M)K!W-TPUSNHMHD[]FS^J6,WT*"RR6CL >A )LS3U5.%]$X[1"R@@AX6&[FP5
M+;#_ )K;:(X(8_09(F!>$@W%.IV&J(;:9%_@R!K!L@J/%G+G\QS?'&,<8QQC
M'&,I;=79ES6]LR@&EYD:\Z]=9YOVJ[!/4&2#XP^CV$I4%K*#@L+*8T9KGEH-
M:,N*/]<)O$-X%'!*&V[&2D]D=DBW(#SNDD$48^+X+$_NW*!^\GXSGDFVNP'W
M8HFFE^M<A%''];:Y)\C:!\Y&,'=>40D,*K"]\36BS2\V4@DKD_5S2OB4>%1^
MNIDL+<EP0&\W4S?&GEBPB-$U2>Y\M#]8K+#@ER);1< S(-7;>Q^SAG2I !N"
MR[@26'@M'0 5B*H&U!NV(RJ_:BJ2;HR6*EH=I "-Y D+674&[*A6((H7>:K!
MI=W=O>8=L']87U3\$%TAV1FM,P* 3.@'LQ%FV<3A->RIBI*YD)M2*'FVA=W,
M5QSUT*%[.1K=NF];I/5/.SVEA#&(@R.Q>-79E?:1N+#A2I%@"Q9H_AD*VHD:
M;9(BB.5HU4QEK 5&Y;>#SN(X&5]L[RF4PS":'FKB=UEU- 6-UJLRWB1VQ8%(
M+I1-755DD:Q*5T<'9QJ219PP"QTFB4(/)$JFH9EXU8<UC"0P@R*8SHNF7=(-
MKS;)%3VL$(1@2'-AA9XH>!\^1F3ZIRL;;DA#PNY+*9 9%.TQBB.%-DGR1X\'
M)^M;O38%;UY35CFX.@)*-NFLY[>7S6;%PU(N&S]A$X''X14(J0J:NDV"\DMN
MR%$&9]+5790;7Y?.?7MU'*2M$@5F9=W'?6%&_"V+.1\@(OCZL,T?4.BHY6J@
M>>1.";"J%0-="W;SSPOXY,$: ^4(CABL9?++&HRSAL@D@1G=%.!JX(5XSK^+
M'L9U+&JJLMS.),5DI.NG"J"BPZ8@U$[#&-7WL_:&D7#)).A.G(8!9%(!*.6#
M%B!P'7:  W/(/ML>1F@&I!1F>-P2.Y&$VA5/DHY8DE/HP]PO[IK(#@D_[Z6I
M [TNNO+HIC.M<7QVF@\-H^6T0_5&26/T+<\_@ *.%;0"VB,-BRDG#1%MIO)T
M(N^2%%7OBU0A-JCNV5N5@5D1D?W)$2X<6#(BL2%*U0)\7XXN^<R5]0ZR.KQ^
MR69%1HR=PBD90"X<$%@OD+P>:(XS;;$[M6N8K#I/;]'U4/Q5G9:9=/GL\L*;
MR =Z$/AW8VS(!%5H%%8J.64/2&QL,98K@@9)M0<0C8Q/<BU('CBB 1N6!0\Z
M2-[HEFVA1Y:-6-DG@+8X LD\4!9R7U#E-.\:#9,T&YF/W5E=1M ')8 \DTH'
M-D\9B^P/:>\8S/NX+F#3NFJZAG2BI8C9)&'6-%7YP_=KD_"RU@O=U9(E-XS\
M 8.Z;#=:XC1L2!DC_>?IG';O4@@(1C1!'$C+$"KLTSE0RD!4YVCBCN:SN8$C
MVU57>)9I%:;:T:+ BL0X),EKN\[AM7@J" QW6>:K+%0#L61/WG740)82V@/9
M+K:U[ 4HLJU2;E A&'KPMI9L)+.DL::$M70:T:XE<:4W2\>FLE8"+A=0<S#M
MVF;1@1LP^]')VW^A#;MK#Z<J5/[U^;S59;D53]V6+NQ\>-I4.I-\V'4CC_*Y
M\9<?F.;XXQCC&.,8XQCC&.,8XQCC&4OG_5SXS^TINRIRPB4FI.6].9?UIET-
M*JOEBYMY+;+%2E\FX&^S?9NT<<1QJ]9K/=329-(BHCJ@PPGCQJ6ZR[(@JDAQ
M,L@(^ JL//UL_EG.T.^8LP4QM T3 \DDN&\555^/GXRBM2^3/NR"AST2G=CP
MJW06O?JC;] ')BY*O)&;Z\TK6$1K !&YZ@M%56!>T6D;B0P4^7RHY$2E9EM(
M"1M@^)N&:&TFI1MI560B!T( %"1W+$KR*0DD_P#N@T 0,YX])(MAF5Q]HBD!
M:[,<:*@#<&W 4?-,1N)!.6B[$]+2%@V+O+:G$5="A;KIEW&Z]$$-66T:>/9M
M?N*<Q 23I*/1ITBYC0?X!2+V^^7<;DAN'S'V2(*^+>>%RCF"K3%F/>AD^OMC
MWW5GR=PH>/Q&;30%WW)M4=B>(_!+2;-O@>!M-GXXH'-$6JKOC-^M6_52<UKU
MFA<0-5-%J.D=BP7L;9DOE.(:NC&X+8!(;$C76B!,4"3^M]I>Y$ZXF6JC,]N*
M;:JJ);J/F]MT"R=U7D9@Y<*T2J+Y9>1*3PU?!OSQXRH34M%V72)5*+&669RV
MWVJU#M+1V;B/=YH?CDDR;HP#N3L?95N7BX-*PP;7->4UUYC55W1=M4/XU 1B
M!.26<XF&:ME%=:.GTXG!<>/]BK$),)TC%=PY[A5H1</&#2HG*1JB599GD+HC
MVUTM%U8^U038KEF'.6.G#RM))NVA%CB"22)2BR^[8RV68@4;%*I\\"N4'Z?]
MP.OQCKHK4HVA;.C?5U3MO6%9 K(N*QH&]VZ]W)):L/4N-*R 52EFN5996@2&
MD((48[L7#)V&$QPFC(7;QX0;,]#+#()-Q=#+VF8JBO\ K$#A^-Z<,2&!XHDB
MN+.2P3Q&(H(W$/>1 SLA[3LIC!.Q^4 *_4@ EO(R7997?>M_?%-]F@E4=6EY
MK%J0N6F9K6Y/LA:+",LTYW8U8R^.R*-3UMU<(DSN^@ZN]D3 LE!H[JS>%,)L
MR!%%KZ]>H:#8\6^7:71U;M*3PK @KW17)_RN1],LRZHR1S".'>(Y(V0S.%&Y
ME*D/V23PIL;!R:YJ\W''6FR^P1"_"O:P! (=I;_5[7J\+C-33X_8C2*1Z4E;
M->VD?&2N4U]7#I0A*VIZM/5Z*1%IAH_@2&N^7B"3=RO7N+'L$19MDO=MU"V1
MMV"@S>*8^?ZW%&\OVGE[IF"KW(>SM1MVT$OO(8JIY!3XX*_NS%!8;Y1XN(KZ
MGY5).O\ !8Q$B\+TG/9>NY7,S5H63#863&/70Z.TQ)ZU;16NI58[(3@+,29*
MRIR'C;(R:7C;(NXV8>!F]."S@2,2&VQLH"JS @$N&)8*38&U22!9\C("ZH[8
MV,2JI7=,C,7<*02!&R$(6JF)9@ 37-5B:0K;O#U_E%PQR/U?UBFU8V5VINNZ
MV,O+]B+-BDW'0^WK'?2O#1U!F?624!%)""$/?0\$E/<CWY!/P_M9JWW\7J=H
M9%0EY%=8D3;VU()1:/N[@X/QQQ\CXR$74Q,X6.%D::23<965@KN6^YVB+ /C
M>!?SGZZX5OW>Z].9-72-7]8Y954C[+WE:.T\4[#V8%GC."77>LOLU;;%=Z]9
MB@%Q*8X!EFS5,-FQD194JPU0VD(YJYR]0F5H)*;?(&$4:[>VM;D0)][N71KS
MMO\ #$*:B(E!'$R--(Y;NL&"R2,Y.SM$6 WC=1/R,],N<N=F.,8XQCC&8]+^
M%7G]7C/\26Y/P/WG_=C,AR,8XQCC&?Q3>4.\@QW)G?;VU;1Z[B8K95:W?8<B
ML?! G. $5+P,K-BS@[(14F825XP</1XXP^?["G\;R>7<AO"X<M$26JC;;^PO
M07Z;O2.B]*=,Z9U^74].ZCT;0:?IY2/13ZF+71:*)88)=/)ITD5))(DC[L>H
M$*K-NVL8J8?R_P"LOT2^IM5ZCZAK^C1Z?7:'JNNEUN]]5#!+I'U4K331SKJ'
M0ND<CL8WA[Q:()N D!4_U!>3OZHO>E'4"H>NAB1-95(X:Q.DI6<':N=!#F43
M"3&)>;;!-7>B+G(44]-*"!CEPV9N"#1BF2=,F;IXNV2_F[U[ZG3UCZKZKU^*
M!M-I]6\$>EADV]U=-I-/%I86F*%E[TJ0B6159U1G,:NZHK']X]&>GG]+^F^G
M=%EG743Z99GU$R;NVT^IGDU$JQ!@&[4;2]J,E59U0.R*S%1=?GQV?48XQCC&
M8\9^]=OZ82_S%WQC,AQC'&,<8RC';#KM,;1-A9G!\-")!B&T D0;IX@P640;
MO7CYH]8N7FZ3+?/I/W"3I!9PWVUPFW40]=MNMA/_ #X_[9/_ &8_7'Z7.O=
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M163"Y]6?:^M3.X9838UU2ZZ(E*VK".O5S%:6( 7E3[221-RP,MW;21/HP^<
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M:;ZP-1, 1O!!8N=RHUL?))922<EM+ Q!*$%55!M>1:5?"TK 4+_C\WEM8A%
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M&92&>)A# \UAC>30UZ/9;Q">L #2=Q9%LDT R0>SQZC.8FD4* Q 5BRFA8+
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M[ZIZ:[[TX"]+;737&VW_ #E]G_:VQCSY^7^7.>;ZG_ZQ+_YSG-HQ_P"S0_\
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M?B2DY/,&"#<M*R $&QC(1T=?::8<$%1,?&L1 _Q&^^K1BVT01UTUSMZ61)(
M))"@A03P 22:^EDDG\<U"J"S  %B"Q^6(%"_W  #Z#C()G72GJ39NZBE@]=Z
MFF&ZDMEL]WR>AXI_YYI/$P:4UD^,*HYQJ:E6D: >WW^F-5RFXEBH[V541UWY
MH)I5^[(Z\!>"1[5O:./@;C0_',V@A?[T2-9+<J#[FK<?WG:+/X9@2W0'I0=
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M@ ML'#"V:><YT:CA8YLV8LFVF=MLZ(-D$DM<[9SC3'GSR2239))/DGD_GD
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M8EIO836C9\]&K6%.$H#&S_P7BVSX66;,7)/*3TRH%.>PV!/4&7RRJD+R"QM
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M97-8L\ML98FTXM.)IODF)+5H7.GTXKHP'N "P3#1%76O=D4O[5 )4LIB38K
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M-@T-(Y9ML,CNK"64QE H%"V"D$&]P*V]V +  (O*B]9^T78$=3W63KS2S:;
M&$"Z451;QB2P>@6U\EY')+#E=D1N. S XE.X6RCD #(UV]<'G0S*TDD3XLFP
M%GHI@,LN5VDBCWR2/M.Z9T :3904(20=I)8[J%\"K(-\<\,T@CBBCW#9 CDK
M&)"2[. #;*%4;3=63?!6C?HIV)L>4V]Y(2_[.G,50A$TG'0RWY#+8DU>)$&
M&2OZ5DFYQ@,?(NGNCP2F2\3L(<Y=+JK#=FBBZF5]E,8YXU":R-5;<JZB,*WU
M'<6C^^O/XYU3.SZ&5V7:S:=RR^0&V&P#\B[H_3/,RVS)+'D^K+\G F5))2.K
M UQ^UW&KI3VMITZJ"FDNTE:%]7.BFJCD(092JB^LQYSC;&7CDE*--\)JMET=
M>E:^T+J:X8I].)F;MOQX!L/( >!Q7&<KDC3/I;/L$ED?L(X^ZIL^1[HXB1YY
M/'C+7.>W-S4G!P%'ALQQU/K8ZZ]+]^D>[L'ATDZDUEJ1ZF+1921MH[;^WV]0
M&EPEN%]E<M$M8=(L,G3K"3'T^9=I'8N;VI)-WJ/PMNM&B!O%K\\B^;K-N](B
MB-:+/% 8. >7(C<$6+"&G)->T_AG19]Y>UIV;3&=QJ(S M7<&[7'NOOQ<HT8
M/T@)R P6[OB,F$N+7^_L(<1#6@[=,C4Y!#4(PG%&ZNH2NG$?*/GZDOR,$0"J
M64,T2R;NY[MS() !'MHKR%-F_+;@!6!J9B6958JLQC*]NE*+)VV)DW6'L%_N
M[1PA'];.GUIL:Y#=C2KJ_3TY 5$K*^S'E3;NEMEF(4UGQA<9 .[C^%B83"0!
M8J, ZO7Q6P<&Y48*)E5!P46S'CAZ#LY@L,2*@42."]1Z5 H8@>Z $LQ%GC;0
M'')/P*,0NY8Q(P3=-K9&9E#&DU+*%46!SN!+'P*H&R1N,#[.=P.P,XKZH(C8
M]7U2?:5CW&=6=8;&JE9N,DTTZJ]G 77D7(JZ &YDV0"QZ>.'>\B(L#!&2X$#
MUB8%BX5))CI$S-%#&&<J[ O#L4MM(6:,R4Q -E1QP!9Y\<&R332,J!T4A)][
M;"0S0S+$"JDB@W)HDUX\\C7ZI[L=G6L,ZXW9<5D4?I$.SW2.]>R2L==U^>AT
M&H^0U#!JTFX$@_F R1RZ:2*(DALX=YL!NJ*>E4-V/B(>W0SKH*<GABW2HBR7
M%.D=[@Q<.S@TM  C:-O-<^[ZB(]1)MAD=X]LVFDFHJ0L;(J,+()8K3'<//'M
MKQDL]5^SW8&0=IXQ2EH&I5,8C8G7*=6^S/3KK>\ZWO1DO@$UJJ.OFM?@#4B=
M34E7Q5E92^^J%BQ<?)!C@:*RC(C6[@PU85EBC$3.H"LLBJ0LG<&UE<^X@;0P
M*C[K$$7P*YO#-*9EC<DJ\3/;1=HAD9%.T$[BIW7[@"..39KUKYR9VYCTOX5>
M_P!7C/\ $EN3\?Q/^[_AC,AR,8XQCC&.,8XQCC&.,8XQF/&?O7;^F$O\Q=\8
MS(<8QQC'&,_CB_"8.P'8:+W)2=*@)3+X;196J<SC9".$R8,7.I\I+Y"(-('G
M@Y9JF:^"0<9%E6(5XHX2$*2#<GE'7<NWWU_K3_LZ]"Z#J>D=8ZQ/I=)J^M1=
M4^Q!M1''-+HM"-+IY8C CAC%]JEDU(>9 K2"#MW41O\ FO\ 3AU?K$'4^E],
MAU&ITW2GZ>-54,DD4>KU;:J:.42F,KW3IHX].4B8L(C,9  TBD6G_!I+Z[ V
MG5?82 V;(I3-:QJTW7VE92"5OWI=P#)R5I*E95"A9@DHNZ<B6305'3"(?5QL
MA'E"F^Z22"1U'3GS7_:(Z'T+IO4^@Z[INGTVCZCU.'7GJ,&EC2)9H],VE&EU
MDL,855E=I=1$TNVYQ& 2QA)SW_T(=7ZOK]!UG1ZZ:?4Z#02Z/[#-.[R&*2==
M0=1IHY9"Q:-5BAD$08K"7)  E%_T[<_G#/W7'&,<8QQC'&,<8QQC'&,<8QQC
M'&,<8QQC'&,_GWG3N;2[K?5ELQQ>.*77:_ECO&*O)H@17CK,Q6/9VR*%K:/R
M%(*LW-Y!Q&NZHA4>7:,7"+O_ )@\<H937>*;[=XVB1D.[8FDKB@:>-9&(NQ9
M9R>?.>:Q=HD<%>X^NNSRHV2O&@-42%1%'F^,E2X$^RJ?:ZMOW0KNC76,]&O*
M"_!/XF1T^89TSC]S7[:^$7PW*$L*XVQD5[+]F^I]#T2'B_6>FV]"B]KM-VP_
M_?Z?<7VGXEJMM?C?'T^F6D[O?3N%#_[-J:[88"OU7G<3_#(&J$+89JTNE:-=
MT'1E^OT?(Z];%'X2])XY@04"TS(F.B98(];4U<^S\FLMG5HJTV$AL:-%%%L$
ME<X\-OHY0+-ND>,?:Y:,:AB>/!]Z4/S_ '91 Y> 1QQRD:**Q(Y50+\K226?
MRXKG+"S.CIGU&Z5DYP7VA(BTXMW3A?9F(0RJL$,UK6A&U;^A\1-4S6>Y,8!(
MKQJ35_-IC##"Z8&.X,D["E;ED%&(/T&Z>8<2S;?<5,+1%F^\P6-B':CY# ,+
M)K:+)K-&C:'3EK576<2A4'L3?( 8TL#AE8@\"RQH#C/:CG'G?CC&.,8XQCC&
M.,8XQCC&.,9XX=X[]ND'.;]%TK9U[#]NO-!!['-"*7A/64;!:[DA,7/9.SD7
M86Q>S3UVXE4<+AHT/=,H)38H>>&@&!IR1>ORQT#H/[(8T*QET0]R0J"[2DM1
M4;8UBHA@6^\Y()( %!KX-1+('D"/(!%&'(C6(*A(9KE>8^X$+PJ $ $DV0,J
MZ8F92QK2TL([HT2-SN^?(?3(PDP2W08IE91@F<()LD5%5E$FFCM\MALDHJIN
MFEC77913;&=\Z5M0*/"IK0/G@<?'X#]W\,HQ+,&/EI= QJZYY/UXYK_;EB:R
M["=@GD+ZF=HS-]NI+KV<[,#:>E/6):*UNUK^'QJ7RN:Q=2.01\*B;.V6]DTD
MWC?MN<%9//9*R+XC$X3(QP,VV8>Q<WC0-+%V]O:BWB6V+$@*;;G85D)I0%%6
MM$\W=))-L,IEONRA&B(7:H)9=JTN_?'5L2Q!VM:@55B^WXZ)R+M7T(B=Q-Q!
M&CC4@OEQL#EJ:#B"R#L0)AT2<40*D3$EC8$5))QY6YS$,&%TUO6RP2,=B4=S
M3$?G7.*Q%.R6' CY!IA&2V\CY\[ 2"/:3?%YK/M,VF#UVR9.&^ZTH53&#?!(
M'<*@_(!'(S7;HLWJYU)D?:V>4Z!%M>SS"@((5DE=PAF3&Q:52([+3T%ZZC)4
M-$)M:\:6;.K&DB,4#KE=F]@F(ILAE+#F,"4E&\HLDHB5R>V9& 9N2  &DKRQ
M4*+-6 1\$Y$CPPM,Z =T1*65>%)+%8@P^Z'9O;9]Q4?092;JGM+.K,NF'7Z=
M4U;M/@.S/50M*FYBVB=2OMK%[>TG7[II?LI#YJNRK$02)6Y B4>F[]$[L%=.
M'5=GWK%J[QL1V:[R$3*) Z,8I0*0.-L+L-@.]%)"-8%7]X<YSP[HF:)D>,2P
MD[GV$O/&I[C>QVY=2K40/N&OG(#A,'L);J]Y,Z)7'4W56H:(M47U V$]LZV!
MFY+<T%ET<&5[/JQ'2AZ3C<(0K2872\ (P3:S&)J;  \BD+L&206U.BWCJY9>
M[J61Y7D4S?JF("LIW*Q%%MP0'=M(!(%_%9FJL8-(LB1)&XT]3*"75@$9 UJ
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ME)J@5()OQ0(LW\5D+(C LKHRB[*L"!7FR"0*^;SXQ>]*2G 4M)85<55R^.
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M:T11]QB+H*K.Q +$*HYI118_A8^I( .3-+VD#!=Q9E102%&YC0W,;H#Y-$_
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M_9DYD=95C);&=6Y(J9J0N\:YA=6&K&=$#/PE>Q_1N_?>9H>D0P"W+H1<3(#
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MB/\ IPXW=-_9S_G_ ,S';ZS^VTWY#Z?_ &'^'_#G'Q/_ (3=^=3T[_N[$?\
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ML_N!!IB;*W7B@*&;O7O5NCJJ)0HK7\+Q''5?5E+JAB^4#9]YHVA4\EX*>S%
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MN4Q*S*9@%V JQ5C18/M5@06"$<$W0)$FV1VNC\1LXO35<4A<78RR8F #2:P
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MA,"&Q"521R.>%PL;*LHG8LOG-:GI,-8/%XX,MB&P5R1=(9#;ZMSZB(E75H"
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M98E$=)";$#7K M'SA$B*'HZH,DMN=#S1#88V  T\H"D7L=W9Q'1!!JZ!-@@
MGZ9S+!,P<3+N)U43%@:#I'&J&3@V-VVR/()-<"\L'=W0D= K7,&NN%62O<-*
M/)^][ZL/O7-@36:I.+%GFM%ZU7%T<V+-#ZPTA(\!Y?AIL+U9LG'L]7)=QC*#
M#T<HY[2I&'$\#@!57VKW-Y]H%U:V""?%?.:RZ?;)<2&CIM0A.XM[F";![F-$
MTW(X^OQFY;6G>,SZ??N:8QU1[35K9QB@XI1S>?3*,5TPAT6-2,-&ZI.2Y K'
MK1DACU4,:&BLX;+* $TE&$<64<Y;;>9+:-L:R]TRQ.HD+E5+;B 2P6B@'NH*
M:/SE@\C0=I8ID<QK'N95 4D!"P(8GV@E@:KCGZ9EYET]LR[>PLV\-.YMUVHZ
MDNOD=ZK4NUC<1IV8-+%BEBAF,@O<AH/M&$S]$2 68AZHK9JX',0A1PX@DD3R
MX7&.4<JPLRI&/:)'>0RO9=0K*:C'L9;(][5X&X?PEH'DE:F:*..(0I2QMN#B
MY#[U:A0115&U;XK(,KL/V;HF1]+7UAT!>%S)]4(EW'ZR%)'6["%'9#,X5D]1
MHWK_ &HJVD4TB#7=G.JWA2.YI3Q^2#:4BCB2['77*6^VC&)Q-MD1.Z89 &L!
M6IS(G"G[K-0X\$<YDHEC;3EHI'[(GB+(%8LMH(GY*_>5>?H;^#DV3.R;1U[7
M4/VC9]0>TQ6&)=:K^J4[$1T8K%2Q8I*)!;-,'X^M(0SBV6P- 2;$08X]8.Q\
ME).,I>$PX9M]UE-4:!4[,D?>BW=R-@;;:0%8&O9=@D78'[\T9G[T<P@E*B*1
M" %W@ET(M=]40">"3]0,RTYJ6:]Y'_8=W)Z\L:BH_).D<UZS52E;0D,/D8>7
M=@"TOS;QYX(C,BDXU5@R8U[0KA#9D;>>-:9?LU-F[CQ;1. RP=NF60B99'V$
MT1&%V"R ?+/Y H\CZY+(=09=R-&I@:)2XI@TA;>:!(H!4/DWX^HS;8WV,[>F
MP-;52"Z:SF"7.@2@X&TYY9;F$O.M4,C8E^+1L67Q651"R-9/8VA4"V*IUI'
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MVF[\R##T_ #O2QEVX]'&OB"GHYQGP7GSMG/I^EC.,8QC&N<9SG.<8GX_B?\
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M=P\#]PS+<C)QQC'&,<8QQC'&,<8SS@[8]@#-8=D:::-)(7'5_3/7+MYW O8
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M#.Z@V[$.3=%1@L4T8T6:E"2(LJ@DKN+!ELV:96!HGD@V+Y%6;NT%L7CD>)B
M&V[65@HH6KJRV!QN !H &Z%0A,/)B0N2PR(19AV$O\*5!7F:[)R^;/EZIG!N
MV;J*!!<?'32P8_/*ND5<N=H>/$,=H4# P<%'HR09C3(X4D;$C23;1=4RL3VX
MR#&(E7W*$0$DJI5@WNL[B6)()!-',VTBLJCNR@B3NLWL8O)0 9PR%#MH;0%
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MEEJEVXE :G/UYJ6=SE$JB(T:MI-E)XFQPFEJCR.^_=$HJPP8+SM 6@%J_NT
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MC3$N3S!#S\].I:^7;"6ZHI(9&I6YV)I#-GTZL\CGA3*R*J-&M!0"6.X@4-P
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M=8LDDDFJP0]J.4N5>D<ZC<=S$T268\%7)HJ1MHT .,U:@NH773L3.N_\NN"
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M/-.J6'&:'[)=-9:PZD+].X?-FD^@1J10RX EB@.P<ZD=-'SU?53/(=&R;?4
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M&)G9<CD\5BL4CD;+Q%H&'M!@"NM@+N6*F#1@HX(2QM&'8$<Q3V-[:Z+,%BF
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MPGP-1*H4 H-@"JW;C+  D@!BI;@DD&[%\8.EA9F8]RW;<P$L@1B0 ;0.%-@
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MJR8B00 (R6(EBQ)XMIJDV8CV+==TY64SC5-%+?;/Y/-RRAF(5;))  %DD^
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M?0V_[/DV?J?SQCV4+^;6'T-O^SY%GZ_A_#Z8Q[*%_-K#Z&W_ &?%GZ_]>/\
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MTA<8E)9UU[\G3;(.JW(8 5>Y=]@NX$['06+:!7#5FI[0*QD=3C)P53';KKA
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M@S=09(T33+)''( C!CN;<OZV2ZVN%-<-17GZT15UCE=]6\4KQ%I%*+M38_\
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M'8@*C,6LJ I-@&B10Y /D_'SEFDC4,6=%"UNM@-MBP#9X)'(!\CQF'+=BJ
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M#=%=U'98-(A^]&0H YWL75%5>1R;+#YH'CZ2-0I2%P#ME!;W<;$5"[,WGA:
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M92:_ZXF,17#2",0F2/8HM)4#08FP<PY8HH =/FQ$4XUUW:2)=G:92JZ:4 .
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M+9;?1.@<B19(J$,0HRINM(D##;=@V"*XL_B>6GD* QM%,&,TQOM.5IYF926
M(HA@;NO/TSUJYR9VXXQCC&.,9CTOX5>_U>,_Q);D_'\3_N_Z_P"N69#D8QQC
M'&,<8QQC'&,<8QQC,>,_>NW],)?YB[XQF0XQCC&.,8XQCC&.,8XQCC&.,8XQ
MCC&.,8XQCC&.,8XQCC&.,8XQGA:VH _<772&=>GL6,GC%/>5;L$Y?8\/)'\2
M-,(+).PELWDUG&)"'.1Z2,D3M4W!7DO:O )1$YAK($4QV=MF^WH=QD"RF2P
M^E4(2 06$2(5H@CAU9:((L<YYXB+Q+$1936.9 "5.UI7D#$@@\HZ-P;H_P ,
MM5V#ZIL:VH$*)ZVP"<S!U"^T'6'L,;@KJT9;/9=* ].W=7$TF3&(E[LL HBB
M;S#HL_7#1[:2@Q10FVU;)9T)$/6+91REI+E8*#'+&&"*H!>-E!8(HXLBS1-9
MK+ %C A5F*S0RE2[,2(Y$8T9&/.U>!8L_B<JG8E07/:\E[#7*6ZX]AX<SD?9
M'K79U4.(/-*;"]@H,+KB@3=;$;: PJ0O)Y6TO)##;]T()U%,"+=V_A<F=FDM
MM)@%;1C;571!&@DC)$<JON5RAW.&"%A3 $>'7P>/!)S)D=S*YBE4-+$Z;6C$
MJA8RA<*VY20;!0FRI)'N&W/K5=6=DX!)>O\ ?=J=>"MF1JMY?W%&;PR&P6EH
M1=?AKV)U0;K[LG.JIBLM&U6YM1^I#;'B$YUAIQ.1-H_9 \\J#:OWDU%L#/&P
MDC20*6$)W%G9/U88-$K%2^P6K"QY6K-#(5)4:.5XRZJTX*JJ*Y[A0K*T8;9N
M.UE;:00&!KE@-<J2N)]0=YU]/)A0F\TWFD6[OR&*=1HK+Z4?VC0$0N;L/"IR
M(/C(I,K%B\$>QTJ'RUBUKD()(B V 'Y,%!^O(1PD1?(RS*Z,!)MVF &8A]KE
M(F5@2JEKOE+ W $GFLA%:.16:/<674,L"M&7C6256!IF52".'*DA"0.02173
MK/2=U?%=U OR&@+O$UIGKI>=8,XMUC!]9+%D%<&9'V@G<X:M4 G8B/&H^0KZ
MQ(>\!!$Y;7^&ZF4H0 VD&<Q<JV=L[R.F^:-BA8R(Q,AD4,!&JV3&00RM9(8'
M[Q  -YG%')L@D59 G:D3;$(69-TK,.)00492!:5]T$\41=[K+TRET(GL-=SV
MI2&X$#Y/!Y3@_-A':XL0O&)9++RL&;DZJ7,Q*-Q"+**"HH:CXE9&)Q$="V E
MBSCHDB68#4W[W&28,IIZ)G#G:&4$"-5W423R03R2UDGB\WB@*NNY#2Z79[MC
M$,9&8I:@ TI .T;:  OC,S7U?S<!%_(JT;(1;H%;M,1 9/[1$KN$'I.(Q.J>
MG4FI:>,B3E@N]9[MU[(MJ Q+95)XLT=NW6N[)9RFUW43,R%M:XY1R50@4"S2
MAU(NC]U&;^'XX1'"Z",\/& S@FR%2!D8?-^YU'G\?CCV&YQYWXXQCC&.,8XQ
ME,NZ-:SBRQ/6IO!H^YD"T*[F];+*E";9PQ;Y$0>%37).42!?+YTUU6;"&/\
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M7N6'M!NDDW(Z-LI)OVZ::#S1=+373&B2/'9C=TNKVDK=<\T?@^//\,H\4<H
MD1' L@.H:KX-6#5CSDFB1NH 4-! @ (*$#,&8H.'$J:CA8H6/;IM& T:/9B$
M6C%@Q:I)-FC-JBDW;-TDT44]$]-=<4-$W9))LDCG\3Y-G_J\L      !0 X
M \ #X S(>M)^YLOK%;[MXX^I_+_CDY@TX\P2DCN8IQB/:2M\$8QMW(\;X]M+
MQ\8^($QX10C[*\5D6T(E2+Y)EA7#?5V\7<>KRKMZ7)OBK-635<7XOSYH#_KS
M%"RU"R +^:'(%_2R37UYS.>M)^YLOK%;[MY''X_E^?S_ /3^&3CUI/W-E]8K
M?=O(X_Z'_'&/6D_<V7UBM]V\GCZG\O\ CC'K2?N;+ZQ6^[>./J?R^?S_ -?^
MK&/6D_<V7UBM]V\<?4_E_P <8]:3]S9?6*WW;QQ]3^7_ !^G_I^.,PAB/,9
MY /3D8CQ9Y%36LCC+L@IATY 'M1I(-@P'76$[*CB60YDN*W=M-TEE!I0@QWW
MV:O'"2D@U=$@$4>/(X-'GZB_X _N@@&K .TV/P-$6/QHD?N)&9OUI/W-E]8K
M?=O(X^I_(?\ KDX]:3]S9?6*WW;QQ]3^''_'_P!<8]:3]S9?6*WW;QQ]3^0_
M]<8]:3]S9?6*WW;QQ]3^0_\ 7&/6D_<V7UBM]V\<?4_D/_7&/6D_<V7UBM]V
M\<?4_E_QQCUI/W-E]8K?=O''U/Y?\<8]:3]S9?6*WW;QQ^/Y?\<9A&L>8LI
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M!C%+9)%9Y,<[U$_>G+M(BLLD06"C( U2&) *2RI$A):AS9&>BA_RI56 K*E
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MLEC:.8QA %O9(9?)Y;:%7C_W:L?-DW\5SRZ<2F0ER.Y$L55]U0Q9JYYWW1_
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M7N]:#JR%G/\ DY!(60T=EEODP_5?;MM31TDX:*/S#YSNEN0)/7CU3T5%LXY
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M_&*EC$@VF]?,069<W@1N;%=EYC&62DML(ZN^,-4=&^6G>@5)"EJ FF+;F7<
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MYVRR+]\JNT1K8W!2QW$;>!3&ZJ9>G9.P[9UEUG(MK%IQY)^EO2.3/JY?$Y4
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M\Z\D<F?.QT=,Q63&,LJ\W61.'9*_8EA#5Q(TZ=QE.]:0,J.T:,Y+40LA_5L
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M8QQC'&,<8QQC'&,<8QQC'&,<8RCD)ZC"V*TK@<Q0W?57%.UK?MU0BHHVJS(
M9=(Y&0L^4Q8ZQU;XRJ-"W*:G$F8:ZJ[,B4<F@H/G"3H"\5<;-*33#[QB[3V/
M( "@C]Z!1^!4_7.=80+1A:+-WHJ-4Q)<@@>:<L>>"& ^+RQ5V4M"K^@#NNIW
M@X@*4.1.5BC$7./HU*8O,(')Q,SA4MC!\=OH[%'HQ*08HR-<XPLWV<,]4'K5
MVR6<-5J([1MN6KIE((!!5@58$'R""0?]6:R1K*NUKJU8$$@AE8,I!'@@@'*[
MMN@-,MF4L7TEEV*3R8V!"[7*V^M:IU2TT;(@43?00!+!TA]7ABS4UA9-]%'D
M=P'WACF/.-@_P:3'Z)M]+]]^!2;55E"[1MVL0Q%?^8!KO=?-YE]F2C[I-S,K
ME]YW[U!4,#_Y3M(K;MXVY]M>@M*- X#4(=MF.6)'9S.[(;WH#L,BVN8A,;0'
MBQ%BD3LH<-G0PTQF(@!&AA6-OX^M%D6L6BWLL*.7C899D[[\BE*E5785!0!2
M2H \BB2;!NR;/)R?L\="BX8,S=P.>X6< ,2WR& %K6WVKQP,@2XNEQ^$;TVE
MUKK?VZ,@PFX&AR3CNRMD4;V'<R2WI,$F$M,&;@0'39M8<4L4^S(F+&$2</K(
MQ\J;1650HLU6#X&)Z),&W=QJLK0,:R1@*-HI+7:RCA2#1%JWF\RD@*E.TEA1
M);"5XY;<AC[_ ';@YLL&Y#!2I%9LM$^3FC->T3U\AQR;3F"W'3T!E4->630\
M^D$6>K [%F;NQ)=7FQ0RW?+3"$#I.\3Q'2$N#J2-JH-3D(Y< 9*$_60^H+/(
M0JLCLK;9%!Y4!0W'@D#FC7-<C+1Z8+'$I9E=%*EHW(-,VYEL\L-W@D7Q8HDY
M:* ]4Z=K,V-/Q 8=9OA5(L>O[;9_)C!O96 ,9*7EWI$'9IR_)E9,^D!TH1*R
M8F_=E"3ATHJ[555VV4VR:5V%&JW]S@ >Z@/ H 4!P!FJPHA!6[$8B%L3[02W
M)-DFSR223D> NK+:-SWJ;' *"3&@^F-7O1U9,")14O)C%AN85FFHJY([J(ZX
MPQ@52JS%!R0<[9<GSL_9.6VC7$<=9=V,I*RDG]9,WO- #;>\C_[9Z/'@+7-Y
M00A6A4"HM.AV6;);;L7F[]J;@219+?ONZ7,<Z,<8QQC'&,<8RHUR]+:IN^2R
M^02:06L :6;$!L!N&(0:Q3$7AEP0P2D8:,P$\!MM5O6)9%GS 1X2C;J-G"8)
M[L&)%78]NT;M]4F= H 0[&+(Q4%D8UR#^\ @-8!%@><P?3I(S,2XWJ%=5<A7
M46*9?W$@U1(-&QF/E?16C9?(K3D;U6P1:]L':RFI1A&IR6CH^)V93XF/@8#:
ME=Y%X;D87/1 **QT*L1%D,#28D9J/)"735Z32>R)Y $'M.P,HM0;5R2RM=@J
M22:(X/C#:>-F=O<"Y1C3$ .@ 5UKD, H%W1 HCDWD /2VIA*H,J9-V=/I>&N
M2*WJM/+ GA"12PU.X1$B\(BFI-QE%H*;QD'&SA%FRBH$0$!Z.'"Y+9GL3=OW
M;N#,YL *HV%-JJ  K$%J^;)')))R1 @HDNS!UDW,Q+%E!47\4 2*  YOSSFP
MONI=/$!,D"N6)[+&5=E(?VO+ZZ'7&BF]O0:706; 7R"F$\Y0!)G:ZC2CH'KC
M+=RV2=MME,:N]\ZN\_!L<1-".!PC!@1^^F//G'8C((YIIEG//_B*RL/X;D4U
MFSW3U_AEX? P@<*S.'S&N#!$Y7]BUQ)7$3G,1>FA#D ?1'%$D7C)Z)D 5THP
M-@3HPN#(ZILG3@=L_&#';.J.4L  A@ RL+!HV/W$'P00?//.6>-9-I)960DJ
MRDJPL4?P((X(((/TR#D_)_TD)0B[J"2*Y*OF<=&S(00L^O[1/"K'GC"Q)>YL
M&<IV1(2."Z<T=2*<OB,K]J%F"A:/F21%>(OX\F\72WOWWY#!'4E2%9057:-J
M[0*V@+Q0-$ 79 .9_9HQ14NC ,"ZN0S!FWMO/AK8DV18).TB\RQ'H5UT(BM
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MR/Z ^CO[!T?YS_SL?BN^@?YLD#^E2C/_ .4''^,KUR/_ ,H];_F:8_[8,?T
M]'?V#H_SG_G8_%=] _S9()\O_P!ZE'_7_P#:#_N_D_BX_P 97KG^\>N_S=-_
M(Q_0'T=_8.C_ #G^/_NW_P!/SG/XKSH)Y_/^YE@GG_)^^I1_Q!Q_C*]<_P!X
M]=_FZ;^1C^@'H[^P='^<_P#.SC\5WT#_ #9(']*E'_3_ /S!_P!.>/\ &5ZZ
M_O'K?\S2_P C'] /1W]@Z/\ .?\ G8_%=]!/S98)]+E/_$'Y/^C\G'^,KUS_
M 'CUWF_NZ;^1X_#QC^@/H[^P-%XKS/\ SO/X^<?BN^@?YLD#^E2C_B#C_&5Z
MY_O'KO\ -TW\C'] /1W]@Z/\Y_YV/Q7?0/\ -D@G_:ZE&?\ \H/^_P#E_CX_
MQE>N?[QZW_,TW\C'] ?1W]@:+Y^9_G_[M_\ 1\9S^*\Z"?FRP3Y/_O<I_C__
M !@__-Q_C*]<_P!X];_F:;^1_P#1\8_H#Z._L'1_G/\ SO\ Z?G./Q7?0/\
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MQE>NO[QZW_,TO\C'] /1W]@Z/\Y_YV/Q7?0/'_HR03Z5*,_^^0<?XRO7(_\
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M_P 97KG^\>N_S=-_(Q_0'T=_8.C_ #G_ )W_ -'QC\5WT#_-D@GTJ4?\0?\
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M2($ZV9&@3_9HJKJT+"7FFS4D/7SHZ9.-=D7"2:F,Z\D@CR"+%BQ5@^#^X_7
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MNHJ<[ EJ!I,O.I2A*FMC&93M4$H'9,DL2C31>6.6Q30I,P"=R-E.Y6*@W^I
M8JQ$?<<**V@;QQ[? S(/ C%S'(K#:RJS#:>\S .BF0QH6:PQ.QA?-6;])*VN
M!Q90N$F&U66;%V,O8SAP_7E;6&MDH6^A1]E'TA4@7#30V@7^&RCAZ8@$A@"D
MUALCC@AV;S)63-\ V,\[)M)!921MJMW(8$V+457A@VU@2!7FNE)-X4A' 8-R
MP7VE2!1IB#NY*E2RD"[Y%U(N3NB4KSMI#JK&O()I4D5)51#K\=F%LZ3-G-.R
MQ"11VFTHAMJ8;Z)MXM(1$-6L%%T$((8C=MQ\Q@F*U#.$WNJ0AH68AMYW&.O&
MV, O?[P3M-^4(HV,QDG*S*@V[ 462_.Z4D1[:/\ 58*&L54BFQ7-CJ&M:3V5
M,NU(&0I"DV-,=CMJIB.PUJNV76C&M#T39/K3*BSMUH\*_"&R) GETW39(>S4
MQK;PGKFRSESFZ!1$1=O'O-_7>Z\?A2C-8W+-,#5)+L6OIVXVY_&V/\*S5.NY
M9OVDH/K]<-M @Q"8##3FRP>1&"HD8"F@A::PAB8',TRBNZF4XX8+,MFA-P09
M;[$%G&S?*R;7=O,GZJ21$)"FT-^2IHT>/J!\ \96(]Z**1P"WWQ5@!AN4$<_
M0D<WYR:;=L_6I8EK*,0><6$X7,BP;..0)D$6)[N2BN^F'Y0M*S\4AD4CHY%)
M9V7D\PE,? L$DTV^S]0D]','E$7>:W*O!-L37'X %B?H%!)^F:.^P7M9N0*4
M"^?DDE5 'R68 ?6R!E6X]W^@\X!QA>MZ?NFR9R?VN7<C5,-2J5]+XF/H29,(
M!8Q4V=>6RPK BQ1E9<,+BVL0L&3O9NH505B[,DW8G%1.I@87N=%4; &;> W<
M&Y:&S?X!))4 5S1(O%=2K ;8Y'8E[5=A*]M@K$L7">2-M,2W]6\D9#N%6[B.
MRB2:QNQVR$2OBE.NY,66C+<!(=9Y>XRC2L045!'BPTB*&#$NP$,;2Q"0(!Y$
M#?CI.SS'W*PUI@E7LM8%KRCR6#8VH7#<@$'[C55@BB#SE^^E$T_MDCB(( .Z
M01E>"00!W%W71!!%<<UKK_RDC1]7$,,V#3$W;6;+G-TF<5W&3](CG ^N:KLT
MG DY>L3FUYAXXON]<IM(\U ,Y.YF,GE0B6/8Y$-HJ/3)ZZ-I_<0KKL&P;V#U
MN=0U4$+?C>W: 19LYDNJ]JEXV#L9/:#&*5'*[K:0#GP!>YF!I0!8L?9G8Q-*
MH^OMOU"]%2"*WC:_68,'*D6#S9$E6]Y3.+#E2;)KNN.<L"KB,R##D=N^U_\
MD][NGEZQ5RDHWSFL?O='%%%D)%^&12?X\C^(_/-'EI(GCHK))$+/RDA XY'-
M'CZ?(\Y'QWRA],A(=&9@C$[6/YD%>Z6 _C ".QUU*X?E2ZX5U[3A4M'.Y<Q:
M,)VK:LO(1M (Q(DFRZU?V%LD2WV!-DR5AIW)()5:;;;$@'V&3<."=NP W0^\
MOUR#J4 !VN;7=0"VOZQ8MK6PIM[$4+'M;GCGN1?O9'#LW:P@Y15\P!9&Z&/7
MJ72"6LZF6C<$N [$FDZB42..XE;4I?&$Y7%3$8)CI#!QLMC(]271\;(# <FH
M49BQ@(7<'1O9W !OMD!*EA: "F!%,5)HD BB2Z@%MICD7]9VF)V4KD!E!(<W
MN4@@J& W &C=07-/*:"R'6<M=,"J>U8"^EW7J07_ $$^M^,1-419T?C&8LH=
M;, L%L:2GFI@<TEP8@V!2-&,NI,)=[&XBL>$LWSMM<:8B41LZ-4@CDV$@H3=
M664"N.2+ /!HYDVKN$R(CJ3$98RX!#@46H*Q((!%!JW78L U8'?O#&&BQB,F
M:8NT%<#*PH16H&C7S2KG5@34Y8D-D=AQ9['"P:TBM8)!%(5"I[(39&16&!^#
M;."2C0V@S<MAZ!*G8)Y#QE-K,9!OV@*0IL% ][F4"E-EA7&:_:%Y!20/N5!&
M0FYBRE@5.\H12L22PK:;^+BISWZ.$;HKV&0:B;<F[,O678Y_8E5!@<!;7!7M
MET58=-1E^P/D)%:8"N=0C8/.RBK;8!+))B:KG80]ACTHP(>FM;L (S-(@(:,
M*Q)V,KJYXI2UVH\@;:;=64.I/=55C=@4D+( HD5XW0$$LX6J)\$[B5VFC>;#
M%>\J4B)V5)(W"Y5:M<>JZ\/ZC;U\#$"3[@)<]0/;0<'K /6-+87"84#9-6>V
MBI69GHDV8$%QT3UR1E9@0*?08*V L$8]P/NL@%'"TH568DWX -U? !.2-2"7
M8*73]44VT#4B;[8LP"@5Y8@ T/.=1AY3&G3C*N5(K7EM2PU8(JPS.T/!_%+O
M+0#6JK)?U/.FS<4_MAAI:)@/,1)5)$%0[JV"Y04S2+BV;MH9CF3(Z9QNMD 4
MJ+.^CO3>O.SV@K\OMH\&J:@U:$+2N2P8[1LW#8Y1P 7&\JP/$>\D41P1?6;]
MXR ZR+%"6;'GM5P6N>V<WI)I*'8&.R,=,(-".FT@[*&2Q)^)M1P7ASE@C'W\
MOW/J1!_XB,/8;"_@@C)2<U,09V/:I4[RT2O0)!#-,(@ -ON^E6.;:Z"JS[13
M,'!15F:,-0(95@,I)(>QXN]OBEV@[BMIJ6O9W<*KW1[2EU5*GB-QJ8Q]]:(&
M*("9;&)7DA@8[#F8-,YR)8&VNH[*IV$2A['YT!;/Q3HI&V[8@DKS)TV>'1^2
M#M)L$?4,JFOHP!4_!S9)-]^R1. PW@ $&_!5F (KE33"P2*.4TC/E)8V!ABJ
MUCQ<Y+9N(*=@9%-&5;J5\&:0JI:T[)7-3D/DC]C9-F1$C)2YH/59-1*,5]K,
MI@<?QV1.V$8;Z+"F+O8Z<EJ5@H(C +[N7:-'86J$  N.6VJ 19^<YUU8"VX+
M-<A8+M&U%EDC4TS DTGW5W,:) RSNG<2I7(:2R$8C*# .-7O0/7[8F.'C-VQ
MF4]D65$$*\D(3+@RW47AVC/L/!ESC]XFQ+L]&DA\"#);,Q^I3/LO8!H$QR25
M?(6/?N!H'G]6:^/%D<UK]H2B19 DBBL 46E,>TCG[OZQ23P?/&5UISRC]?2.
MJK!F<X1)%W-+;'V=O2B!B1NT(CLV>VP4@5:TPW7)R=-Z\MZ6C5HJ_P @6VBX
M@*F=$OI@=BB<A!MWFCZ=@ZJO&\ HK7N*[0S/X(V [N2;-&@:.9QZI61BUDI8
M<J!M#%RJ)9/WR*-#@6"Q6QF[-?*&UV]]G F-56X5M$G:T9J%O40!Y2LEE.#L
MTK6QK4B1_:4QZXR=3;0TU':JFS38XC8RNX8V$?,) Q%:,WCEO4Z=N3O39M+;
MR' I65"**;[!=21MY!X)\9;[2O V.7+A-@,;&V1W4E@Y3:51N=W!X/US1C_E
M)(>ZJJ9S1M6]UU4AK2/9&R(1-IW"*[DHUW(.LS-=I:\91A("Z6APK(H+($W;
M1,<<(P>(3S($M\$[$6$*,#[FPTS;E7<C$O$I568<2_<.XI0##GBV4$6MV!5M
M6NQFVR(.W*RLRH;,7$@"B2R5/UI6H[6(Y,YR3N9$8=<45J.3UM:@9M,K&$U-
M'+**-:_%1 U.#4=V/CDA,9(V&VM\K&'6^B@'2=BJR?PG,@35:Z'U&#=P32H(
M6*%PRFE+E1N)"@T;(4H#\[2X:OBR =#J%#A"CC<X0,=H!8BQ2E@Y7XW!"MV+
MXS=+M[ .:=ZT63V ?U^?:%(3$#QH=74H=AAY<@?;/%@T8#EB4=)2H0,8R(RH
M*WW*,WI38:&):OG+3QC=<<G5(]\BQ[A[B 6%D 'DD< FA?TY'FN<L\FR)Y-I
MM5)"F@2;H T6 !-<BZ!NKXR("A'N[4<?F4ZL">4#:47'TW9TO--8S6DMK,A6
M]A1:*J'XHVC/CK%GWQCP,H];OPYAH?VBDF9>'8G&YIPD[<@6EQV'(55D4[U
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MKJ.**)Y>[[ZC_39.%,*ZUCC#AA8!!0 DTH+.%MB >.?/QYRTLIC,?!*D2,P
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M.OU,7'--#,JD%TIUJ:%0[6TA2!J:*2Z,M%I')A<(C821:LATJD]>SPIW*J[
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MK,:YE-$#(HW9,Z^$20BQ"K"K EJAAP[ *M-W: ;3VHP4QHW(6CB[D3L/OJZ
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M# :N$6.J?MTGE?9&D",L>X6Z%F4D$FF"*2"."2U#Y/GP,PD2(R*TA#4C[48
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M,IMUU%EI>['06 UA&G'P/9F68P@E!ZW! (YM*BV#Y%>83%TV<G91OH(9NW"
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MRXTVS1<]$+(%A!$9W:AEDW*I/;*Q#DL"57EC8JB";^G/.LA><KW/9ID:+:7
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M1]QEX&P!>31)-D*U4!0NQ"-==A;RO)6A:>@-YU$]-32%WY:$[[(5U"G)=(A
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MDB8*KV<G/C0EK% 2C4P,>R=)T@DI;[*QV4P(??1V2"^VNX[05!>Q]T+9)!!
MR/M:C?:$,@0D;XR!W&*C<P8JFTCW[C0'@MFQ3+RE590H!6SLM#G+*56'&YM-
M$8F>M[KO$&C6(0.38BCLX%GTIMH57TZTF9';5S63>&R,MO)A.=B9O>(MT'>6
M\+IF8L >%*K820DLPL J%W+0^]N H\"[&2=4@"VM,P9J+Q**5MMABX5MQ^[1
MY')VY<BIK;&7*  SF( C.:SFE<UO94 G[Y8*D-F(JQ1A$UH.9AD"KB3"2D:%
MHA')S4^'&,E=I*P;AGA1PQ-)C<70H2K$;E9E9>;4J:Y- $$W5$^.:L7LD@D
M90=C(CH_%,'!- 78*BKL#R*^:\Y#O9+L+&+[,@K)LQG1>,]C1,%K6O+.H.3H
M]=[6I,G+!0,*]$=J08HX,8W7.(R[=%HX$*2@(BPL-85 "%?N62FYUST"*,H"
MJ]S]668K(.XK[2>8C1**:!H&P"=U\9S-+(LA#N(_U@5%>,B-T+ "I@" [*>
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M7D$>>*I>EYM'P(X7$/D<INQQ%VT617WQ8;6*V#1JQ='\P#_ @'.A&W*K45W
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M"[+&Q';#.&!/"[R/<U L0NXT/%5WISHY:DRFIB5=DI)8S40.K"AJ[B@H[:D
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M"L)IT1M^YBVYG8D* Q9 AM550/:!X LBS=YKL7\GA3L!JJ%UI7LJL>($:WM
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LC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g55600g07g07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g55600g07g07.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X6S2:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 V+C M8S P,B W.2XQ
M-C0U,3DL(#(P,C O,#@O,C4M,3<Z-30Z,# @(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX
M;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@
M(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F
M(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @
M>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O="]P
M9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @(" @('AM
M;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]G+R(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T<F%T
M;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^"B @
M(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z
M9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U
M;'0B/F<P-V<P-SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @
M(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SID97-C<FEP=&EO;CX*
M(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE($YA;64Z(" @(" @(" @(" @(" @
M9S W9S W+F%I)B-X03M5<V5R;F%M93H@(" @(" @(" @(" @(')R-C U-#DX
M)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @(" P-BU&96(M,C R-" Q-3HQ
M-CHT-"8C>$$[15-4(%1I;64Z(" @(" @(" @(" @(" P-BU&96(M,C R-" P
M-3HT-CHT-"8C>$$[4V-R:7!T(%9E<G-I;VXZ(" @(" @(" @,BXV)B-X03M)
M;&QU<W1R871O<B!697)S:6]N.B @(" R-2XP+C F(WA!.T=R87!H:6,@='EP
M93H@(" @(" @(" @1FQO=R!#:&%R="8C>$$[)B-X03L@(" @(" @XH"B(#$@
M<&%T:"!O8FIE8W1S(&AA=F4@=&]T86P@:6YK(&-O=F5R86=E(&]V97(@,C@P
M+B8C>$$[*BHJ1DE8($%.1"!215)53B!04D5&3$E'2%0@4T-225!4*BHJ)B-X
M03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE
M(&1O8W5M96YT.B8C>$$[(" @(" @(" @(%1I;65S3F5W4F]M86Y04TU4)B-X
M03L@(" @(" @(" @5&EM97-.97=2;VUA;E!3+4)O;&1-5"8C>$$[)B-X03M4
M:&4@9F]L;&]W:6YG(&-O;&]R<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE
M;G0Z)B-X03L@(" @(" @(" @0FQA8VLF(WA!.R @(" @(" @("!#35E+)B-X
M03LF(WA!.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+28C>$$[1FEL92!.86UE.B @(" @(" @(" @(" @(&<P-V<P
M-RYA:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!R<C8P-30Y."8C>$$[
M3&]C86P@5&EM93H@(" @(" @(" @(" @,#8M1F5B+3(P,C0@,34Z,3DZ,C F
M(WA!.T535"!4:6UE.B @(" @(" @(" @(" @,#8M1F5B+3(P,C0@,#4Z-#DZ
M,C F(WA!.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T
M<F%T;W(@5F5R<VEO;CH@(" @,C4N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @
M(" @(" @($9L;W<@0VAA<G0F(WA!.R8C>$$[(" @(" @(.* HB Q('!A=&@@
M;V)J96-T<R!H879E('1O=&%L(&EN:R!C;W9E<F%G92!O=F5R(#(X,"XF(WA!
M.RHJ*D9)6"!!3D0@4D5254X@4%)%1DQ)1TA4(%-#4DE05"HJ*B8C>$$[)B-X
M03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U
M;65N=#HF(WA!.R @(" @(" @("!4:6UE<TYE=U)O;6%N4%--5"8C>$$[(" @
M(" @(" @(%1I;65S3F5W4F]M86Y04RU";VQD350F(WA!.R8C>$$[5&AE(&9O
M;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C
M>$$[(" @(" @(" @($)L86-K)B-X03L@(" @(" @(" @0TU92R8C>$$[)B-X
M03LM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TF(WA!.T9I;&4@3F%M93H@(" @(" @(" @(" @("!G,#=G,#<N86DF
M(WA!.U5S97)N86UE.B @(" @(" @(" @(" @<G(V,#4T.3@F(WA!.TQO8V%L
M(%1I;64Z(" @(" @(" @(" @(# V+49E8BTR,#(T(#$U.C(R.C$V)B-X03M%
M4U0@5&EM93H@(" @(" @(" @(" @(# V+49E8BTR,#(T(# U.C4R.C$V)B-X
M03M38W)I<'0@5F5R<VEO;CH@(" @(" @(" R+C8F(WA!.TEL;'5S=')A=&]R
M(%9E<G-I;VXZ(" @(#(U+C N,"8C>$$[1W)A<&AI8R!T>7!E.B @(" @(" @
M("!&;&]W($-H87)T)B-X03LF(WA!.R @(" @("#B@*(@,2!P871H(&]B:F5C
M=',@:&%V92!T;W1A;"!I;FL@8V]V97)A9V4@;W9E<B R.# N)B-X03LJ*BI&
M25@@04Y$(%)%4E5.(%!2149,24=(5"!30U))4%0J*BHF(WA!.R8C>$$[5&AE
M(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z
M)B-X03L@(" @(" @(" @5&EM97-.97=2;VUA;E!3350F(WA!.R @(" @(" @
M("!4:6UE<TYE=U)O;6%N4%,M0F]L9$U4)B-X03LF(WA!.U1H92!F;VQL;W=I
M;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @
M(" @(" @("!";&%C:R8C>$$[(" @(" @(" @($--64LF(WA!.R8C>$$[+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M)B-X03M&:6QE($YA;64Z(" @(" @(" @(" @(" @9S W9S W+F%I)B-X03M5
M<V5R;F%M93H@(" @(" @(" @(" @(')R-C U-#DX)B-X03M,;V-A;"!4:6UE
M.B @(" @(" @(" @(" P-BU&96(M,C R-" Q-3HR,SHQ,B8C>$$[15-4(%1I
M;64Z(" @(" @(" @(" @(" P-BU&96(M,C R-" P-3HU,SHQ,B8C>$$[4V-R
M:7!T(%9E<G-I;VXZ(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S
M:6]N.B @(" R-2XP+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @1FQO
M=R!#:&%R="8C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O
M;7!L971E+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L
M971E9"!P97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F
M;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @
M(" @5&EM97-.97=2;VUA;E!3350F(WA!.R @(" @(" @("!4:6UE<TYE=U)O
M;6%N4%,M0F]L9$U4)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R
M92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!";&%C
M:R8C>$$[(" @(" @(" @($--64LF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03M&:6QE($YA
M;64Z(" @(" @(" @(" @(" @9S W9S W+F%I)B-X03M5<V5R;F%M93H@(" @
M(" @(" @(" @(')R-C U-#DX)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @
M(" P-BU&96(M,C R-" Q-CHR,SHT,28C>$$[15-4(%1I;64Z(" @(" @(" @
M(" @(" P-BU&96(M,C R-" P-CHU,SHT,28C>$$[4V-R:7!T(%9E<G-I;VXZ
M(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" R-2XP
M+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @1FQO=R!#:&%R="8C>$$[
M)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0;&5A
M<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@<')O
M8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E
M<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @5&EM97-.97=2
M;VUA;E!3350F(WA!.R @(" @(" @("!4:6UE<TYE=U)O;6%N4%,M0F]L9$U4
M)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN
M('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!";&%C:R8C>$$[(" @(" @
M(" @($--64LF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.F1E<V-R:7!T:6]N/@H@(" @
M(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D^<G(V,#4T.3@\+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @
M(#QX;7 Z0W)E871E1&%T93XR,#(T+3 R+3 V5#$V.C(T.C R*S U.C,P/"]X
M;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B
M92!);&QU<W1R871O<B R-2XP("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L
M/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R-"TP,BTP-E0Q-CHR-#HP
M,BLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T861A
M=&%$871E/C(P,C0M,#(M,#94,38Z,C0Z,#(K,#4Z,S \+WAM<#I-971A9&%T
M841A=&4^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @(" @(" @
M/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIW:61T
M:#XR-38\+WAM<$=);6<Z=VED=&@^"B @(" @(" @(" @(" @(" @(#QX;7!'
M26UG.FAE:6=H=#XQ,3(\+WAM<$=);6<Z:&5I9VAT/@H@(" @(" @(" @(" @
M(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B @
M(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G
M04)!9T5!4T%"24%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP
M04%!04%!0D%!4T%!04%!14$F(WA!.T%10DE!04%!05%!0B\K-$%$:T9K8C)*
M;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"9VM'0E%92D-W9T="9V=,
M1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%03A/1$)-5$9"451%>'=B
M1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O9DAX.&8F
M(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!8T%%04%W15(F(WA!.T%!25)!
M44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'05%!2$-!
M:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&0F=C24-1
M;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A15D5'13)%
M:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4:W%+
M>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q4S!6=$Y6
M2T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U=EDS
M4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59;5HF
M(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1545"
M45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:>&=:17DF(WA!.V]B2'=&
M34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%9WAD56MW
M9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U45350
M4FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF
M,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP
M86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!;5AN6'DY-6=U4$Y7
M;UA';7)D>7@F(WA!.UAL=V93:VDQ0TM/,S1/:TIB;6I':7)60T]N:GDU8EIS
M35=34$-,<C5.16]M+W="<5%7;6=E8C11:U0V6&1Y,GEX4%1N9C(S3FU5>64F
M(WA!.VYZ,V%L5$E+:7 K>E5(3$1/2&50:WA&.3,R=EAV>2\Q=E=L:&TP>E<W
M84-X='1.:FEG<V)G4W%X;E9E4T9I5$DR.49"-F0X=W,P63@F(WA!.W@Q8F]N
M=EIF*VLY3B]W0U=U2"]K678X05A+84Q+,V9P4%1F*U=U2"]!2D=,+UA':71S
M1C%0>C$U,V@Q=3ET8E!23&4T,#9&,E<P=2\F(WA!.W)%9C<U9E)D,4Y055AJ
M*SA654YF2$UI3TM&06LW<T]-,WE3.69Z12]-,&EA3F9,3G,P>4Y,-DUH=5EO
M-&Y#1VED6E-15V]4=C=$=E4F(WA!.U,X2$@O3U)X>3=K9C55.#EE97(O048Q
M3%189$1T=$XP=W%X82M7-&IF8TI64G@Y4FE+=&MC;4M!:EE.;%EZ:U1U1V0O
M<%!49BM7=4@F(WA!.R]K678Y8W@V3%IB=C!N<'8O3%A$+W=!:D8O<FI25S-F
M<%!49BM7=4@O:UEV.6-A2S(X,T@U9R]M6BMK56@O=S=A1WED9T1C+U=9=U$F
M(WA!.T]95FE6.54P,DYF;'8T9UI89S0V*W)D<C0U6'DR5E@X+V9M3#!J.'8R
M<&%.5EDX<FE-0U%T-F9W<695*T%J;3%A,2MZ9SA,2#-P-&HF(WA!.S-*:C59
M.#0K8S<S57)E3%<Y3'1,0W=K5V-Y,T-80TUY8T-"1E9F55EJ;C1B-4A*:F="
M<V)+67E05FU8-E0P,R]!2F$T9BM2:2]W0F,F(WA!.V]O<W)E569M.5IA-V8V
M>F%8;6=2=F5E:&)*6#!B=4M"95-4*W%2.%1B<V5+.75L84AS8WI44VE"56UR
M3&92:',O;&9Z;W-%:TYT8C,F(WA!.V9%5SA%57ET9E=N3U)2-DUK9T1K<TMI
M5T1A;$11=%AQ5DXT>5$X=FMW35186#5T+V]8>GA*1DI$1F)8.$0S17%225AV
M<E-N,5EV4'DF(WA!.T5R9VUH,FER<S%E<$]W<3AC3SAF2F95.6\X:C9V<41A
M17-/=D=+,G9,5U)R94UT3$-7;&EJ04-3;C R2VIL=C1F3$U$3$58<S-X4&4F
M(WA!.WE$.4HV8B]Y,7<O.&I&+W)L9$9.<TLX,&5D=D]7;C8V24Y',&DR,5!2
M,5=.;G50<D-,2WI.6&UQ9W5"=%1Q9DAO8W9X-&]%8FUI=VPF(WA!.TDS<TYK
M4&\O;C-Z>F1A:$Q(9C9&0EI744YQ65A-.&)S>7I815-4,4EL;T1&0SAJ,' K
M>FAL:6="<U5#6C=M92]P4%1F*U=U2"]K678F(WA!.SEC>#9,6F)V,&YP=B],
M6$0O=T%J1B]R:E)7,V9P4%1F*U=U2"]K678Y8V%+,G=,5W90=FYQ>#%M84MY
M,$,S,413:VUK4TME3S526E@F(WA!.VI%65I(2W,S169'864O=&U22$9!:F,P
M5W-Z25!*1%%F;48K63=2,TIL.'0R>5-P3UDW95 V>DA1>"ML27=K3&5P42]'
M<4$P+VIT230F(WA!.V-F.$%/551L,TTO<TY8=#5B1S-L=35924QQ4TI'=4E"
M2VI"2D-O3'!Y0C,T='1835EX,S)B3%8O,&YP=B],6$0O=T%J1B]R9V]R8G8F
M(WA!.S!N<'8O3%A$+W=!:D8O<FI25S-G6&U44B]/,&YM1%=B,C!J=DQM,D]O
M5'HR;'-,-D)92%$Q0U-+0W=906=5-"M(,UIS651H=V='=5@F(WA!.V,P15-S
M;&LS-5IW95HY3#AX;RMQ22\Q2U-Y5S)N=4QI-VEK0VU+3T]65'@U16QZ2DEY
M13DK3F-Q>FU*:G0S<V]71'5I=%<P2'IN4'(F(WA!.TEV3DTQ-S9L67-9>$I:
M4U=Q5')W6#=956MQ47@V:'$Y>E5':3!O4VQM:RM8=GI6=&18=%1F95EB82\P
M:T\X;#1I,G9O5&)K14ET4E F(WA!.WE1+T8K,&A8=%5B649:=G=F*U4O9&A1
M-V<O.$%+9G5X5C-"+S54.3)+=310+TMF=7A6,T(O=T-5+V1I<G5$+WEN-W-6
M9'=F*U4O9&DF(WA!.W)U1"]!37 K-T988T@O;% S67$Q>&)W3TMU-'0T2$98
M8U<X1&ER=4QE0GA6=S-&4G5.>'0T:EDT<3=I,V=C5F1X8G=/2W4T=#1(1E@F
M(WA!.V-7.$1I<FPK24)L,T(S0DA1:D988U<X1&ER=4QE0GA6,T9V031Q-VDS
M9V-68TYW0TYW9'=2:7)U3&5">%8S1G9!-'$W:3-G8U9C9&<F(WA!.U-D9TYY
M5&ER=4QE0GA6,T9V031Q;RM99DMF;FDO=T)9=DQV5'9.8W5N,DTO<&968DI)
M2VU$9TEX25$U2E9U6$)I07E%5F)E=E1+;34F(WA!.VM0;&94=%8P=E-)-U!6
M9%-K,64W:EIY8BM34# S9%,Q5C5+2VEV>3)W2VTS3F9!+V-F-EEQ>"]Z8F\R
M=39Q;'-.23%D.4M-2EEZ0E4F(WA!.V,K<%9K27%62TU+2W)$+UI6-UEQ:S$O
M-58O34]30U574&TX,C@W,V$S151V6FE12D5S9D@P<6-H>59N*TIH441#<6]0
M3#,U;&TV=' F(WA!.TI03G-,45)O=C%I2F1.0V,U4GDK245/84QU4&=.96Y8
M1EA,-6$O34(W4C0U=DY#:6%P848T<E)L0W1W8U9A<FQM1E-V=VLP-FYR5$8F
M(WA!.U5B-68X=CA!;65Z=4QE9E8Y96951$9*8U-Y>'!%.%5B:5I60TIX-5 X
M361#5BME2W-O-7(T2#=J+U1!<G5A*T(K-"\P>%94=4A(;U F(WA!.S$V94(O
M<&A#0S@U,#-Y<C4S=%!-839J8V5:,G9D3CED,V)46DE'5E)%>6-"1W)+*R](
M-U%9:G)K;41.3U$Y+W5/2W4U1#,K-#1Q-VLF(WA!.U!F-VII<GAY-78X07I6
M6F$W<3145'(K*W1M=C=L<EHT=%<K<E)#3G!K4$9995DT.%1%+R]!06)6-UIT
M36-C6F=.=TYV-79V8U=2:THF(WA!.TA9;C0K-4-8*W0K9C5B6# W4%-B-D-9
M;S9M6CE95B]I34I25%%33#!L269X,G!L:UE9<C-)+S!R1U=42E<P5#AW=S<Y
M1R]N9B]W0E@F(WA!.T15=BLT;5 K<2M:9DAP=390*VPO6310:&%J=E K;2]A
M-SE'+VYF.$$Y6$15=BLT;5 K<2M02'!U-E X07!F,DPT5V\W>B]P=C)U+U(F
M(WA!.W8U,R]!4%9W,4PO=4IJ+W%V:G@V8G5J+T%+6#EI*T9Q3S@O-F(Y<7E$
M5&9Z<#E'4#!B+U521'A(<&AD5$%!5VTQ0C8K,C)02'!U-E F(WA!.RML+UEV
M:&%J=E X07!V,G(O=T)'+VYF+T%.6$15=CA!=4IJ+T%+<C0X96TW;R\V6#EI
M*T9Q3S@O-F(Y<C)F.$%+5S X-C(S;'AV.$$F(WA!.T96,F)M5U-1=&%,22]R
M>F]M+TPQ2F=Z:'%N-TEQ865066%J5WEX;69O1D]X,'-::5!R6GAY2'8Y>'I$
M8VPS264O=T)X>%9#-E=13DTF(WA!.W1"+WA42#(O>4)H4$Y55GE(=CA!8V-#
M=35$,RLT-'$W:U!F-VII<48Q46<V6F1J+T%)<&LW9C5"=VIM<5@K6F1&,5!6
M4EI#=S%A9E,F(WA!.VA"34AU9E)5:WI1+W12.58T:S R8F5N:&=65SAT-F)Q
M1VUA4$1:-FIQ16UQ6'%&>DQF4TM53#AM2E5C87112W!!-C1Q;%AM6'E&;S(F
M(WA!.W$V+V58;'HU:79B3S1V5V=8-FI(9%)X<$=Y0TU$,%9"5U)':T59-DY8
M-&E246Y)=&I*9DHK:U=E:F%(1EDR3C50<59Q:GE'2S9N;%,F(WA!.V1Y1UEK
M<5I!9FEO92M"538U3B])9G<O<FER1U!01V=A6')%5G K:V13;#!T64=B,'ES
M<U5A3U-563AH2G-X<$A4-44K3T95;'9F>2\F(WA!.W-,,C-L4S,X,6%N8G9,
M9G!0-C!&,T1Y5V19=4-2<5-$.%90:6]E=4MO;'9Y.'5&=7)386)Z6G)B*VEQ
M4BML3&-18UI*0GDT>45C0C@F(WA!.V9X9'1T=6U+<68X06=3,49I63=N>E!Q
M16EY3U)$33 Q=6=76# S1E5#<48U,&%V5&]0;FEH1V584$LR:V%89E=R+W!M
M9E5R,DMA-V4F(WA!.U V>$Y#>G9,37%I66-5-"]90SE+8F(T<%IH>6(K42]H
M+UA!<G549GE(.% V-'%P,T1(,$@K13E08BMU14E,>C=3=DPK;3)M=3(X.70F
M(WA!.W(P<S!S4W5H<U=K=#5$3'EQ-5HY=E5,54\U2'5C:W=:26US854U8TIE
M44U9.6Y!;&I02'(Q*TQB<&EQ<VPS8E-3;4I*16%686MX<7DF(WA!.VQH>%!&
M=&=A-TA9-'%Q0G=3=T<U53!906I9,')1-RM">%8T9F91>C(S;5!76EE4;TUX
M;3%#-65T.&PT.7=P85=.:6I'2T8P,BMR<E,F(WA!.VA.2VYX3V)F2$E'079J
M-61+."]0>F-346M*16=2*S-Y.'9*2W18=7)O=T,P;#%$>7I9=5DS6&PO<'EY
M1EAI845%8S1/>%!-8E4U1#(F(WA!.WDV04A/<&XU9G)A<VLU8VE91#4O<5E6
M+V=M>B]!3W!Q,%0O:V)D9CEK*UIN-6<O>DHO6BMT=U!Y,SE+4'ID+V=M>B\V
M;7)24"M2=#$F(WA!.R]W0FLK4#5G+W=!>68R9G)8.'0O4VHX,V8T2G,O=T1Q
M871%+S5',U@O6E!J*UE0.'EF,F9R6#AT+U-J.#%S9FMU>F1&62MA3D=5<T$F
M(WA!.V5,4S-.4EAS85<U>"]-2"M:3#=0,7(K5R]P4BMA-R]"3FXO,4Y7:68X
M:F)R+W-N>"]-2"M:4#=0,7(K5R]P4BMB,W8X;&9,-#!F>6\F(WA!.U-M<G!Q
M,%8Q2WIR.5=C=&)1;%-62W@X9W(Q4%9Q9V9,=61*<CAV2% V94=V;3=84UDK
M1TA/,V]&5#1(.$UW6$MD52M"+T1&54QP6E F(WA!.S9-=$YQ+W59.2\X05E$
M0V5A;W%P.$0K1T)85E!G9G=X5C%4-$@X3591=7%%+V]Y-S)P*S5K,R\R0G=J
M;7%4*V(Y13!05E9S4#!T978F(WA!.UER87II85!H3VM!;' Y<4HK6#)K3S%A
M8BLK0E56-50P=E1T2S!/0W@P-C=K=C=E2FY0,7574DIN9&UC<V54<%)D<3 R
M2%1&5U K8W0F(WA!.T4O2G$V,796;CAY6$5596\S0WA*<39T9'IX04EQ4F-0
M54-%3$=#:7@Q8F)A;%1K5WAL9FM#,3AQ,G9L>$EV2VII8E-"3$QX:SE74U4F
M(WA!.VU4;5))0SAT6$I6:%1F07))-GEF>6HW>B]41E=+965R8GE88TY9<#5N
M;%=#5#DT8D4K<DQ'>F-7:F1W=G!J-&IY5DYU*T9735 U62\F(WA!.TIN561*
M=C1Z95)V63)4+W!'*UE8,'EE:GIJ-3AY459+:FI0>3EI,VII<7%N;&(X;6M.
M=G%#86A$+V\Q<U1%+S96;6(Y>D5$>5IL37 F(WA!.S5&9E4S66IL:7%V+T%)
M82]+=4),;3!K=7<W8U0V;VMV<#-K26]526I*67-X-5,Y17%E5D(T1$9#2C!)
M+VQJ;VLP63 V.&I.>&%T2DLF(WA!.W9+96$T:T18578Q5C)03&TQ5VQI.5 U
M:D9,4&%Y9GEJ-WHO5$%R<7EF>6HW>B]41E9/-$UN;U!S3VYJ+T%'65%G=DDY
M3#!(.&]*+TTF(WA!.VIT<&PP:#%Y95IZ3D9$9'HX,VQN:&M,:&LU9#19;G%0
M04A*344Y;2]+>GEB8U-*2F178EA$24MF=DI8;V$X<3%555AF;#)(:%1&5DLF
M(WA!.U@X<&9*8W5O,T=O3F(S075B<5=7959K=DQP0C9K.6952VA82$=V23 T
M.41U3CA6=%!03'9L:E,O3#%V8U<K;4DV4EA->EA%9VQL954F(WA!.S@R04)O
M>FQM<'0S4#15>%8T;#5K,6I18DAZ2G)%16YM4SAS2G9R.3%*2F)X5T-40T]3
M56A'-%-L=WAQ<4QM-W=1;5E!.$E/,V4T1U@F(WA!.TQ'36E/26HT2D)R,34U
M2C$V-5,T,4QZ3F534TE/2SA.35--9&A7:5-G5C)'6D=/3U=!;U)(*VUC9DQ0
M1FLU>5!Y4WHY169L;B]W0E0F(WA!.T9F9CEW.&8Y5G-S.%10.$%Z4C@O,DY8
M:#10-7@K5$]T0R])5%%D9#!U2%4Y33AZ3F-7:S1Q<FDR1E%E-G-057%R1'5$
M;4AK-U-N0U@F(WA!.T1+3R]V8VE'9VA)5TIB22\O;U=E,2\V=C<O.$%335 K
M<6U6+WES9C5V,G,O-4]J,VQ2<W8K8V(W5S5S-$QN.4]Y3#8P85-C9G$T3D\F
M(WA!.V%G,"]V4&9#93%J+T%$9G12+THP93AQ,R]1<SER+S%F,R\V4F@O,55W
M9GES9C5V,G O:S9095AO6#5E+VPO62M3.4UM=$QA-&4W;74F(WA!.UI0575*
M-4MQ0U8R54Q'0U979RMK+V140C%7<$]A5FM5-5=$04U9;TUQ*TQW2#,O,EIJ
M3C=V:3A".2\X05II<48P=78V371+1&(P62\F(WA!.RM)1$-E86]R-'9!9F8O
M6F=6,WAE02LO*WI&6&9&-$0W+W=#>D953'%L9C!:9#%',V]Y9CA13T5C,5-4
M>F]V:WAH<'@X,&5M0D9C0U@F(WA!.U0O54UG<DUL2T%#4#=8569#9&IG5D9E
M5%DO3&-8;"LS:3AT1E<P9$=K141+>G5#>&M9>69&2E9J.%I06$972&599DXS
M-6-N6#E6='8F(WA!.TU&='!9,5=&24=V-6)M,%EV2VAI33!F>$)Y>FA%9W%F
M-6%9945*-&EG.4HO-7E"+TQR5'1/4T]W;71D3W,S:FUU-&]&=$AH1%5K2W0F
M(WA!.U)"2CET-4LP2%AV,#-W544R539J+U!Z>7)*95$R4V%R86TY;F$S5T\S
M345W8B]3;E9)-FMU1B]B1$AF6F1Z:G=H2$55<S%R.#0O>7HF(WA!.S%"<D=8
M5G)R5')U5DMT6D-A,&UK6D1*-F9,:E5N:6%/<#AF=7<P1G-O065E=GE-:6%1
M02M8,&%D1E-4+T%%3FAY5FQ8:E4Q+VQ#-S0F(WA!.S!&<W)0.&%F:W%,,&%-
M*VXV36YR1TMA171P>$U5:E-X2DQ'-DU#9FI+6$E)4%AC*RM.0F5)<#4U9CAX
M9FQT-6<Q3UI.1FDP82LQ0DDF(WA!.S-E57A7:F-H1WI!=3-)<T]R>3E1971E
M.6-E14QX1FM6=G!U;5<Y,4QD=V%6<#!6>D]Y=DY-='-1>DUK;VU5:V@Y-E-Q
M2"ME*U!#1C0F(WA!.VLT+U0R<F5.=B]Y3&8O<7!J=T)E3C,V93%B>'0O=T1K
M5R\X03%5>#1!=D=T:S%Z5FY1<51!2SDO5&8X039Q63A)4GA-97-V3&UJ,DXF
M(WA!.S9,-GDP=E1B93E6>DET>D9A0EI!-TMY<S-)4%=P5C)"4'9H;TET3V9R
M*W O>G=F.&EN+S9Q63!&=#,Q+U4O-310*U)4+W=$5E1'9W0F(WA!.W4K=C9N
M+U!"+W=!:6XO-G%9,$9T-71R6#5,84QR1W(S;7$S96]82S-.-TTX.'%X0TY5
M0F,Q;V]93V1V;FUW>&1O5&A%4D%'>F@U3D@F(WA!.T-C:DEK;TPO04M&+SAT
M+SE81S@O-4IF.#!:4"M636YC4'0O5W<O:RM(969X.$AF.4,O.$%L=CA!-G5.
M-2]W06MV*V%-9C55>61W*S,F(WA!.SEA+WEF1'90-"M$,$QY,7!+95<Y26DP
M<E-L9VET;W1Y5$=X95)Z.7%34G952$IM<"]M37=C=5$U2F-5=6)M631#06]*
M<#EF,5 K940F(WA!.R]K52\O5E1+<41/,4=Z;C%+,G1)3%E3=W-)63%J1$=*
M.2M#9U8O=E!B0U%Q=#EF,5 K940O:U4O+U940E%7,V98.50O04HT4"M25"\F
M(WA!.T%05E1'9W1U*W8V;B]00B]Y2V8O04MQ63!&=#,Q+U4O-310*U)4+SE6
M36%#,G!7,7AQ549T1D%*25=%4TMG67A0=GA&2R\S;4=L=%8F(WA!.RMV-FXO
M4$(O>4MF+T%+<5E+0S(W-B]Q9C@X2"]!0TMF+W%P:E%7,V98.50O04HT4"M2
M5"]!4%941V=T<59Z8V%L4&)3=T=31E)+:DDF(WA!.U=%5#=C:%-V.35H<&)5
M-WA8=F92*W51,F1Z.5AK13%V-G1U6#E/5F9S=6Y+43A71F5O=U5&='5X.6%W
M=%DW4WAI=$Q7,6ER-F-%34(F(WA!.VIJ6&M3>#1Q<V=!<5-4:E%7,'(X>&5:
M8F)39%IV=%!4>7AQ9"M,8C!E5C-$1U!3;CE654%%8G-V0FEV<3A4>5E!54Y3
M0FME27,K14HF(WA!.S<U5G-T33%V4FMV<&1*=4Y+:V1N:FMS8G!&4U9/3%5O
M=S0P+VAG-&EV0T4S2&Q84C%.5FEO5%$W0F4R-"]:.7-E27)W:&HO;3!A8F\F
M(WA!.T-7<E)A3&-A;#E93$)J0716:D%:1BM)<D<U1F95<C V02M'2&E+.$E3
M8E5032MK5U9V3E!,-58Q95-/2SA7,G!&82MO>DM9:DDP<6<F(WA!.TPX6$AD
M841Q96AX-&EV0T9196%V3')89')$2#5C,7-.8TES<7EV64]I<6A"1D=9<G,T
M0U4T2&9P:GA&945,;V9.1VLO5DAN=%!,*W$F(WA!.VM213@Q1G,X9G=C5V(T
M05EW>DXK-RMZ>"MN<&IX1DA#17<X=C9V1').>&)O;6HS,7!B>GE80T=A-412
M1E5G5E-J;$=J0B]E;'%!9'$F(WA!.TA(:4ME14UO+U%&:C1V.$%E4#993TUR
M=V@S-D%S9D8O=D@Y365-<G=H8DYO9&MK5$U#.5%.='@O5$1X1D)I>%!13EI4
M5C<V5S(O4G0F(WA!.S-A>'=X:'IC>DMY>&PV9T=.4WE,56EU.4U.<V%4+SA!
M4C%V-'0Y+SEM3G)4=C!D8BM,9F8O6FIA,#<Y2%<O:3,S+S)9,G103S504&,F
M(WA!.VDV<G%&:"]O15IS-S%R4F9R1GHV8FQ05T5F<4UP1S-!3GEA;F)F-5HP
M9$YC460Y>#-.6&EB:V))1%4O>E!U3$11-4Y6-&%88V-/0E<F(WA!.S!H=BMC
M-V-X161K0S$K17ES1SA#:#=%2$Q)84E3;'<K<C5E.7%Y86IH:GAB2#0K-6DO
M.$$P34YD9CE72U O<$EB+W%N;50O2E$O;F8F(WA!.UDT=CAO+S!F="]9-R]O
M66$V+S9S568X03!K3B\Q5'@O:V]F>G9S6"M59C90,B]S9"]W0D1$6%@O0499
M;R]W1'!)8B]Q;FHO2E$O;F8F(WA!.UEV.$%+4#A!4BLS.6I39C@U1%AG4E$R
M:5)-=T$U34QH:%4K3D]'4#AL1"MD.6DO>6HO4BLS.6IF+U%W,3$O,5EO+SA!
M<$EB+T%+<#0F(WA!.R]W06Q$*V0Y:2]Y:B]2*S,Y:C S.'1V3C%R-7HP95<Y
M*W!45U4Q=DHV57EK.&]M2C-(<%-52$QB-U%P569D;74Q96Y/2U988FTV9DXF
M(WA!.S1K8G%M6&9O-C,X5RLO.$%S>D9T=G S-D]T+T9V=CA!-TUB5VQ#>71)
M<')+,VUE=D]73DAA;E-R2T-C2DLP<B]!2T]T+T9V=B]S=U<F(WA!.W1/+U(Q
M=C1T.2\X05IJ83 W.4A7+VDS,R]W0FU.<E-H93)K54YL8U1*6&Y&1S=R6'!6
M5DI'149A4WIZ3&94-E%,3#9P<%9Z<6AU-6@F(WA!.T%W='HO9$9U:GEF0S%%
M-C%B;TU&<E-V-6)N3W-A4$1Q1GA96$=M4U1&+SA!43=N-%I60TU60EI3<6MC
M<59',U1',7!3.'<K679Z2G0F(WA!.TY9=DQB4V9,:5AU;E$K;#E5=DAN4E).
M>D5F<4%G5F1/1$TY5'=/>3=!,7!K1S%K4&QE.#AW,W5K4GHV.5I$5$Y4-4]S
M,7!'-GEO07(F(WA!.U55<31R545D.$-P='AB*V,O:"]41E=0*V)D4S@Q,D-7
M>#!$5&AQ2FM,9E=3>%5E;4%Y0F%+5VIR54UZ9&8R860X5E-A+W=$3E U:S(F
M(WA!.S!%<W-(;$YR=&MU,6II:5,U:%5V8F5N>60V<V1M-2]#<$EP:%952&TS
M>BLQ,6)2+S1.=4EO6E574V%:<GDQ8C!Z.%A+26A46&QS3G@F(WA!.U9D.%9C
M=FUJ.'=*3%(U13AR>7AY>&MK4GEZ44%U3T1N:6]6>4%A<5!I3%4S07 T2V\S
M>2]R2&YA+W5,8S9N<$$P>3)E4S0Y8T\V4$DF(WA!.W-3<79O1W%->3AM66YL
M.'-66E)X8BMC+V@O5$%R=4QF>FXX4#99<7 S0VXP2"M).5!B*VU%24QZ,WDO
M-6<X.3-7<F96.5DX=FUZ,#DF(WA!.VDV<F1X=D<R-G,T0EIF535!1D%P*WHQ
M2DAH5U1";49$-&XX359D42M*+T1&6%50:69W>%8T6G%N;4AY<D@U:C%E,C%2
M3DAI=4ET4FLF(WA!.U)N=71.5V56;S)N060S:TEB:WEO>%EE4%1T=G0X5TMF
M041(:35F>FY#;E!(>$AI-&(Y>55A;C5T.' R*VAY6&1L2#5E=3E32$%X-F8F
M(WA!.RMH9VA025)C<752>"M!=$M/=31!4&E-=FAG;5I594U$=C1V9BMX;WE:
M8UEJ631#9F0W;4PO=T1+>35V*W!B.'9F.7<R3"MU6E U5"LF(WA!.VQ0.$$P
M>FEF;78V35!K-R]!2E=83B\Q3&9L-R]!3&AS6#EC9GEN.4MF*VU8.#$O4F@X
M;F8X<DQM+W=#<&(X=F8Y=S),*W50-50K;% F(WA!.R]43"MA+V]W*U,R3#AX
M-6\T:VI(;'I11T-+1D1.<#!436%#;%-39'IJ*U4O<%0O,'DO;78V35!K=2\U
M5UA.+S%,9FPW+W5'>&8Q>"\F(WA!.TMF,' O=T-M6#@Q+U)H.&YU=C5.*UIB
M,UAV2WAE9E-O.4QI='!$2$$Q<D=S3G)+0U-366]X.6YI9&TW5BMK1%,V+T-)
M5#).+V4W6%,F(WA!.UI$3TA+;64P4&EF=WI#8W Q1#1N.$U6475L9R]O>3 S
M<"LU:C(O,D%W;FUQ2V]F12]H9U8Q1#1N.$U69%$K2B]$1E5,<6=0-DUU.38F
M(WA!.R]U6DYV.6=C235Q;"]M5S<X,#)W<W8P0EI26'!M;45D-%IN0T-+3G8Y
M,CE6-4)E-$<K0E9B>3-C-C=D85!$8V$U87)986LU9C%B4TXF(WA!.V<T44)I
M1BM)1F=35D%/>#<T<6=034U0-7%.<D8T9$1N,'504V8S6#%!5$%T2TYO>$PV
M<3!!24(Y46II-')S2VIR:U=X:U!L9$YE:C F(WA!.VE.4$US;'!.<7%S-&QL
M=$)X:5IE6'=L47="1S-B07%B9C90+T%*2#19<7@O>F)&-7-D3&(O1$UT<$51
M5RMT*W9X-45C:S0X0U9K2#(F(WA!.V5F8G)4,W=Q:S$K4'IB4T-6<D$V3$Q0
M.6)6;T5M36ER.5=%9GA),T9D=55N8T=O1TMQ9VTO3G!R<3(U,G5G<&)&1F$V
M36,P-6-31&PF(WA!.U9&-4I1;V9H*TQ9*S)+=54O;6Y*85!Y5%-93&A35VE!
M:UIW,W=0.$%#>F5M048U8V5I,3,X0G5Q:F9,.%AN<')I,VLQ,E=X:FE%;'<F
M(WA!.S%X0F)58T=.;%57-D)M4E0X1&-I5#,R>%9L2"MJ+S5(-%E&9"]O+RM2
M*T=+<61X-DAO=E1J5VYT:$-#=TLQ6#AX-4Y8='9R8F%D8C8F(WA!.U5S:DYC
M*VM7959O>$I+5E91>3 S:F%*4V%J8TUE-$=364US+V0K,S19<3<Y,S=F:&ER
M=C-F="M'2W9(3'I5.6%I,3-667!B2%<U8F0F(WA!.V11:TU%=&Q9:6%%=V5U
M4%5#4'<S<6Y,:60Y+V]P=$UC24=!,VIY-FQX<%I#2D5%4RM35C9N<79M;CE"
M>69O,G@X>"]P;SA05$4R;4DF(WA!.TE"=$8V;%-)>3-66E-U,U)H6'!83&]1
M>#A7-6AW+S%V9BMX<'E:6F-0<$5U3"MR-VU,+W!4.#=V*U=,52]W1'5'+SA!
M6&Y-;F<P,V8F(WA!.T@O5&9T8U1X9%(U+TPY:G8P<"MD,R],1G%F.$$S1&8K
M=D]00G!U*U K;2]A=FDV:GHK6#=(9G!4.#=V*U=,52\K-&(O04YE8V5$5&0F
M(WA!.SAF.$%49G18>&12-2],.6DR2%4O>G%%2T-+>3%)>$)2-EI';E9(1VTQ
M1#9/*S)00G!U*U K;2]A=FDV:GHK6#=&,S95+T\W+T%*670F(WA!.U0O-VAV
M+UAN2&<P,V9(+U1F=%AX9%(U+TPY:C)J.'!B:GIR4#5C6G9.:TEH;$5H1FPV
M<4-+-$UE+TPQ66=Q:&%(-T\Q4U!O2C%'=$<F(WA!.TE4.41S=$UC:&HV*V).
M+S-F="M'66)K3R]D*S,T67%H9$TT9F\R,')3=F]X,7(O<41#5E)8-W8R+T1!
M<G8S9G0K1TMU+V0K,S19<6@F(WA!.V14-&9O,C=P4W9O>55P+W%(0T93+W=!
M>3(S;65C5U$X=C-D=&$P;4%V>F-*>G)!9G1'4#17*TUD9V1V9D%Q=#5B:3%Y
M3%(T5CAW5%$F(WA!.U0V<E9Z3SES2U)5-4AG1G%Q2#=&2S=D8U934'I$6BM9
M-R]73'DW,#=Z:&-A9EEZ*VPY5G-K<S5364]!:D5H1&Q3<F-U1$5":TEQ,CDF
M(WA!.V5M1&A,3&E$25!+.2]W1&]V4TDW4%9D6&TQ93=J6GEB*U,R;&ID,4Q6
M6&MO56EV>3)X-%-N:4-B+W=#23E)+S,U2B]Y2FTO-6]X-%,F(WA!.W9%1U K
M8EIR:E95=&AP1W5485594WAM0S(Y=V95<7E%5DMH1T9&5F@O<W$Y<V5%;S1G
M:W0O82MB<$E*4EDK8S-T-3-U,75);F94<$HF(WA!.T%K4W@X9E-P='E6;BM*
M:%%$2&A+.%%605!/>'5R85-4>FMJ45)O=C%I2F1):U1N2T]8>$%G;6DW:C1$
M6' Q>#13=D5(3$0U<F4P94\F(WA!.V)Z85).571#.%=N>G%&8F<T<3%35UE6
M2R]#5%1Q971-4$-6<TDS>2\K:W)/-'0U.5@X>%1A9UEP3&E75TY,5S1I:F-4
M2V]23U!X+T0F(WA!.TA1;&9N9S13=D5'52]W0TDY22\S-4HO>4IM+S5O>#13
M;FE$=CA2-E(O=GE4+VM43B]W03!9.$I8:4-N4#5H,'!O5T%K:TI),DAO>F8F
M(WA!.S@P66E*45-(;E-74&YI3%95=4EV3C5A=TI(<3)K,FU/-30Q2$QG*S-%
M=%%T=4-&<E%F0T%-;'=L:F$Q8E!Z.'1Z3$E03G$K;55:64DF(WA!.WIP8W)C
M5%(K2$MP;S-X34]2-FM#;GIE17)A2SAV4BMD3$Q565@Q9GI/;7 V86Y->E<T
M,'531U9Y=V)J*SE"4$5!<T1S=F)S3G-E17(F(WA!.V),=C Q665-=B]);6(O
M;6I(:$M,9E S;3=Y.2MA1C,U;S%7-C!H8CAA8DYD4W9A.$QG>$QW6GE146AD
M0W1F;&TW,#)B04U917%V,V8F(WA!.W-D6G%-95EZ2FID93E+4#A+9FY.-&%L
M+S!L+SEF8W8O041';3AV;"MX<#A(565F>B]A-R]!07 K8S-H<5@O4U@O=T)F
M8V9Z1VTX=FPF(WA!.RMX9D(Q2&XX+W="<C-8.'8U.5<P,WET85=N;4\X:W4Y
M4U%%<S-O>DTP84@W36)Y8U0V:DPS8CED2VY3-FMX;$UM06]/,'=I46E"23(F
M(WA!.U=2+W!Q=SA:9BM233,O3D=9+T-7,C!,<%=Q,F-7;#)C56YQ<DI(0D=R
M<5E:<6=H04-0<UE33C%26#9A<U!'6"]!2D5Z9C@P64]%<F(F(WA!.W8P,5EE
M378O04-*;2]W0V%-945R8G8P,5EE378O26UB+VUJ2&A+,C<Y3E=(:DPO>4IM
M+S5O>#13=&]F5'17<S0Y4'1O,SE66%-*1EHF(WA!.U1$3G-1;T)(,DU*0S)I
M4# Q665-=B]);6(O;6I"=VQB9"MM<D1X;"\U17IF.#!9.$I7,V9P<7<X6F8X
M06M43B]Z4FIW;&)1*V\V=%HF(WA!.WEA9F-X<#9R3SA4<7%I1V)C;%-!4'-9
M449T3&9-<7EA<4Q)5T=S6&5L0T-94&,K:D)-5$Y$*S%(,%AI5%1:=#9E1T1H
M2S)R95<U:G F(WA!.VUJ=S)E;S9L8V%P96]8370Y2F)Z25@U35-O-#!A9U93
M0C%X-%-T<UDQ=GEN*V%R87)F6%=H-C)L=F%8:G<K:%HS5FU:4F)):6]S<E(F
M(WA!.W1V>4Q59'5*04)R,5=M1S P=5AY<"MA-5922C5G:5DK<5,O1%1E24U*
M2#)".%I:6$A:=5@P2$<P56AR=GE.*V)%:3)V,69Z4UDS=&DF(WA!.S-*;C X
M2#%62WAC9E4T4$='6EAJ63%!1E$Q2UDR;79*5&@X:69M+T5:5R]X6GID<&UL
M:$1A84-I<2]+<4UP8VMQ2VIJ4FA3;F9'+TXF(WA!.V$X;6525T=O3$=I>5)3
M4$E!03=I3FQ"3DYZ5&5L8V)#2TLW-FQE+SAS.&XO04%$9C!W,D9O=2MP6'8X
M07EZ>68X03,Y36)#,%AF57(F(WA!.S,O;&YK+S1"=C99,D9O=2MP6'8O04-Z
M>68X03,Y36)#,%AF57(S+VQN:R\T0G8V63)&;W5.;F5!5DU%9T$V:V\S.4UB
M0S!S.4-F.$$F(WA!.S,R,R]!04IX=$1V46XO,S(S+T%N1S%D-D4O.$%V='8K
M0D].<3<P2B\Y.70O=TIX=%=K:FMC5E)3=T)+:V=%:7%M:$@P155X=%<O46XF
M(WA!.R]W0CET+W=*>'1896A0.$$W-V(O04E%-#)R=E%N+S,R,R]!;D<Q9#9%
M+SA!=G1V*T)/3G$P:V-K:4LV2UA2=T=6;$))24\T24EX5G8F(WA!.S!*+SDY
M="]W2GAT6&5H4"]!3#=B+V=4:F%U.4-F+V9B9CA#8V)6,V]4+S<W8B]G5&IA
M=$I&239H,%)M4F=#<D%%9V<Y0T1I<F9O5"\F(WA!.T%/*S(O=T-"3TYQ-S!*
M+SDY="]W2GAT6&5H4"]!3#=B+V=4:F%T4$9):6PS4FQ245-Z145!06135&ER
M9F]4+S<W8B]G5&IA=3E#9B\F(WA!.T%(,C,O06Y',5-V>DHU9C@Q6%!M3S=U
M=$\X.&Y3;S-A3C=44S)I5U))>7-32S!B;WIQ5U-1<7IM;D9H>3)/,E9.>DHO
M2CA..6)A2VDF(WA!.U@R<F9P=55T55@V<G-W0VA34&AQ4'1Q>#(X8T-P,WI8
M=U S2"MM2W-B.#1A2C5J,5DR8F%,<DQA5#9!;#ED9E1K6EIE9D1H6# S:4DF
M(WA!.S1C5S<Y.%93>5114'I.5UI&=%!-.$5D=&)E:VM*=6)0-GI*2VE1>'))
M,#-%,B]X4U-Q-3)/=TDS-UE652]W1$0S-7%Y45)R2C5R=&PF(WA!.W5%8T9P
M4EE%;S8P<68S85!#5BM+;3---T1R.%9!<78Q5'DS*UIL>$)!=' U=6ET-31N
M.5(U4#!F.$Q%9$%65U)A<G5F:$I)-F5'-G(F(WA!.TTW4D=G=$E92DI:3&E3
M2TY596529FIK2V=!=3-%059B<6%$07%R>EAW4#-(*VU+=35R-$@W:B]41E9/
M-&-E9R]8<#1(*VU%24Q"3$0F(WA!.WDW-6YT=&%T-W%46#5*.4YI931A4WIE
M36MU<W)K>$M82B\S5W1"5VU364UP-40S*S0T<3=K4&8W:FER=5$Y+W5/2W9M
M6'IV;R]M1V8F(WA!.WIH<DUT=')&<&)W4&541T]'5%9,93-D4GI/>&EE5E=8
M-E)N46%82D%9>&-4+W!4*W Q3V]J4&I.4T$O>FMK+U%0;7(O04MV.6HO,T<F
M(WA!.V)4+W%V;"]I=R]M;B]3;CE45'=4+VYJ+T%%>G8P1#5Q+W=#<B]9+SEX
M;3 O-G(T*TQ$*V%F.4MF,4QW5"]N:B]!17EC=V9L8BMB8S@F(WA!.TM4=T8U
M65I61'AY<&92<W)+=W%'5FA*46<U561:9T=X*S5S+TQ:*R\W5B\O04-Q8C@T
M9C5*9CA!<$Y4+T%+<5E0>G5N+T%4*U9Z.2\F(WA!.S)R25!Y<2].,E=#3U=*
M6D1&27%T1U)E;T)X27%0.3)E1U U,U0O9TDO2S4K+W=#,68O>7%B.#1F-4IF
M*VLQ4"MQ;5 U,U0O9THO2S4F(WA!.RLO-UAS9C54*UAF3F5G*UAN='9-5C1:
M-6YK3#(Y<50V<&=896\Y6&9L>D\Y3V<K:S5Q=&)L:$]D=T1N-F)(3TUA:V),
M3G51.2]U3UDF(WA!.V)K3S5$,RLT-'%H9$Q)1VU79R\T<&HW9C5!=VYM<4LU
M1#,K-#1&9'E(=CA!8V-69'E(=CEX>%9#-F]19$UU>"]X5$HR+W=!9S12>E8F
M(WA!.TPO375I-FYQ;W-H66%T4'!19VU$,U!O<5-:;V8R;RMQ.%-A8DYV5'=W
M2W)E5SE.,4143DAH<SE2,4-45DPQ0S5L=G!&2T8K5$5Q3TXF(WA!.U=O1E5G
M9&-6469M2'E&*U<K<&%V9E@R<WA)8B]!1D%2<&5R2F1&0312559!66I)1BMZ
M1VYB96TY8VDR36@X<V%8;VUL85-L<&]A,3 F(WA!.S=M-WAL6F975W).5G%/
M5V)V-S1&5%AK,SAH+T0K=4MS6C@V84)A-G5,2G Y6G4Y1&QT;5EW5#)K.&-$
M<WA:2$EQ+TE(84MH1D]H238F(WA!.TA&57%U9GDS=611,# R5G@U=#%U-&@U
M5$Q)9E=T>%531&E9,DM2<50V8D-Q:VYK<#<T5E9B>CAV3&EE-VUD9DY'<S)Z
M6$14>7!&0E F(WA!.T-N1#%N-45P.$)0=R]:0C=,<TM9<7-L.&@S,S$Q;V]V
M3C)Q,G=K2G5%=%DU66<U4#%I4V%6:E5'<4@Q550T5E=G6')U2TMR,2],:2\F
M(WA!.T8O1F1.-7,Q,E-/3U5Y:3)E945P4FY$.$LX3U%!031J979(1E8Y:BM8
M9#-A>E-39C1N,7%22DA,:45Y,C9O=%1S059J5GI29FA(2FHF(WA!.W0Y*TMO
M+WEH-4]M.'546#AJ879Q1W%R9DU*4%1V6&E:63-Q4S=)1590:69L.%)0:&=6
M:T9W>#E"+VA05#(O<FA#0S@U,#=Y,6]&<'(F(WA!.T5E<3(K=5-T2%ET4$DY
M<CE9:4U+:35K3%5F96]683A6,WE40FQ387!P>C@K1C%#,W!P-G-L2D501TUJ
M;'IA:#)7:')81EA*<75M=DDF(WA!.W-A6%5,4T]Z4F]G:U%K=71/4V=!.5)5
M5D=+;W%P.$0K1TMV;7)Z<#57.' S9FTW5TQM.#@Q,CEH8WE8:WAL<S-T<#5'
M:E!-:6A:9F@F(WA!.T\R*S)B-U,U.&=X9T-"4'A$<7129V=::VU90U1F-$TX
M:V8X054W,C,O4TAC-6MF;4UN*W!N-6AO+TQ9+S4T9"]G>GE2+W="5'9B9CDF
M(WA!.TED>FHK67EF-FUF;48O3%DO=T-E2#!**U=7:6%:;S-K*WIT=$UV>G%L
M<DI78C8T1W%J32\R:$=T5'=5169:-T=T9#8U;W18:VQ025,F(WA!.U)29'1P
M-$--04%B6E95*T(O1$U:=5%E:D@O8U!9-U8O,&5,9B]91$-E84%J2VYW4#19
M175Q9D$O:&ER<6YW4#19<39P.$0K1TMO6%,F(WA!.WEF,%IA8E8O8W@W+T%/
M=T=%.#%25E0T2#A-0W5Q9D$O:&ER<6YW4#19<6AD54HO4FPS=%0Y>DIV+W-$
M:$A.56XX,S9*;V5Q<EEF<&$F(WA!.SEE>%<Q;D4P9D-D24),5#=55#AV=$ED
M<3 S.3A#;W)Y;G!E;F%6;V-&:G Q,TIF,CA43V9R8W-I5$\W3359.&Y3:3=6
M<'-/;4MQ97 F(WA!.V9L=F]M<&$S8V$Q9#9812MO6%II3GA)3#(T5E<Y04E%
M*T%2:%)T0VQA1&5M4C):<'0U9#AV>"M89$XO4G5J-F1B,G1N-FMK,W!#-6PF
M(WA!.V(T-5=,=6%T151U5&IS;$TO5C%B+VQM="]W1&ME+SA!,5)X,E9)+TTO
M;$<R.'I*0VUR,D55;W1X27-24SAM:4E764):0E9);'%'0VHF(WA!.TA:1$@Y
M5"]*=E%.4CE0,7)A5D1"8FTR=%1&<61Y:&EQ5TIK52MN.%1N;#%F:TYH=#%Q
M-TMV+S55-S5C6453,DQZ1FY-<&%453=S+W8F(WA!.T="1$]Q:$%Q13%0,E%"
M5&)P=&@R5DUO4'DY,'5$52\P;$990F)V-C)B.6TO4TXR5DTW94ML0T-L9"M(
M,F$W,'=B2WEF,617+S5:<F8F(WA!.R]K92\O5DA(6DQV5C%B+VQM="\K4C<O
M.55C9&QD-G5R9CAS,78O>5!F+W%J:G-Q,E9T6&5.;"MR,C1Q3W9R=B]!3E5C
M9&M&:$5F-5,F(WA!.S921S U5WE1<&1+63=I2G(R-&5.-#)93S!:5F]Y3TQ/
M07A!-VHU,6Q963!63WDO2C-23$=7-FMT3$99>F921T,W2#$V-&-34FU,,&4F
M(WA!.THU>'14-&%D4$%9,D4P5E=X+TM043=(5V\Y871D36AJ,4-+85,T5U58
M;'A1>51"4DEX6# V171W1F9(=FI95VEY=C9P<D@K*V)F.$$F(WA!.S5(4"]!
M3E5C8D-/1C54<C,O3T\P,G1A,V9A=%!Q0W=Y,S X:S=227A+<GI9:T%%>%8V
M6G-C4&%::$52<FLT95A14FY)>4HU;T0O;U8F(WA!.S<O=&$O:B\Q-WDS*U9Z
M+TYA+S5-:C-L,R]1<C,O83$O2"]R,VHO2S4O;7(O04-:2'9,,')Y9#5';#AQ
M84A&<$]N>%%T1W)'4V%A4V0F(WA!.WDP:W)!0FY0-W%G-D%51V$O4'%$;&QX
M1GI-5T51:E%4=C9P<D@K*V)F+VMC+W=$,5)Y;7<R8TMH639:<DYT63(Y<S!D
M<WAH:5--<THF(WA!.W!+16]O1F8W;C)X36=V0W(O5DY9+W=".#(O.$%Y3V8O
M04MO-#)&-%AF5DY9+W=".#(O.$%Y3V8O04MO-#)&-%AF5DY9+W=".#(O.$$F
M(WA!.WE/9B]!2V\T,D8T6&963EDO=T(X,B\X07E/9B]!2V\T,D8T5DLP,#=7
M64Q31T%X5WI'2TY52D5Z-SA10B]V;D5K3'=Q=C%45U Y.#(F(WA!.R]W1'E/
M9CA!-F\T,D8T6&963EDO,WIB+T%0234O=T1Q:FI96&AD.54Q:B]F3G8X03AJ
M;B]!3W%/3FAE1E-U.4\Q;64P;6=%5G-P;&HF(WA!.UI!5$TK,TE%9C<U>$)#
M.$M",79Y96UU9E90,'!95W1Z.5-M5S1T<3-%<3A:1C9%.%EH>4AI<#)X<TQW
M;%8P4'EX3&]E;5$V6G!L;F(F(WA!.W=754A)>'@O5TI824QS6&%R4$5Z1W)-
M97!X<TQW;"\O,E$]/3PO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X
M;7 Z5&AU;6)N86EL<SX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!0
M1$8@;&EB<F%R>2 Q-2XP,#PO<&1F.E!R;V1U8V5R/@H@(" @(" @(" \>&UP
M34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C,P960R8F8S+3DT,34M,C@T-2TX,3@R
M+38S,#AF8C4X,F8U8SPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.DEN<W1A;F-E240^>&UP+FEI9#HS,&5D,F)F,RTY-#$U+3(X-#4M.#$X
M,BTV,S X9F(U.#)F-6,\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX
M;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#IA,V(S,S1B82UF8F$Y+30P
M-CDM83EE9"UB,&(Q,V9B,3=E-#D\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM
M<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R
M;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12
M968Z:6YS=&%N8V5)1#YX;7 N:6ED.C0S.#AC,#8V+3=C,V0M9#<T82UA9&)A
M+31D-3)D9#$Q-69D9CPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HT,S@X8S V-BTW8S-D+60W-&$M
M861B82TT9#4R9&0Q,35F9&8\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @
M(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#IA,V(S,S1B82UF
M8F$Y+30P-CDM83EE9"UB,&(Q,V9B,3=E-#D\+W-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L87-S/F1E
M9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-
M.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.#(R961C,SDM,F8Q-BTQ-S0R
M+3DR-C(M8V0X,#9D-61E9&(S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(T+3 R+3 V5#$U.C$V.C Y*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B R-2XP("A7:6YD;W=S*3PO
M<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II
M;G-T86YC94E$/GAM<"YI:60Z,S!E9#)B9C,M.30Q-2TR.#0U+3@Q.#(M-C,P
M.&9B-3@R9C5C/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z=VAE;CXR,#(T+3 R+3 V5#$V.C(T.C R*S U.C,P/"]S=$5V
M=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N
M=#Y!9&]B92!);&QU<W1R871O<B R-2XP("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y
M/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S/@H@
M(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^1F%L<V4\
M+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/@H@(" @(" @(" \>&UP
M5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^5')U93PO>&UP5%!G.DAA<U9I<VEB
M;&5/=F5R<')I;G0^"B @(" @(" @(#QX;7!44&<Z36%X4&%G95-I>F4@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W1$:6TZ=SXT
M-34N,# P,# P/"]S=$1I;3IW/@H@(" @(" @(" @(" \<W1$:6TZ:#XQ.3,N
M,3DX-34Y/"]S=$1I;3IH/@H@(" @(" @(" @(" \<W1$:6TZ=6YI=#Y0;VEN
M=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO>&UP5%!G.DUA>%!A9V53:7IE
M/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@(" @(" @(" @(" \<F1F.D)A
M9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y4:6UE
M<TYE=U)O;6%N4%,M0F]L9$U4/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^5&EM97,@3F5W(%)O;6%N/"]S
M=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O;G14>7!E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN9SY697)S:6]N
M(#<N,# \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93YT:6UE<V)D+G1T
M9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y4:6UE
M<TYE=U)O;6%N4%--5#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IF;VYT1F%M:6QY/E1I;65S($YE=R!2;VUA;CPO<W1&;G0Z
M9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E
M/E)E9W5L87(\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E/"]S=$9N=#IF;VYT5'EP93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^5F5R<VEO;B W
M+C P/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^=&EM97,N='1F/"]S
M=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S
M/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D^665L;&]W/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \
M>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3
M=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @
M(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @/&EL;'5S=')A
M=&]R.D-R96%T;W)3=6)4;V]L/D%D;V)E($EL;'5S=')A=&]R/"]I;&QU<W1R
M871O<CI#<F5A=&]R4W5B5&]O;#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 0("7P,!$0 "$0$#
M$0'_Q  ?  $  @,  @,!            !@<$!0@" P$)"@O_Q !>$  !! (!
M 0 *# L$!P4&! <% @,$!@$'  @1$A,4%197E)?4"1<84U18E9;3U=;7&1HA
M4E56D9*8T=(*,3:3(C5U=Z2UMR0R=J6S(R4S-$%1)G.!L2=#865Q<K+_Q  =
M 0$  P$! 0$! 0           0(#! 4(!@<)_\0 6Q$  0," 00*"PL*! 4$
M @,! 0 " P01!1(3(3$&%$%15&&1E-'2%1=3559QDI.AT]0'(C(S4F*!E;'A
M\!88(R1"8W.RP=5R@J2T"'26I?$E-$-$-:)D=<+B_]H # ,!  (1 Q$ /P#]
MF_6%1=V;%#Z:K&D[9;J))F[@<8V+<JD6ECGJQKLCJ+;(;)XE!@VNGS+%#$;
M)T E'!PBCDEPG$@$%Q'!P\BXU[N!5&'TLE?-B$,%0UM"#2T\[ X353:VBDS3
M'.AG;$Z2F94L,CF!H8YS<K*<P'S,3AJYVTL=))+"35'/RQN+<W :6I9EN EB
M,@;,Z%P8'$EP:ZUFDCAJR:X]D@&VW>K%'LNPB <D.WJ&U18RE[K+SY D]6=
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M9*=2C"Y$J0XM^0\I;KJU.+4K/YMSLISG$-!<XN(:T-:+F]FM  :T7T-   T
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M!KIGU1=#15,E2Z%D<PCB;.733L&4&E\#F2$RQ.#Y/?$$^K1RR2.E:[;1;&V
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MD15NMI6N,_F.Z_'R\PI66G<L/O,Y6E66G7$=JO/XUP <0"' $@.%[. -@1<
MV.L7 -M8!7Z,&X!(() )!M<7&HV)%QJ-B1O%?4_XHO\ E(W[_$GU ?>5S]'G
M!W"CYC1>H7@YC]_6\_K/7IXHO^4C?O\ $GU ?>5QG!W"CYC1>H3,?OZWG]9Z
M]/%%_P I&_?XD^H#[RN,X.X4?,:+U"9C]_6\_K/7IXHO^4C?O\2?4!]Y7&<'
M<*/F-%ZA,Q^_K>?UGKT\47_*1OW^)/J ^\KC.#N%'S&B]0F8_?UO/ZSUZ>*+
M_E(W[_$GU ?>5QG!W"CYC1>H3,?OZWG]9Z]/%%_RD;]_B3Z@/O*XS@[A1\QH
MO4)F/W];S^L]>GBB_P"4C?O\2?4!]Y7&<'<*/F-%ZA,Q^_K>?UGKT\47_*1O
MW^)/J ^\KC.#N%'S&B]0F8_?UO/ZSUZ>*+_E(W[_ !)]0'WE<9P=PH^8T7J$
MS'[^MY_6>O3Q1?\ *1OW^)/J ^\KC.#N%'S&B]0F8_?UO/ZSUZ>*+_E(W[_$
MGU ?>5QG!W"CYC1>H3,?OZWG]9Z]/%%_RD;]_B3Z@/O*XS@[A1\QHO4)F/W]
M;S^L]>GBB_Y2-^_Q)]0'WE<9P=PH^8T7J$S'[^MY_6>O3Q1?\I&_?XD^H#[R
MN,X.X4?,:+U"9C]_6\_K/7IXHO\ E(W[_$GU ?>5QG!W"CYC1>H3,?OZWG]9
MZ]/%%_RD;]_B3Z@/O*XS@[A1\QHO4)F/W];S^L]>GBB_Y2-^_P 2?4!]Y7&<
M'<*/F-%ZA,Q^_K>?UGKT\47_ "D;]_B3Z@/O*XS@[A1\QHO4)F/W];S^L]>G
MBB_Y2-^_Q)]0'WE<9P=PH^8T7J$S'[^MY_6>O3Q1?\I&_?XD^H#[RN,X.X4?
M,:+U"9C]_6\_K/7IXHO^4C?O\2?4!]Y7&<'<*/F-%ZA,Q^_K>?UGKT\47_*1
MOW^)/J ^\KC.#N%'S&B]0F8_?UO/ZSUZ>*+_ )2-^_Q)]0'WE<9P=PH^8T7J
M$S'[^MY_6>O3Q1?\I&_?XD^H#[RN,X.X4?,:+U"9C]_6\_K/7IXHO^4C?O\
M$GU ?>5QG!W"CYC1>H3,?OZWG]9Z]/%%_P I&_?XD^H#[RN,X.X4?,:+U"9C
M]_6\_K/7IXHO^4C?O\2?4!]Y7&<'<*/F-%ZA,Q^_K>?UGKT\47_*1OW^)/J
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M^MY_6>O3Q1?\I&_?XD^H#[RN,X.X4?,:+U"9C]_6\_K/7IXHO^4C?O\ $GU
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MA"H[.4$61FOT+(>17LTP7D!+CP(<L'FC.9#RH@J-&A"XL@9D+WD]'&PX4.)
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M51%*BK>K4E$RN/+CY"994[7Y;;<H(YE&5BI+:'X&6'4)5@BR!8:D TX0%J4
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MS>\("WSK<M)93L""]WYAZ'&6TO8WW=_^J?I-\FVJ[K[]MW<OXE,!3(,&+&A
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MD?'CJ99BLH2S,O<I/(=T)GHNZQ^6WI7E====-6Q";)FXLT<R4:#O ')N;;F
MZ0$.QS45,(UX,.0D'D1&++94#'#29[PG-EL:Q;L-P^75,9F7N4GD.Z$ST7=8
M_+;TZ/H6HGZ<Z4RD7,$B+H4R&L=?!,F+(MSKD<B,V88GV*Z0"S.3_<S$4K8B
MA*Q1V2B9B MAG2S@' PJ^Y+4S,O<I/(=T)GHNZQ^6WIX@DO3G2F1FX($A="*
M3%QB$,@^4M[I-1^(8K=>J1V+:TSC\A%OCV,'4:@Q9F;0DNW99M0J9DZD@9K(
M,A 9F7N4GD.Z$ST7=8_+;TK(>U1TPR:R'J$MNIS@ &U2[N+C$+^2(2V;7.C3
M(DPV\8FV=\S.F2FYTIQ_O\A):<EK1/4WF<PQ(;9F7N4GD.Z$ST7=8]/SV]*^
M(.I>E@=+A3X8O7S4P>N.J+)5:$ONI8CJ$N)'/*?-N]]!GGP%>ES04ONX8C.K
MU>GSX,F:"$OPV9E[E)Y#NA,]%W6/RV]*E!"M:%)DK:5DSZLW+OK6$71,"[/"
MH5GD) QJIX5,C!9Z&,G'U56% JSED>B*/N5D<-K[A)0<?"A,,S+W*3R'="9Z
M+NL?EMZ5H#FL.F*RF+*>/0Z&4*V]TQ(L<B5:\J03E'JY3:F5FN1$G$PV)\@!
MKRBPFY\6.Q,AN5,#.A/QR(V-+0S,O<I/(=T)GHNZQ^6WCX^,JP77]2OV@#='
MS]6?M-8KE@J0,T];&'9<&NVJ;625C&8[H54U):,SZ959DYV6W(DO2 0]W+V%
ML]G+,R]RD\AW0F>B[K'Y;>GC4G\>:3^N%6^< GUOC,R]RD\AW0F>B[K'Y;>E
M/'FD_KA5OG )];XS,O<I/(=T)GHNZQ^6WI3QYI/ZX5;YP"?6^,S+W*3R'="9
MZ+NL?EMZ4\>:3^N%6^< GUOC,R]RD\AW0F>B[K'Y;>E/'FD_KA5OG )];XS,
MO<I/(=T)GHNZQ^6WI3QYI/ZX5;YP"?6^,S+W*3R'="9Z+NL?EMZ5"[W=Z8L*
MUA%NK"L^$&,]A)\4K/8[C)_+V,2\Y['+LAEN?T4FKY#M\<2YZF6+-_&1_"'[
M;>/C7*=OIF@;\LLY<H]%L3IL:6#SWR1R*[(\%'Z^[5#T"#(P22\*BG:V\Z%-
MM"EPDEAZ\L$,24]CL;9J;5FI-1'Q;M1U_LKB$[6VM*P6T_";K!N#KW#I&\O!
M5)Z?U&XME6Q2%V.&5'F6+ NP,+.=^BCENLHQ+Q=13)"5 @'[[<RL01*D/"6)
MED*N-PD]\JQB,U+W*3S;NC\:=\IGVVMG&6((ME-MIM?1OZ!IUZ K0\<JA^M5
M;^7!?K7&9E[E)Y#NA5SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4W
MI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$
MSD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F
M7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5O
MY<%^M<9F7N4GD.Z$SD?=&>4WI7X.*S[#%UI6BMUZS"V=+^#+$#$G1W?6YJ?%
ME=X%X$<A$[YC.2,.1W^]Y#?=F',86RYVS:_]).>?:.&^[1L(I<.P^FEFQ42T
M]%202@854N DB@CC> X:" YIL1H(TKY9Q#W*]EE17UL\<>'&.:KJ9HR<1A!+
M))GO:2-PY+A<;AT+>?@1>N'WG2'IMIGK'.WMW[!.[8M]4U*Y.U+LO[EAOUE!
MT)^!%ZX?>=(>FVF>L<=N_8)W;%OJFI3M2[+^Y8;]90="?@1>N'WG2'IMIGK'
M';OV"=VQ;ZIJ4[4NR_N6&_64'0GX$7KA]YTAZ;:9ZQQV[]@G=L6^J:E.U+LO
M[EAOUE!T)^!%ZX?>=(>FVF>L<=N_8)W;%OJFI3M2[+^Y8;]90="D=/\ 8,NL
M S:0 NV6#1]-K$XK#CG[5[:U;L"P(A;R>_R3 ,;(Q-+RH\;#BH@UIV,F9*[B
MP]-@L+=F,<]7[NFPN&FGEI6XM65+(GN@I>QTT GE .;C=/)[R%KG6#Y"'9#;
MN#)' ,=O3>Y%LIEJ(8ZEV&TU.^1K9J@5L<QAB)]^]L3+.D<UMRU@+<IU@7-!
M+A^O;I4T-TY]'>H@FG]/SZU!%0<)FV"P3305VRW>RNLM-$;3:2#3S>9I.;EI
M*&F4);@BH+<84*C1!L.-';^3-E.R3&]E^+38OB[I'RONRGIV,D%-14P<3'2T
ML9OD1LN2YQ)DED+I97/D>YQ^CMC^!X3L:PZ+#<-:QD;/?33/<PSU4Y #YZAX
MME/=:P  9&T-CC:UC0%TEXY5#]:JW\N"_6N?G,S+W*3R'="]S.1]T9Y3>E/'
M*H?K56_EP7ZUQF9>Y2>0[H3.1]T9Y3>E/'*H?K56_EP7ZUQF9>Y2>0[H3.1]
MT9Y3>E5O>;?4U6?3:DVBNJPWL@HMS*38W.$(SJ':K>%+SB3G"4Y6M",*5V,9
M6M*>SV58QGHABES=7^CDTT[;>\=PJF.]O+&62/+I_P!(SXYW[3>#S\:LCQRJ
M'ZU5OY<%^M<Y\S+W*3R'="VSD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?
M=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4
MGD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%
M^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ
M'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&
M>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD
M.Z$SD?=&>4WI5;T:WU--GW(I5HKJ<.;(%K;RHV-QA:,:AU4WE2,YDXPI.%H6
MC*D]G&%H4GL]E.<8Z)HI<W2?HY-%.Z_O'<*J3O;RQBDCRZC](SXYO[3>#P<:
MLCQRJ'ZU5OY<%^M<Y\S+W*3R'="VSD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.
MZ$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<
M9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU
M5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4W
MI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$
MSD?=&>4WI3QRJ'ZU5OY<%^M<9F7N4GD.Z$SD?=&>4WI46O-QJ*J3<$IM-<4I
M56L&$IP<&9SG.1,O&,8QB5V<YSG\F,8_+G/-8(I1-#>.3XV/]AWRQQ+.62/-
M2^_9\6_]IOR3QK+JMQJ.*O6\9M5<QG $/C.,G!F,XS@?'QG&<9E=G&<9_)G&
M?[N5DBESC_T4GPW?L.^4>)3')'FV>_9\!O[3=X<:\SLW6%G9'Q[$1I)I@29%
M6(8T2(A9:!YX'+1.$%X>'GU=[D!TMM+T64UVKK2NVPE7:K6E5,U,/_BD\AW1
MZ5H)6#5(P:"-#VZCKW5#)]'Z="M4 48D"U3.IU5J,^@UNM2DUQX,#I12N(J)
M&K"X"W,L0@<VL-M I(]A"([HQMN*I&6VT8PS4O<I/-NZ-7%J4Y]H).=;<FY.
M6VY-[W)OKOI5G>.50_6JM_+@OUKC,R]RD\AW0JYR/NC/*;TIXY5#]:JW\N#/
M6N6;%+E#]')N_L.WCQ*S98\H?I&;O[;=X\:^N/=+73IHBA/;&NNHJ2]7H]IU
M[4'O!%"HBY3139NP*SK2M.O*,>!A\<=BSVX.DI.D3V6APY<D@[A3,5SL>NZL
MJ&#*-1/:[1\<_6YP:-;@+7(OO!8LH*1YR6TE->SG?$1:FM+C^P=-@;#=.A::
MIV+I&M6K-=[A=IVK:E3-I('XIS]WI%/K<TE+)LSI46"TQ)AK8E/.0AA$HU*&
MRIXN4"A2+'!(2J\G!105DY:';9G =:UYI!<G<^%]FYIU:4-!2ASF[3IR6WN!
M3QFP&LZ&7W1XB;'3H4",[GZ*A=\JVOA]&U];2=MF5" /*T^B4$[7XTN[VROU
M$"T2(-+:=C=\R;76C:'&XC[4NJG15C&+GC9T9URIKYPX-VS.22!<3/(N38 ^
M_P",'Q:=U2,.IB"=J4PM?7!&"; N-O>:; $>.XU@VU]MWAT?4FRWBG'M."F+
M10]E:2UF0"MZJHRY9>9U!VUBB:UM@!2WVX\VCS[ADE721V2]!=%E0!J)(@=V
MCQTRQKIP2TU%1<.8VV=?IRS9I'O]5]!.X05(PZE< 12TMBV1U\Q'HS8RG@^\
MU@6-MT$;ZEELV;T2U15;9P%TW9Y]INP"B#A50K&OS91HI8B=9%0R$V&E+#D<
M"PY=*E,DE4]U:4)L@0K"1,@$HK[LFNF%AMJ8DD- $SR;D@?*U:1IWB#NJ!A]
M,;G:=. &EQ)IXQH%]]FO0='$=XKP#[3Z'#(.J&6A^DV9-O9U8J#7FJU0CM@@
MRMQQQTFC02,>J,V&!AR<T3C.22$ B0!Q8^>_\EG!KL:8^%=,0#MJ;WV389Y]
M[O\ @C0XBYON$CC0X?3 D;3I_>Y5SM>,#WOPCI8#HXP#N6NLR3L+HLQ8=85<
M("TY<"^VK.Q5ZNQ3ZO0CN&'I=?N]C@&#6&&D.CZ^3AZ]L[ DFEJ0DM*@KR.:
ME0V)TR&V[/=H%5,<HV%IGG<)N??:CDD [IXKD1V/IK..TJ<!HN;T\8W6BVEF
MD^^'_FP,AP;Z0D6G8U-FUK4@D[JHIK8/<F3%&K0V-"G;?EMBM<(B390EN*11
M;+$MVI"EPG'</VZ)-K:?_>T9R+B=NSW<W;,X+2T&\L@^'H;^U8W.@6W=";0I
M;-.TZ8AV5:T$1^!<NU,T9(%S?4-.I:<+?^ABPOK:$/: EM=^4J!%(XKE09$%
MI6Q*B(OE,0"+OBVAIUH[4+ !/198B3,AXA&1O=9#;TI#7 K9C:U5-IL!^F>
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M4WF(NHGM,:>\E&M?F+5_JOC;53PB?STG63:5'P2F\Q%U$]IC3WDHUK\Q:O\
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MUAEC\9QDGV%Y94 %=G*\*R[B.K#N5X>>[HS,?R?_ -G;FH:]0WOO3.O^5_\
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MVC]U/\N+G?/*43N;?O:/W4_RXN=\\I1.YM^]H_=3_+BYWSRE$[FW[VC]U/\
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M!#^HZO 4UE;CCL5XL]W1$V8U)C$N?QXK?85*@'1S0ZY06*0/M-US*%V[4-U
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M")X*9^%$_E2=]/PBAEZ&M(#-*Q((*_[>QCL+(S%I_P#@R?\ Z*>SCL_D_O\
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M;3E$AY"EXSJ/5KW;.J0O"GG,*=4C#CF5+PTEIK"NYM-I3O,;1TO' XZ0#_\
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M$[V<^&R_^&]6XN>+D'0F5\UO(G>SGPV7_P -ZMQ<\7(.A,KYK>1.]G/ALO\
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M(U[\5>\>E.L_=_Q^;KB7A92_54WMJ=O.B\'*CGT7LR?C)&O?BKWCTIUG[O\
MC\W7$O"RE^JIO;4[>=%X.5'/HO9D_&2->_%7O'I3K/W?\?FZXEX64OU5-[:G
M;SHO!RHY]%[,GXR1KWXJ]X]*=9^[_C\W7$O"RE^JIO;4[>=%X.5'/HO9D_&2
M->_%7O'I3K/W?\?FZXEX64OU5-[:G;SHO!RHY]%[,HX<_M%= +DZ<03TN7)O
M%7LDHZM#NSZ\XX^F14;56<-1E-T5I#+^%V)#ZG'T26LQF9#.&4ONLR(^C/\
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MRWI9RML+Y.!H%J!C+#FE%+)8HU1)PY07*JMFM5&4*CQJ_*)'27TZ=X"PT7
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MU@;/Q!;%-3VQO;%'&?">-S@E<8(:<S4V;@QROQAI9+50RR"MQ'$:X0F6(-?
MZ%M<(<XPO,I89+1@YHY#&*(32SB*H$D^#T>%ORHZ:6.,TE#0T9E$4A+)A*:,
MRY#\@1AP9^D(RQXU_J)I@6N+I2JB7<KL/8=4W"!(L/Q8UA'[,KUY(3)9)W#<
MM(7 <KK(O*I<T>*'B7)9@54+#(>RQ661,N9\!JYJC;FVHA4/H*G"IHW-<Z!^
M'ST3&-C;=AF,L6(Q-K&/EDE#8I:J!HRJ@RM0XU2Q0&E--*8&UM/B<,C<EL[*
MZ&K<Y[R \19J2@D=2N9&R,NECIYB<F 1NU6ZNH^'MZCHK::LY7BLK82-EV&7
M&F-.CK'=C5/ABMB7.5$0TPF";O-L:D'G(,1KO ,(2)KT9Z2R(9DN:X1@#\+K
M34&I$\;: X= QS")*>CAJWRT%(UY)RX:.F(A#W6?+*99W!IE+1CBF-MQ*D$&
MUS#*ZMV],YK@63U4M,&5M4X -R9:JIRI2P LBBS<+7$1 GE/GZ5?GTX1.$3A
M$X1.$3A$X1.$3A$X1.$5\=-O3;MGJNVS7=-Z;KKAVTG7.[2Y;W=6 57!,.M(
M)VJU$T-/($U\2AYM4J4IMV1)D.Q1@R+/+SQX^5X>R/9'A6Q;"JC&,8J!!2P"
MS&"SIZJ=P)BI:6(D&6HE((:T$-:T.DE='$R21OKX'@>([(<1APS#(3+/*;N<
M;B&GA! DJ*B0 B.&,$93K%SG%L<;7R/8QW]$[I7T?/Z;^G_6.DRFP[-M*=K^
MN1PLBYVM[#I$@M*W'\Q(+><N/0:Z([MX*JXJ3+(21%>AC1CI"9F)AY7^?6RC
M&X]D>/8EC46'TV%LKZATS:.E%HV @#+D.@25$UL[4RM9&V6=\D@C9E67VCL?
MPI^"8/085)6SX@^C@;$ZJJ#=[R"3DM&DLACOFZ>-SGNCA;'&7O+<H]!<\!>P
MG")PB<(G"*M:+_BC<_\ O*%?]'M4<Z)OBZ3_ )=W^[JEC%\.H_C-_P!O K*Y
MSK9.$3A$X1.$3A$X1.$3A$X116]?X(N7_A6P_P#*)G-8/CX?XL?\[5G-\5+_
M  W_ ,I675/\+5K_ & '_P"71N5D^,D_QN_F*F/XN/\ P-_E"IKJ*Z?0_4-6
MP%:+FYX",-,D\&'Q>%M3#]&M]1LFOMBT=V;'?BS(,.TU"UDD,S8CZ7A=@@5X
M\RVY+#1>UIHW=6]O[A!XB"=6HV.XMF/+"=%[CD<#=I^@CDN%3=[Z/;#=:YK!
M?MP3A&S*)59Z3][A5N,B'>-GHME5VU5;\6K39%IC VI;NJJ+J-I[TZ6-6"/6
M:GNR,Q#,F8H=(U[EM7&#?E -AHTG4#97$H!?[WWKCH;?4VQ:1??+#:^^ 5VL
M&$P@ <2"&MJ:'!1L$2/:6XMU;4(=%:AQ&UNN9RMU2&&6TJ<7G*UYQE2LYSG.
M>%B3<D[YNMERS/A#Z?L*LSX0^G["KT*2882,F8:MZA$1;[,5$HI(KL",J3(5
MVD>.E^6-::4^^O\ T&6L*RXZK_10E6?R<Y5ZRU\RP5T=+(P"&PH$&<''Y+EH
M<PK5(LL6*PT[(R3(QWX2'H0_###SV9LE#4;#3+KF7>T;6K!%E)(BU*F(3=6U
M+'0(Y4@E,VM95!%S&WG8A*8G _LQH$IJ.^Y'F/X1'?;8>6TXI+2\I(MOWA*_
M31/_ "@WU3PB=X2OTT3_ ,H-]4\(G>$K]-$_\H-]4\(G>$K]-$_\H-]4\(G>
M$K]-$_\ *#?5/"+!FNQQJHJ2-K=@*FOYC0DS7J]%5+DX:<?S'BX?&MYD/X9:
M=>RTUV[F&FW'.U[1"LX(O5"F0"49V:.N/?\ #8<RT]+A2JY*C,NIPG*FW7V!
MSC3;F,*3G*%KPK&%)[./RX[)%ELHQ(>E1X]DEOOP74,36&<@G7H;SK#4EIF4
MV@6I<=UR,\S(0V\E"UL.M.IQEMQ*LD7HB/19[TB/!MCDV1$RK$MB(_7I+T7*
M)<T>O$AID:M;.4SQQ"$K#B4]K+@38V>P]%?0V19_>$K]-$_\H-]4\(L=]OO5
M<5N39)<=R=([TA-OY!-+F2NX/RN]HJ'!:52)'>T:3([BUA;G<([[W:]S:<4D
MBQYLB(-<8:(VY<!V5_\ *MS9%=BN2>Q)APL]P0^-;4]_VPA B?\ L\*_[3.A
ML?\ Q9+*%D65(87$8?E2K#-C18S+DB3)D8!LL1V&4*<>??><%);:9:;2I;CC
MBDH0A*E*5A.,YX1>F-EJ9'8EQ+0_*B2F528TJ,X ?CR(Z<)RJ0P\T,4VZRG"
MDY4ZVI3>,*3V5?EQPBQ6B QX<X89NB'1#/;]V*-3*TX.:[FK"%]TG('YC-]H
MI24K[9W':J5C&>QG.,<(LD>XP6C)F"K4\3AJ4M"90]VOS8REMY[5Q"7XPQQK
M*D9_(M.%YRG/Y,XQGA%F]X2OTT3_ ,H-]4\(G>$K]-$_\H-]4\(G>$K]-$_\
MH-]4\(G>$K]-$_\ *#?5/")WA*_31/\ R@WU3PB=X2OTT3_R@WU3PBAEZA24
M!FLJ+$'<=_L8[5;0K&.SW&3^7_V8QM79Q_=_WNQ^7/9QV>QG%V:SXOZA<]3\
M7_F']52[C\9F9&'.G<-$)C3[T. X\*1,E,Q>T[Y=C151</OM1^Z-]W<:0I+7
M;H[IE/;)[.JX./)%M_WW2O8PIN2J0B,8<D+AOYBRT,+&NJBRL--/YC2$MQ%9
M8?PP^P]EEW"7,-/-.93VCB,J)?YH]/2CN4,+C-/EW&7)C^8T-MU0UM<N2F._
M+5'C(7$2I]],2+*DY::PMS$>,^]E/<V7%))?YH]/2O1-EPQO<LD; B!A[NO<
M<S9 F+W7N+>77NY=WC-]T[DUC+CO:]GN;>,K7V$X[/":]30?*Z5G=[/?#Y?[
MD'U+A+C>'IZ5Z(^42T*=BEW)+:'Y,9;D=0UY"),.0[$F1U+;B*2E^++8>C26
MLYPXQ(9=9=2EQM:<$O\ -'IZ5[^]GOA\O]R#ZEPEQO#T]*=[/?#Y?[D'U+A+
MC>'IZ4[V>^'R_P!R#ZEPEQO#T]*=[/?#Y?[D'U+A+C>'IZ5^777WL[71I5J%
M2*P0Z8ME/SZY4*T!G/0JWJ%V$],$!H0^2[$=(EW2#D5QZ.M<=R>ZY,6UE"I3
MBW\K5GZ(H_<.V8U5)2U4>RF@9'4TT$\;#48H"QDT39&L(;"6@M:X V-KC1H7
M\5J_=<V+T]54T[]CU8]\%1-"]XAH+/=%(YCG"\X-G%I(N =.G2I?^'XZ*/BO
M;4^;&E?K3G1VAMFGA7A_.,6]0N?MQ;%?!RM\QA_M"?A^.BCXKVU/FQI7ZTX[
M0VS3PKP_G&+>H3MQ;%?!RM\QA_M"?A^.BCXKVU/FQI7ZTX[0VS3PKP_G&+>H
M3MQ;%?!RM\QA_M"?A^.BCXKVU/FQI7ZTX[0VS3PKP_G&+>H3MQ;%?!RM\QA_
MM"?A^.BCXKVU/FQI7ZTX[0VS3PKP_G&+>H3MQ;%?!RM\QA_M"W=:]GGZ%"]@
M"BC?3[LJJB"1.%!)6:=2M3$H("'*D(9?,3H B9++2X0Y"\RI; R',(KCM.8A
M0Y<GN4=W&I]PK9S#3S2P;)*&JFCB>^.F968E&^=[6ES8622Q-B8^0C)8Z5[(
MPXC+>QMW#6#W7]B,LT4<N!5=/&^1K'SOIJ*1D+7$ R/9',Z1S&7RG"-KGY(.
M2USK-/WXU6NZBO%;!W&G0J-9JK9A<,W7["$!U B),"2#"),(@/G1A#C$F-)9
M6EQMQM><9QGL9["L9QC^$54^,453/1UD^(TU532OAJ*>>:HCEAEC<6OCD8YX
M<US2"""/0OZ]3QX95P15--!0ST\\;989HHXGQRQO%VO8]H(<T@W!!6_]K2C?
MJM6OFM5_J7F'9'$.'5G.9^NMMIT? Z7S$?0GM:4;]5JU\UJO]2\=D<0X=6<Y
MGZZ;3H^!TOF(^A/:THWZK5KYK5?ZEX[(XAPZLYS/UTVG1\#I?,1]"KRZZ[I#
M-DU$WBIUE6)6PR;"LYK-=1E&$ZGV?)[9*6A3;;N<JCI1VDE$AC"5J<2RF2W'
M?9WAQ"O,=5^O5FB!I_\ <S<*IANOT:]RQW+V)!QEI*/+I_U.ETS._P#@9W"<
M[WVWY58?M:4;]5JU\UJO]2\P[(XAPZLYS/UUMM.CX'2^8CZ$]K2C?JM6OFM5
M_J7CLCB'#JSG,_73:='P.E\Q'T)[6E&_5:M?-:K_ %+QV1Q#AU9SF?KIM.CX
M'2^8CZ$]K2C?JM6OFM5_J7CLCB'#JSG,_73:='P.E\Q'T+:BJB"!..NA!P\,
MZ^A+;[HH."'N/-I5VR6W5Q!;*G$)5_I)2O*DX5^7&.S^7F4M34S@">HGF#3=
MHEEDD#2=!(#W. )&BX6D<,$))B@AB)%B8XPPD#4"6VN!QK=][/?#Y?[D'U+F
M"UN-X>GI3O9[X?+_ '(/J7"7&\/3TIWL]\/E_N0?4N$N-X>GI3O9[X?+_<@^
MI<)<;P]/2G>SWP^7^Y!]2X2XWAZ>E.]GOA\O]R#ZEPEQO#T]*KFD,N+LVX4I
ME/MY;V,,0M:$QLJD*SJ/5KF'GL.1W$)<2AQ#&,,(8:[DPTI367\O//=$WQ=)
MI_\ KNWM'ZU4Z!H^G3<W)TVL!C$1EU'O1\<WY6G]!!\[[%8W>SWP^7^Y!]2Y
MSK:XWAZ>E.]GOA\O]R#ZEPEQO#T]*=[/?#Y?[D'U+A+C>'IZ4[V>^'R_W(/J
M7"7&\/3TIWL]\/E_N0?4N$N-X>GI3O9[X?+_ '(/J7"7&\/3TIWL]\/E_N0?
M4N$N-X>GI3O9[X?+_<@^I<)<;P]/2G>SWP^7^Y!]2X2XWAZ>E.]GOA\O]R#Z
MEPEQO#T]*B]W8=12[>I4R2XE-7/JRVM,3"',8$R\Y0O+<5MS"5XQVJLMN(7C
M&<]JM*NQG&L'QT.FWZ6/2+7'OQI%P1R@CB6<I&:E]Z#^C?H]]\D[SKK+JS#J
MJS758FR484"$9PA*(>4HQD?'SA*<KB+7E*<?DQE:U*[&,=LI6>SG-9/C'_XW
M?S%3&1FV>] ]XW1[[>&^ZZS)\\>+RC!.QLCLNH==;Q/E!X>7&V<MI><1WQ';
M[=#2GFL.K3V4MY=;PO.,K3V:V.\5IKU-OY72O1X9"XDYA9MD+$S$AN'F)X0!
M]\XEO.+99BY8[CW7OAUYMQIMCM.ZK<;6A*<J2K&%CO'D^G[-*:=>3HUW]]JW
M]:V,;*)C#<F(7<E1GD]LU(C*&OL.I[.<=LVZU$4VM/9QG'92K..SC..SV<9Y
M"B_S1_\ MTKW][/?#Y?[D'U+EF_"'T_859I]\- W=_>/&M#UH=-]DZF-=@*M
M3[9(H-NJUA+VRI7J >E"9U4LLG7]UI$.<^%>KEPJ.PZP2'W(M6[UK78-7+U*
MX4PX;@NX'ED"B</E7K V._OC5?=UC2/H5/ .D39E0U/U!:Z=CZ+W+8=D[<WI
MN:E; W )G3%XL6["\TC%&W6HOU&V0<1=9BS;]*K$Z$8-L3Z#3*;55@0T1;KH
M@A-R.( 'Z-&C3NC6+ZR5S>6]B86JB[%%U*S JH4N'2V#T.'HCQNQ6?6=?M*Z
MITL4PW;8Y8V!<NK@JM5;I#U.!H@XDLS+8E-V^U9?!S[K-%CG]58.TW.D7)X]
MVW%K-U]V*>VRE.5X2E>4X[9*596G"NQ_I82K*494G&>SC"LH3G./RY2G.>Q@
MJ+YX1.$3A$X1<[6;4ATGNPCL54>I7*HVG48351:IW5^:VW3_  +<+)9R%@JD
M-H&<@F/'YFR#(5W$3'JWF5G66OW6RTCO=6!Y3N6X_P 7\6YXRN61G19?$ 8K
M$N9K<05#ZL.:Y3"!RS4@7?9IS>]1V^*L]Y(O5,;(;DZQB50@-UU$:#FWH!#8
MM^E8)#VB*<.E-P#<;]][1IT?3?3XMU6NCICV16K!O2V:MW-+I)K9(0N,J#1D
M*+NT2M$B=HW5LI9J3(<'5Z:N.G9&Z9DX4#FYL3E8 5QL.-/R8!U8T*47U7W-
M>YO#[ -Y5;6NE7J-#RY.1^T!M!&E+=:KG(A5G9>R[*L67L!OJTN4/+\HD!K,
MN\1(%WW/IHP6&6&2/'6V)JZ<*.1G!4E@=,)<;G*0-X=!Y=]2:-H+J;(1(T6Q
M;'9RVP:U;;H:&]V;,).AI58WA7MBWO7SLR)0JCBW5JPUT&_ KEX-085E"CRL
MC6A"OE:HRD\Z2_XM^/1X]>E8U)Z=>I=JYZ4L.T=DA+N.UY9 =O-195^MT]V#
M;!U&VU0K:<K,7-#"1#0_9#%^KEBCU2T.-LZEDUHC7ZN=LD ZHE#)<:=%M[=W
M=V^]Q:_MU!KI:ZAK?<)U@N=WI1Z#%V0;L]4B3[1;B:Z_59NR="7*%7QJ"%/<
M<$L8BZ=(3%B&"$T8-.V%# U_P?'4_@@(WOQ8C[3?BMNJPF^G_>Q35T:NWG:(
MJZW 3L[16Q41RLXVY4;8YJ5R@3K:/+2GA3Y2L#-H62J%[C'KPT8? ZZL),>D
M=&LPJ%*@3B:/HM]-^73;Z+[RD5QT9L,UL'5^RZO)IM.(ZFMC1L+4!90@Q53H
M[9)>T,=0[%FDQ*;&GS9EDK]C@V*M?]G5&E;/J86R%DC6))!IPE]'C_I:UOL\
M2CG2-TM6'I]IY^JW9VE7C)ZOZAR[.8S)[1LWK37U>HK5>=%NUD:&EU\3*J,&
MRU>X9',V]Y1YX/9(9*3415D-$)ORDVWKJ]^F_5C^D]":;U20; J.Z_U;KJEV
M4A6V5MBC=@IU* U0B:CN/P1TR4W/4$;6Q(GQ&9N8B8S+Z$Y92E)#I).^2KLX
M4)PB<(G")PB<(H3??]2-?[08_P#1D\NS6?%_4+GJ?BO\P_JOKDNO3S9[1=;H
M49LD%H1>-L]/&T4V%V84C76CP=&E:<2(:[JZ(</*':O=FJ>6B//MV("\)7MW
M9DI<$JW)[Q+Z_;>]]>C>\5QJU>^)XCQAX  M\%LC;6!!+P1E'3K%QN'X+?HY
M_J72EU/4N"AH-MN#&R;'5J+L.'!V=?X<NWS@.D]$:DCGA]L)4JPRJK9():@7
MJ^+L$.O3R-H7/KM3LJG1[[Y2O/3>UR=9]Z&WOIL1I.HWT7TZ5H9(W:VG1?)]
MZW0"YSK$7&C2!:^C2?'>-HTEO&=JIBN5S:#\+8JKINVQR[62N]UD-LP+M0]R
MU'6D(5/<@S9HQNCS;=K,NH4.'P!<274")&!B45?S*)M.FQW^+00ZPUWW1N\>
ML!5:]@<26^]LP6R6G46EU[V^$ X:]T#5JK*P]-74D=-1I<G9("?&KMHV$9H1
M$E>[\\7JH*TR-IPP=9?CO5J8S8)(@%:*:P_:RL]PR[%&$:RIN2)@PYI4+C=.
M@DZ/$X <A&G7K\:D2, -FG2&@V:W21DDG7H!R3[VUM-[[V3<- ]6%KK[(%.V
MQ0MV57MI [28@[*V3&<LY*T:FL6O*U:6!<>LM1ZFA=GFUW9CU/K\MJ#0; (G
MQ*F>,1BJG6!OHMH.Z1H.HV(&YIL2!JM8% ^(&^0=8(&2W19P)&DW.B[;[H.H
M6"W)[1'5$0@66&$W-$KB2$79[M<3!MMPRZ$(VTOU&SZZB7/\!)D%61[6S-+.
M>$GFD$J](TNID0B?%L\O#;?T[CK: +$WMJUVN/%;0% ?&""67M:]P--LCZ/V
M7;FIVG4K>TUKC<]*MECFWS8+=KI\Q-E8K@678K)9282*[;G9M099(%( =#C8
M^FJCACCYU%JL9$U#\*,VEN'-ECUST[PU;FD:?&#?2=>A5>YA R6V(M<V !-M
M.C3NZ18@ :+:BNE>0LTX1.$7\K1O_P"&W_\ Z)__ .<<_P!+<%__  V$_P#]
M90?[6)?!^+?_ )7$_P#^PK?]S*O/GIKSTX1.$3A$X19HT:1,D8 </ FE2Q6;
M%&BQ8V*_.(DB,Y]$:% @0HR'9,N9+DNMQXL6.VX^^^XAII"UK2G-))(X8Y)9
M9&111,=)++(YK(XXV-+GR2/<0UC&-!<YSB&M:"20 2KQQR2R,BB8^261[8XX
MV-+WO>\AK6,:T%SG.<0&M ))( %U^]+V'KI$WMTD=-;@+>EY,2BEX)1[6&TV
M^]%FA=,19;3SLH9&G]H[*Q8K"[);(VL9!FXK@PBPAN!%<*NFRQ/X8]UW9;@>
MRS9&)L$HH6Q4,;J6;&&M<R;&7,+0R1S+ANUZ<-,=++(S;$L;B7N$0ABB^NO<
MVV.8ML<P/,XM5R.DJGMJ(L-):^+"VN!+HVOL79Z8N#ZAC79F-X 8TR&623[:
M>?RE?T-.$3A%6MZ_Q1IC_>45_P"CVU^=$/Q=7_R[?]W2K&7X=/\ QG?[>=65
MSG6R<(G")PB<(G")PB<(G")PB<(JUHO^*-S_ .\H5_T>U1SHF^+I/^7=_NZI
M8Q?#J/XS?]O K*YSK9.$3A$X1.$3A$X1.$3A$X116]?X(N7_ (5L/_*)G-8/
MCX?XL?\ .U9S?%2_PW_RE9=4_P +5K_8 ?\ Y=&Y63XR3_&[^8J8_BX_\#?Y
M0J'ZF^G:-U$UJO5]9U5:5 )FQIXA&8SF>7UM?:D=HFR*C$G-*1*%R2H0ZR="
M$HR\+%W2JU(UV,K%-J33H(\8((MXMWQ@'39;QOR"3:^@6U:' @@Z0?$=\$C=
M5+W[I$V%< ^L3L'9E=";?JM;=)7BSQZN^FN7C;8FZ -RT.PK%L36BD2GU+<0
MLXMBNY*+ER=<7BWU*20D9*OR')O]FD;^KCN!>Y W+E6$K07"QR"; 7%PPC(<
M+G1<MMIM\( KNBOA(-: A:Z,PXD<!%#PT##JDK=[T&1&8<?+RT(;2MW+3*,N
MK2VC"W,J5A*>SV,0L2;DG?-UM^69\(?3]A5F?"'T_85RYX_=3?EU%>B.J_6'
M/6S&'\#=SF3H6.7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZ
MR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[
MG,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=1
M7HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#
M6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF
M,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W
M4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0
MF7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJ
MOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UC
MZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&
M[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=
M17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'
M#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQ
MF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/
MW4WY=17HCJOUAQF,/X&[G,G0F7B'#6\UCZR>/W4WY=17HCJOUAQF,/X&[G,G
M0F7B'#6\UCZRUI6T]21B,F++WJ.PTEY+V.Y:FJJ%=NA*T8_+F<K\G8<5V<=C
M^_L<D0T U4;N<R="H_;TC<EU:+7OHI8QJ_S*.]OU >7>-Z*JIZWR<W0\$=SF
M3JK+,U?#?]-%TIV_4!Y=XWHJJGK?&;H>".YS)U4S-7PW_31=*=OU >7>-Z*J
MIZWQFZ'@CN<R=5,S5\-_TT72G;]0'EWC>BJJ>M\9NAX([G,G53,U?#?]-%TI
MV_4!Y=XWHJJGK?&;H>".YS)U4S-7PW_31=*=OU >7>-Z*JIZWQFZ'@CN<R=5
M,S5\-_TT72G;]0'EWC>BJJ>M\9NAX([G,G53,U?#?]-%TIV_4!Y=XWHJJGK?
M&;H>".YS)U4S-7PW_31=*=OU >7>-Z*JIZWQFZ'@CN<R=5,S5\-_TT72G;]0
M'EWC>BJJ>M\9NAX([G,G53,U?#?]-%TKG$!TAURN@@M?C0=&S8P,0-#QYA7I
M6TM/)RV!D-F$U)(SG1/=9L]]MA+LR6Y_[21(6X\O_27GGMMV0XJQK6,Q3'&,
M8T-8QN.XDUK&M%FM:T36:UH   T   +RW;',/>YSWTF%.<]Q<YSL&P\N<YQ)
M)),9))))))))TE;;W+@+]$=/W\)FD_JGD_E'B_?;'OK_ !/URK^36&\"PGZE
MP[U2>Y<!?HCI^_A,TG]4\?E'B_?;'OK_ !/UR?DUAO L)^I<.]4GN7 7Z(Z?
MOX3-)_5/'Y1XOWVQ[Z_Q/UR?DUAO L)^I<.]4GN7 7Z(Z?OX3-)_5/'Y1XOW
MVQ[Z_P 3]<GY-8;P+"?J7#O5)[EP%^B.G[^$S2?U3Q^4>+]]L>^O\3]<GY-8
M;P+"?J7#O5+; NGKQ7+C[!65Z4KI\3(3+%' 72[I\07&2T8SA$D>2'CX\V'(
M3A2L)>C/MN)PK.,*QC.>93XYB%3%)3U.(8S402M+)89\;Q"6*1AUMDCDD<Q[
M3NM<TCB6D6 4=/(R:"GPV&:,Y4<L6$4,<C'?*8]D;7-/&T@JXNWZ@/+O&]%5
M4];YY&;H>".YS)U5Z69J^&_Z:+I3M^H#R[QO155/6^,W0\$=SF3JIF:OAO\
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MZ'@CN<R=5,S5\-_TT72G;]0'EWC>BJJ>M\9NAX([G,G53,U?#?\ 31=*=OU
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M'_HZB."EIZ>HB:XBU1 Z)L8?)%:^:D.1*PN9=CRV1G[%=8;/H.YZ%6-GZPM
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MYJW=8^_7I5R^0WT6)+C<-TW> '&_&!;[+7*Z![_@_#8GG+/]?"SL=X\A3O\
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M-)L</7.+,6BAV<?B!#2]*>;@L3V&W1Y(;*EDM^/3_59=<NFJ;55Z-<1)&LI
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+J]W_ .S-O'YZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g55600g23i89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g55600g23i89.jpg
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M/*B-%Y':V^5D8RQCAQ-7W% A>Y+>2@)2.8CJS</I6<K=5'6:-$EI5Y+:7KJ
MGY'%XKN[T!VYE8Y;.V9&V_D>&9*[/+9Q,[\<]+Q2&2S4ZFX'<K2/%$I)%.0\
M :QMGUISN.DC@W BYJCR%>=5CKY*)?EU)(@2"STCDE)T620\<VD\DN2\:>46
MC^76KXK;NA+S'76HR*L"FI9]PD[69E#3;I=<ML"3[)&OSP276U.@G,H22,X/
M)1KQT48$>2I>XMMYG:N2EQ6<I24[4?Q(6X:"S"20EBK.O,<\#\'AT)*L&CD5
M)4>-66P>>Q6XZ$>2Q%M+5:3X6X^&6"4 %H+,)^.&9.1RCCR"'0O&R.T@.H+4
MQI);DX7$3_J5:@!MU;.*K%;NXX1L"-+Y3]L;4/J;7\M0QFTD9RPL62OYD>4M
MI65,NR$B2VXGRMQO#B[<66#[/-I\4";,N&W#).T(/<(;*7XKK'I^(-%161>?
MF(XU(/@'2N9UHIO7"LF2(]O'E,(D*R?@!&.IRTU'4>"KW'1B#X+NP(\D:=IZ
M3K31Z.C1KK,A!COF%#B#,$R#C3QY#+#33YSK##8K#ICR$)<)<9%99&:6\I:F
MV&FV49PVA*<=B[LJ*SLRQ@A%+$J@9BS! 3PH+$L0  6))\DG74*JEF55#.07
M8  N0 H+$#EB% 4$\\  #P-=GKKKMJI'N#=X[C'P'+?HDBD_<6]_I&BL:CI$
MB$(JO-E,)) ?V);"6C0*8T>.MM\6/:CYZT.BD!R&*WB),8D5:GL3TEW'OA%N
MQE,3A.LK]ZW(W?OE25<8^JK1O<,; J\AD@K!E>/W'=1HQG6\?4K!;08U'Z\E
MEN@,,=5=%[(8<H;M@AUJAU/4J!)IRI5^QVW5]46L>H3[E.U3#);0W#G6DO4A
MB',8: UAO3;!8B4*SGZ:1LE3N=:C7'&T^,.K;@X]658]V&VL9]F-H;T(]/,8
MB19O=F1BM,H\R9+"XM')_>CKVJ=B0 GY S2#Z<GYZR@>LF]\@S28C;5&2NK$
M<)0RV19>/W7FKVH$)'UXB3^P:D3QZ]2F4!=1:!SCXY$ZL6LE@65N^MF;(VJL
MN/J2C!$_JFY?5V=,6SA7U)A<3:9679';6D&N2KZD-9@,]]GI)*;7ME[@7)@*
M6BIY%JQ]R%\E8,I4Z*W=/'2B2UHHBQ'78B4$ZFL-ZWLEI:>ZL(V/)95DM4A.
M.P3XZIL?9ZIQ&/Q,T<\D@4'IAD/ U97W%>[=5N&&DM [SU+2*UR3IN_YB9&K
MDW%;%_3< F'B(<>2^Y"20-8M*CB'R"L!/@NL OQA AHIR4&M+'9SS8/I;9W?
MF,[A<I<L;>MX**%K$,N/]Q.9996C[;QO9K!%55ZU<,XD5T9.4(8WC>GJ)7VQ
MB\/E<=5@SE;,22K!+'=[$/:CC5^XLB06.LEFZ"A53&RLK\,"HM/U7=%[(UAK
MC8CL>B(=OM"I]T<BFR<FHC%VFO1TXN/08I@51: E'9&22H8?+^&L.Y8:ROXT
MYIDZ8Q^2R% 2&44;UNF)2O09!6GDA$A0,P4N$ZBO4W3SQU'CG5_H63=HTKA0
M1FW4K63&&ZA&9X4E*!N%Z@O7T]72.>.>!SQJHOBWW=CN1'<2WOP=E-)QM)AM
M12N[H*,V,S?7YLV;,TM>%50DZ3A'ZM#"10-A ',ETLLR9CD(\VR LF5;<6<W
MJ>Y?2M,#L'";SBS$ER;*Q8:>7'M16%(4S%+W2I',MF9Y7KNR1<F-!,"9 L1
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M]J-<GX)R4'%<&, /*>OT_P!P87>N/3=]2E#4S4U=,/F50DR12TV[ZUW/($T
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MKSA#3 X[3CSSBLX2AM"E*SC&,]+_ !QO+(D4:L\DCK'&BCEG=V"JJ@>2S,0
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M\5L=49@WL\="6]O 2"09&+//893TM9FF9.$*J'AV?MFMM+!5<3 5DE7F>]9
MX]U>E"]^7Y A%"K#"".5@BC#<N&8S6ZI^K1HZ-&CHT:.C1J%?.5"\:]UB7F6
MA*\+&[YUV?(V.S4TF_5J !:8L#3DI/54:0B5R<<TX\RQE*Y,)IHE\=YQ[.$8
M:<M^S#^OY%>U-.TF$R$<=>M;6C8G<F B*"TT<HCD(!/(C<E590//(K&Z_P#R
M5%NY%"J9:F[SSUFN00H!,#)-75XS(@) X,B ,5)/C@ZWUUBVUGMR[.!A 9#]
M04_5W)0"B2[-/.KZKPF&>V&Y3K[7M;30"R*Q#79:0I^K43Z J%BXDZ.B:W]R
MJN(4DJ0R'M;&_P#'/,Z=BUDMO/=B:VECV1E6@+=&QD87"V9J?QP6;W6DTDJ2
M2V.W9[RKXJ(L0;+O)&C]VO0S:59/;-#[H1FZ:UN&E(G,$5KX9J]7H,4<;I'
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MDY8_![&2DVQ!*LT\>2>.C$UE84,X=KD$$LYA:,Q=;1EY)%,7:'+? $\#:6I
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M.I#(,!V-RC?-$8)RC#+I(C,@ \4PVM3H[1PCCJ$()9RNLV'0[9Q48=3(N=W
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M4*0X,6ZVM*LM/B<WB,]56[ALE3R59@/TM.>.8(6'(255/7#(//5%,J2*00R
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#-?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
